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Background:  Survival rates for colorectal cancer are highest when cancer is diagnosed at an early 
stage but very few cancers are diagnosed before they progress to later stages.  A model which could 
predict who will develop colorectal cancer based on genetic information would allow targeted 
screening of high-risk individuals.  Genome-wide association studies (GWAS) have identified ~100 
genetic variants (SNPs) that are individually associated with the development of colorectal cancer, 
but models built using these SNPs do not identify all high-risk individuals (AUC of 0.629). 
Methods:  To improve the performance of polygenic risk score models, three methods were tested:  
first, the use of rare allele principal components; second, the identification of clusters of colorectal 
cancer patients with the same underlying genetic causes of cancer; third, the incorporation of 
interactions within gradient based tree models. 
Results:  Both rare and common allele principal components were found to identify population 
groups, but this did not improve the performance of models to predict the development of 
colorectal cancer.  Clusters which represented similar underlying genetic causes of colorectal cancer 
were unable to be identified, although models that predict the location of colorectal cancer 
performed significantly better than models built with linear discriminant analysis (p-value=0.022).  
The use of gradient boosted tree models significantly improved the performance of models to 
predict the development of colorectal cancer, compared with linear models for the same dataset 
(p−value=0.0258).  However, there was only weak evidence of interactions in the gradient boosted 
tree models.  When variables were selected with random forests or gradient boosted trees, some 
of the SNPs selected had missing genotypes that were highly favourable or unfavourable for 
colorectal cancer (odds ratios of 0.446 and 1.77). 
Conclusion:  The performance of models to identify individuals at high-risk for the development of 
colorectal cancer may be able to be improved through the use of gradient boosted tree models.  The 
treatment of missing genotypes warrants further study due to the strong odds ratios attached to 
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AUC - Area Under the Curve of a Receiver Operating Curve, also known as concordance score. 
A receiver operating curve is a graph of the trade-off between the specificity of a model (disease 
predictions that were true) against the sensitivity of a model (predictions of no disease that were 
true).  The area under the receiver operating curve is the space between the plotted line and the 
x−axis.  Concordance scores (AUC) measure the ability of a model to accurately predict cancer status 
on a scale between 0.5 and 1, where 0.5 is the performance of a random variable, above 0.75 is 
considered a useful level of discrimination and 1 is a perfect ability to predict whether someone will 
develop colorectal cancer.   
 
Figure 0.1: Examples of the differences between AUC statistics at values of 0.55 (a and c), 0.75 (b 
and d) and 0.95 (c and f) are shown on the graphs.  Graphs a, b, and c show the sensitivity versus 
specificity of the model estimates, where the AUC is the area under the model line.  Graphs d, e and 
f show distribution of cases (teal) and controls (pink) for the models shown in a, b and c. 
Decision Tree 
A diagram that shows splits of the samples being studied into groups based on a set of criteria that 
are successively applied.  These criteria are chosen to give the split that best splits the samples to 
predict the outcome.  The categories are mutually exclusive, i.e. each sample can only belong to one 
group at the end of a decision tree.  For example, a decision tree to determine whether someone 
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was employed could first split the samples by sex (male or female) and then split each sex by age 
(under 15, 15-65, over 65). 
EN - Elastic Net 
The Elastic Net method selects variables at the same time as it constructs a linear regression model.  
It differs from ordinary least squares regression (a.k.a. linear regression) as it applies an additional 
penalty term to the loss function that is minimised to find the best model. 
GBT - Gradient Boosted Trees Model 
Gradient boosted tree models are a set of decision trees (see above), where the final prediction of 
the model is the sum of the scores for the path taken for each decision tree.  Each tree added to the 
forest successively corrects the predictions made by the previous trees by selecting the best 
available variable out of the full set of variables (using the gradient descent algorithm).  This differs 
from a random forest, as each successive gradient boosted tree depends on the outcome of the 
previous trees, so the trees are not independent. 
Genetic Variant 
A variation in the genetic sequence of an individual, relative to a reference genome.  This is a generic 
term that includes single nucleotide polymorphisms (see below), short tandem repeats and 
variation in the number of copies of genes or chromosomal segments.  See Chapter 1.3 for more 
information. 
GWAS - Genome−Wide Association Study 
A study of the association between a disease/phenotype and genetic variation.  Typically, this 
involves fitting linear regression models for each genetic variant separately and testing the 
coefficient of the genetic variant in the model against a commonly accepted probability threshold 
for significance of 5x10-8. 
PRS - Polygenic Risk Score 
A score that measures the risk of developing a disease/phenotype with multiple genetic variants 
within a linear model.  The weights of the genetic variants in the PRS are determined in a genome-
wide association study. 
MAF - Minor Allele Frequency 
Single nucleotide polymorphisms (SNPs, see below) have two or more options for the nucleotide at 
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that point, which are referred to as alleles.  The minor allele frequency is the frequency of the 
nucleotide that occurs second most commonly within the dataset or population.  As each 
chromosome occurs twice, the total count of alleles is twice the number of samples and each sample 
can have either zero, one or two copies of the minor allele.   
RF - Random Forest 
Random forests models are a set of decision trees (see above), where the final prediction of the 
model is the sum of the scores for the path taken for each decision tree.  The decision made at each 
split of the decision tree (node) in random forests is the best option selected out of a randomly 
selected subset of variables.  This differs from gradient boosted trees, as in a random forest each 
tree is calculated independently of the other trees in the model.     
SNP - Single Nucleotide Polymorphism 
A single nucleotide polymorphism is an alteration in the sequence of nucleotides in DNA relative to 
a reference sequence.  These alterations include a change in nucleotide, e.g. Cytosine to Guanine, 
or insertions of short sequences into DNA, e.g. Cytosine to Cytosine + Guanine.  These changes can 
impact the structure of proteins, the binding of transcription factors or proteins to DNA, and the 
ability to regulate transcription. 
 
Figure 0.2:  Differences in nucleotides between the reference sequence and a sample are known as 
single nucleotide polymorphisms.  The picture on the right shows a SNP where a thymine (T) 




1.  Models Which Predict the Development of Colorectal Cancer 
Colorectal cancer is the second most common cause of death for cancer patients, both globally, and 
in New Zealand (Bray et al., 2018; Ministry of Health, 2019).  Survival rates for colorectal cancer are 
highest when it is diagnosed at an early stage.  Five-year survival rates in New Zealand are ~80% 
when the cancer is localised in the colon or rectum (i.e. stage one), but ~6% when the cancer has 
metastasized to distant locations (i.e. stage four).  However, only 9% of cases in New Zealand are 
diagnosed at stage one (Sharples et al., 2018).  The implementation of screening for colorectal 
cancer in ages 60-74 by the end of 2021 is intended to improve these statistics (Ministry of Health, 
2021). 
The ability to identify those with the highest risk of developing colorectal cancer would increase the 
likelihood of identifying cancer at its earliest stages, as knowledge of their high-risk status is likely 
to lead to more active monitoring for symptoms and diagnostic procedures being conducted more 
rapidly.  It would also reduce the cost, inconvenience and potential for medical complications for 
low-risk individuals of colorectal cancer surveillance screening programmes (Lin et al., 2016).  The 
identification of high-risk individuals before they reach the age groups when colorectal cancer is 
commonly detected (above 55 years of age) would allow people to modify their behaviour to reduce 
their risk of developing colorectal cancer as they age and undergo more regular screening to detect 
any cancers that did develop at early stages. 
To identify those at high risk of developing cancer, a risk model which accurately incorporates all 
relevant information is required.  To build a successful model, the causes of colorectal cancer and 
the variables that measure those causes need to be understood.  To improve on the current models, 
the level of risk stratification achieved by current models and the areas in which the models can be 
improved need to be understood.  These topics are examined in the following sections. 
1.1  Causes of Colorectal Cancer 
To identify those at high-risk for the development of colorectal cancer, the causes of colorectal 
cancer need to be understood.  These causes are generally accepted to be genetics, the environment 
(including lifestyle) and interactions between genetics and the environment, all of which make 
significant contributions to the risk of developing colorectal cancer.  It is estimated that inherited 
risk, i.e. genetics, accounts for 15-30% of the risk for colorectal cancer.  However, these estimates 
depend on the methodology used and may be inaccurate, with 95% confidence intervals from 0% 
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to 48% (Graff et al., 2017; Law et al., 2019; Lichtenstein et al., 2000).  The remainder of the risk for 
colorectal cancer is determined by the environment, and interactions between genetics and the 
environment. 
Genes and environment can interact in three different ways.  Genetics and/or the environment 
(G+E) can cause cancer additively in an independent manner.  Genetic sensitivity to the environment 
(GSE) leads to the development of cancer in susceptible individuals, where some individuals are 
predisposed to develop cancer when exposed to adverse environmental factors.  Inherited 
genotypes can cause individuals to be exposed to the environment, (genotype controls 
environmental exposure (GCE)), so that individuals develop cancer because they have higher 
exposures to adverse environments (Kendler & Eaves, 1986). 
Two of the gene-environment interaction types, the additive impacts of genetics and environment 
(G+E), and genetic control of environmental exposure(s) (GCE), allow the environment to cause 
colorectal cancer in the absence of a genetic predisposition for the development of cancer.  If these 
interaction types are the true model, then lifestyle factors that increase the risk of developing cancer 
would cause cancer in those who have adverse lifestyle factors.  These lifestyle factors include 
smoking, obesity, physical inactivity and height; high consumption of red meat and processed meat; 
low consumption of wholegrains, fibre and calcium; and high levels of alcohol use (table 5.5.1 in 
Wild, Weiderpass, & Stewart, 2020).  However, studies of long-term couples, i.e. genetically 
different individuals who have the same or similar lifestyle/environmental factors, show that 
detrimental lifestyle and environmental factors alone are insufficient to cause cancer (standardised 
incident ratio of 0.96 for a partner with colorectal cancer) (Hemminki & Chen, 2004).  Adoptees into 
families also show lower risks for developing colorectal cancer than biological children (standardised 
incidence ratio of 1.63 vs 1.12 respectively), despite shared childhood environments and the same 
likelihood of following adverse parental habits (Sundquist, Sundquist, & Ji, 2015).  Therefore, 
lifestyle effects alone are insufficient to cause colorectal cancer.  Exposure to environmental 
carcinogenic chemicals may be able to cause cancer (excluding any exposures through lifestyle 
variables), but the level of exposure required (peak and lifetime) is not well understood (Madia, 
Worth, Whelan, & Corvi, 2019).  For colorectal cancer, studies of the incidence by industry suggest 
exposures to chemicals at work may increase the risk of developing colorectal cancer (highest 
relative risk of 1.7 for leather workers), but the results are confounded due to the lack of inclusion 
of other known causal factors (such as alcohol consumption) or proxies for inherited genetic risk 
(Oddone, 2014).  Therefore, there is no evidence that environmental exposures alone can cause 
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cancer, as required by the additive effects and genetic control of environmental exposure gene-
environment interaction types. 
The genetic sensitivity (GSE) type of gene-environment interaction suggests genetic variation 
between individuals leads to different levels of risk of developing colorectal cancer, which are 
triggered by environmental exposures.  In identical twins, i.e. people with the same level of genetic 
risk, the absolute risk of developing colorectal cancer doubles when one twin has cancer, from 0.05 
to 0.11 (Lichtenstein et al., 2000).  Families can also inherit an increased risk of developing colorectal 
cancer, as people with first or second-degree relatives with colorectal cancer have an increased risk 
of developing colorectal cancer of approximately 2.2 times (Law et al., 2019).  The genetic sensitivity 
type of gene-environment interactions also requires that the environment be important in the 
development of cancer.  The importance of the environment can be seen in familial cancer 
syndromes, where adverse genetic variants are generally insufficient on their own to cause cancer, 
although the risk of developing colorectal cancer is much higher (Aaltonen, Johns, Järvinen, Mecklin, 
& Houlston, 2007; Fahed et al., 2020).  This evidence suggests that those who develop cancer have 
a genetic susceptibility to adverse environmental exposures. 
Genetic susceptibility to the environment can occur in two ways:  there are genotypes that are 
susceptible to the collective impact of the environment and/or there are specific genetic variants 
that are susceptible to specific environmental exposures.  Studies that model genotype and the 
environment separately show that genetic information improves models based on environmental 
information (or visa-versa) but that the improvement is relatively small (Frampton & Houlston, 
2017; Jeon et al., 2018).  The measurement of the strength of the interaction(s) between genetic 
variants and environmental variables has been limited in colorectal cancer, due to difficulties in the 
collection of data for these studies.  A meta-analysis of studies published through to December 2016 
found that there is reasonable evidence for six gene-environment interactions, although five of 
these show no genetic effect in the absence of the environmental variable (Yang et al., 2019).  
Therefore, it is not possible to determine whether gene-environment interactions occur through the 
interaction of a susceptible genotype with the collective impact of the environment or through the 
interaction of a genetic variant with an environmental exposure. 
The type of interactions between genes and the environment determines the effectiveness of 
different types of studies that assess the role of genetics in colorectal cancer.  If there is a susceptible 
genotype, then genetic variants which increase the risk of colorectal cancer can be identified in 
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genome-wide association studies (GWAS).  If colorectal cancer is caused by the interaction of a 
genetic variant with an environmental exposure, the GWAS may be unable to detect specific 
interactions, where the genetic variant involved does not cause an effect on its own (main effect).  
As there is no ability to determine which option is correct, the ability to build a model to stratify risk 
from genetic variants alone will prove that the susceptible genotype option is correct, and the 
inability to do so suggests that specific interactions are important. 
1.2  Identification of Genetic Variants that Cause Colorectal Cancer 
Genetic variation which can lead to the development of cancer includes copy number variations 
(CNV), methylation alterations and single nucleotide polymorphisms (SNPs).  Some genetic 
variations can greatly increase risk on their own, but most colorectal cancer is thought to result from 
the combined impact of beneficial and adverse genetic variation. 
Copy number variations consist of both duplications of long stretches of DNA and duplication of 
chromosomes within cells.  Alterations in copy numbers may increase the level of expression of 
proteins affected in proportion to the number of copies present, disrupt protein functions, or create 
fused genes (Hu et al., 2018).  Relatively little is known about somatic copy number variations and 
their role in the development of colorectal cancer.    Only a few copy number variants have been 
associated with the development of colorectal cancer.  It was thought that inherited copy number 
variation was highly correlated with single nucleotide polymorphisms, but this is not always the case 
(Hu et al., 2018).  Rare copy number variation (<0.5%) appears to occur more frequently in people 
who develop colorectal cancer than in controls (Li et al., 2015).  Copy number variations are 
relatively common in cancer cells.  Acquired copy number variants are thought to contribute to the 
progression of a cell to a cancerous state and some copy number variants are associated with a 
worse prognosis (Ried et al., 2019). 
Methylation alteration occurs when the methyl groups are added or removed from a cytosine (or 
less commonly guanine) where cytosine precedes guanine (CpG) in DNA.  Changes in methylation 
state occur to epigenetically regulate gene expression.  The methylation profile of the genome also 
changes with age and can be used to assess the risk of developing cancer, by comparing methylation 
age with chronological age (Yu, Hazelton, Luebeck, & Grady, 2020; Zhu et al., 2019).   Colorectal 
cancer (and other cancers) show global hypomethylation across the genome and hypermethylation 
at CpG islands in the promoter region of genes that supress cancer (Lao & Grady, 2011).  Aberrant 
methylation patterns which cause colorectal cancer may be inherited, but this is not proven (Jass, 
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2007; Wong, Hawkins, & Ward, 2007).  Methylation alterations are also associated with mutations 
in genes involved in DNA methylation and chromatin related functions (Baylin & Jones, 2011). 
Single nucleotide polymorphisms (SNPs) record the variant alleles which exist in the DNA sequence 
of a human genome.   SNPs include alterations (e.g. C→G), insertions of short sequences (e.g. 
C→CGG), and deletions of short sequences (e.g. CA→C).  Approximately 100 SNPs associated with 
colorectal cancer have been identified (Huyghe et al., 2019; Law et al., 2019).   These SNPs explain 
~11% of the heritable genetic risk of developing colorectal cancer (Hemminki & Chen, 2004; Huyghe 
et al., 2019; Law et al., 2019).  The difference between the estimate for the contribution of genetic 
variation to the risk of colorectal cancer and contribution of GWAS SNPs is known as ‘missing 
heritability’.  This may be the result of interactions between genes i.e. epistasis (Zuk, Hechter, 
Sunyaev, & Lander, 2012).  However other explanations exist including the role of rare SNPs, the 
unmeasured impact of differences in the environment (e.g. nutrition), the role of methylations 
differences (including inheritance), pathway effects as one transcriptional product (e.g. long-non-
coding RNA) alters the expression of other transcriptional products (e.g. protein) and the collective 
impact of many small effects (Eichler et al., 2010). 
Copy number variation, methylation alterations and single nucleotide polymorphisms have all be 
identified as associated with cancer.  However, further work is required to understand the relative 
contribution of each of these types of genetic variation, and how they might interact with each other 
and the environment to cause cancer.  Ultimately, once genetic variation and the contribution of 
the environment are known, it should be possible to identify individuals who are at high risk of 
developing cancer. 
1.3  Models to Predict the Development of Colorectal Cancer 
Models that predict the risk of developing colorectal cancer can use genetics, lifestyle factors, 
inherited colorectal cancer risk (based on the number of close relatives diagnosed with colorectal 
cancer) and medical data, either individually or in combination.  The accuracy of the discrimination 
of these models (ability to make correct predictions) can be compared using concordance scores, 
a.k.a. the Area Under the Curve of a receiver operating curve (AUC).  Concordance scores measure 
the ability of a model to accurately predict cancer status on a scale between 0.5 and 1, where 0.5 is 
the performance of a random variable, above 0.75 is considered a useful level of discrimination and 
1 is a perfect ability to predict whether someone will develop colorectal cancer (Alba et al., 2017). 
Models which combine lifestyle, genetic factors and family history achieve concordance scores of 
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between 0.56 and 0.74 (Frampton & Houlston, 2017; Hsu et al., 2015; Jeon et al., 2018; Peng, 
Balavarca, Weigl, Hoffmeister, & Brenner, 2019; Wei et al., 2017).  The highest concordance score 
of 0.8 was achieved with the inclusion of medical comorbidities (which are the outcome of genetic 
and lifestyle factors) and family history (genetic inheritance) along with two lifestyle factors (body 
mass index and smoking) (Nartowt et al., 2019). 
Models perform best when all relevant variables and no irrelevant variables are included.  However, 
models which only include genetic factors may be more useful in some circumstances, as the 
inclusion of variables that have underlying genetic drivers (e.g. body mass index) can alter the 
assessed importance of the genetic variables (Janssens, 2019). 
Genetic only risk models can identify high-risk individuals and allow them to make lifestyle changes 
to reduce their risk of developing colorectal cancer (Le Marchand, Wilkens, Hankin, Kolonel, & Lyu, 
1999).  This is particularly relevant for colorectal cancer, as it is estimated to take four to twenty-six 
years for cells with pre-cancerous changes to progress to the point where a diagnosis of cancer is 
made (Chen, Yen, Wang, Wong, & Chen, 2003). 
Polygenic Risk Scores (PRS) are scores that measure the impact of risk SNPs on the probability of 
developing a disease.  They are generally constructed from GWAS identified SNPs using the 
univariate odds ratios (or relative risk) from a reliable GWAS meta-study to weight the SNPs from a 
new dataset to determine their risk score (Janssens, 2019).    For colorectal cancer, recent studies 
have PRS models with concordance scores (AUC) of 0.60−0.65 (Jia et al., 2020; Li et al., 2019; Tasa, 
Puustusmaa, Tonisson, Kolk, & Padrik, 2020; Thomas et al., 2020).  This is a similar level of predictive 
ability to PRS models for colorectal cancer which report odds ratios of around 3 between the highest 
and lowest deciles/terciles, or odds ratios of 2.6-2.9 between the median and the top 1% (Frampton 
et al., 2015; Jenkins et al., 2016; Law et al., 2019; Shi et al., 2019; Weigl, Chang-Claude, et al., 2018; 
Weigl, Thomsen, et al., 2018).  The PRS concordance scores for colorectal cancer are lower than 
achieved for some other diseases, for example coronary artery disease has an AUC of 0.81, and at a 
similar level to cancers, for example breast cancer has an AUC of 0.68 (Khera et al., 2018).  A 
concordance of 0.65 is estimated as the threshold at which the benefits of reduced screening begin 
to outweigh the cost of genetic tests to construct risk scores (Naber et al., 2019).  Further 
improvements in the PRS models would improve the cost-benefit analysis and are likely to lead to 




1.4  Areas for Improvement in Models to Predict the Development of Colorectal Cancer 
Improvements in concordance scores for genetic only models may be possible by addressing the 
limitations and assumptions inherent in the methods used to identify single nucleotide 
polymorphisms associated with disease.  Fundamentally, there are unanswered questions about 
what type of statistical model is appropriate to represent the relationship between genetic variants 
and the ways that variants that act to cause disease (Boyle, Li, & Pritchard, 2017; Janssens, 2019).  
These broad questions are beyond the scope of this thesis.  Instead, the focus is on specific 
limitations and assumptions within the statistical models which may lead to progress in the field.  
These limitations include: the unknown impact on model performance of adjustments for 
population stratification; the assumption that all colorectal cancers have the same underlying causal 
genotype; and the potential impact of epistasis (interactions between genes). 
Population stratification occurs when there are differences in genetic heritage between cases and 
controls.  This can cause confounding, where genetic variants are identified as correlated to the 
disease phenotype, but this is due to differences in genetic heritage instead of a possible causal 
relationship (Hellwege et al., 2017).  Population structure can be identified with principal 
component analysis and adjusted for by the inclusion of ten or twenty principal components within 
a statistical model (see the introduction of Chapter 2 for a fuller discussion of population 
stratification corrections).  It is unknown whether adjustments for population stratification with 
principal components improve our ability to identify causal SNPs in real genetic data, although it has 
been shown for simulated data (Price et al., 2006).  Genome-wide association studies with principal 
component corrections for population stratification have identified genes for some diseases that 
are confirmed to be causal, but the impact of many SNPs identified in GWAS has not been 
investigated and the process by which they alter disease risks are unknown (Gallagher & Chen-
Plotkin, 2018; Tam et al., 2019; Visscher et al., 2017).  Principal components may also include 
common patterns related to the disease for studies with high proportions of cases, so adjustments 
for population stratification may remove information about causal variables.  To address these 
limitations, the use of rare allele principal components and an assessment of the impact of principal 
component analysis on prediction models were performed (see Chapter 2). 
The assumption that all colorectal cancers have the same underlying causal genotype is likely to 
have originated from studies of monogenetic diseases, where defects in one gene can cause disease 
(e.g. Huntington’s Disease).  Genome-wide association studies use this conceptual framework, with 
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the construction of “a” model for colorectal cancer that implicitly assumes that there is one set of 
genes that causes disease.  If this assumption is false, i.e. multiple sets of genes or multiple pathways 
cause colorectal cancer, the conflation of different types or subtypes of disease would obscure these 
pathways when searching for “a” model for colorectal cancer (Janssens, 2019).  For breast cancer, 
a recent study shows that this may be the case.  The set of significant single nucleotide 
polymorphisms discovered in a genome-wide association study differed when the estrogen receptor 
status of the carcinoma is used to stratify the data (Mavaddat et al., 2019).  For colorectal cancer, 
genome-wide association studies have not been conducted in a stratified manner but the existence 
of identifiable molecular types of cancer and differences between distal (left) and proximal (right) 
sided cancers suggest that there may be more than one predictive model required for colorectal 
cancer (Menter et al., 2019; Peng et al., 2018).  To assess whether sub-groups exist, cluster analysis 
was applied to the genetic data for colorectal cancer patients (see Chapter 3). 
The impact of interactions between genes or genetic variants (epistasis) on the risk of developing 
disease is an understudied topic.  Interactions are understudied because of the computational 
power required, due to the large size of the human genome, the number of samples required to 
form reliable conclusions about the presence of interactions, and the number of possible 
combinations of SNPs that exist (Niel, Sinoquet, Dina, & Rocheleau, 2015).  Logistic regressions for 
each SNP are the standard method of analysis for genome-wide association analysis (Cantor, Lange, 
& Sinsheimer, 2010; The 1000 Genomes Project Consortium, 2015).  However, logistic regressions 
for SNPs fail to detect SNPs which interact, as the full impact of a SNP may only appear when the 
SNP it interacts with is also present (Chasioti, Yan, Nho, & Saykin, 2019; Guyon & Elisseeff, 2003; 
Pickrell, Clerget-Darpoux, & Bourgain, 2007).  To identify SNPs that may interact, Random Forests 
and Gradient Boosted Trees were used to search for interactions (see Chapter 4). 
Population stratification, sub-types of colorectal cancer and the potential impact of interactions 
have the potential to obscure genetic relationships that exist that lead to the development of 
colorectal cancer.  If these limitations and assumptions prove to be true, improvements in 
concordance scores for genetic only models may be possible.  This leads to the main hypothesis of 
this study, that the concordance scores for models which predict the development of colorectal 
cancer are improved through the use of rare allele principal components, the identification of sub-




1.5  Conclusion 
The ability to predict who will develop colorectal cancer would be useful in lowering the cost of 
screening for colorectal cancer and allow interventions for those who have the highest risk of 
developing colorectal cancer.  Models which predict the risk of developing colorectal cancer using 
genetic information from genome-wide association studies show a poor ability to discriminate 
between those who will and will not develop colorectal cancer and are not currently used to screen 
populations.  Improvements could be made to these models by addressing the limitations and 
assumptions inherent in the current modelling techniques:  that corrections for population 
stratification adequately adjust for population stratification; the assumption that all colorectal 
cancer patients have the same causal genetic background; and that there are no interactions 
between genetic variants or between genetic variants and other model variables (such as sex or 
age). 
 
Figure 1.1:  Diagram showing the different types of genetic variation thought to play a role in the 
development of colorectal cancer and the thesis chapters that assess assumptions or limitations 
related to these types of genetic variation. 
The significance of this work is that an examination of the limitations inherent in the methodologies 
currently used to study the causes of colorectal cancer may reveal techniques which improve the 
quality of models that predict the development of colorectal cancer. 
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Main hypothesis:  Concordance scores (AUC) for models which predict the development of 
colorectal cancer are improved through the use of rare allele principal components, the 
identification of sub-types of colorectal cancer and the inclusion of interactions within polygenic risk 
models. 
First Hypothesis (H1):  The use of different methods to correct for population stratification with 
principal components will detect genetic variants that improve the performance of models to 
predict the risk of developing colorectal cancer. 
Second Hypothesis (H2):  A model for subtypes of colorectal cancer performs better than a case-
control model to predict the development of colorectal cancer. 
Third Hypothesis (H3):  A model that includes interactions performs better than a model without 
interactions to predict the development of colorectal cancer. 
Each of these hypothesises is examined in the following chapters:  Chapter 2 covers the first 
hypothesis on the effectiveness of corrections for population stratification with principal 
components; the second hypothesis is examined in both Chapter 3 and Chapter 4, Chapter 3 
examines whether subtypes of colorectal cancer can be detected and Chapter 4 determines whether 
there are genetic differences in colorectal cancers depending on their location; Chapter 5 assesses 
the third hypothesis on the improvement to models from the inclusion of interactions; while 




2.  Population Stratification Corrections in Colorectal Cancer Models 
2.1  Introduction 
Population stratification occurs where genetic variants have different frequencies in the case and 
control samples, due to differences in genetic heritage between cases and controls.  This can cause 
confounding, the erroneous detection of genetic variants as related to the disease phenotype, 
where the relationship detected is due to differences in genetic heritage between cases and 
controls, not a possible causal relationship (Hellwege et al., 2017).  The presence of confounding 
from population stratification makes it difficult to identify genetic variants that cause disease. 
The cause of population stratification is the small number of samples genotyped relative to the 
number of genetic variants.  Even in the largest, well-funded genome-wide association studies, the 
number of samples genotyped is still substantially smaller than the number of samples required to 
represent genetic diversity in a population.  For colorectal cancer, a maximum of 100,000-125,000 
samples have been genotyped in genome-wide association studies against an average of 4-5 million 
genetic variants per person (Huyghe et al., 2019; Law et al., 2019; The 1000 Genomes Project 
Consortium, 2015).  In statistics, a greater number of predictors than samples are known as “the 
curse of dimensionality”.  Under these circumstances, statistical models are often unable to find 
unique solutions, model estimates are highly uncertain and variables included are often not 
significant (Johnstone & Titterington, 2009).  In basic terms, it is easy to find a variable that is 
predictive when many variables are available, but this is often due to random chance instead of 
causality.  This is particularly the case for genetic data, where it is generally assumed that only a 
small proportion of genetic variants are causal for a disease. 
Multiple techniques have been developed to correct for population stratification in linear models 
including genomic control, the use of principal components, and linear mixed models (Bouaziz, 
Ambroise, & Guedj, 2011; Hellwege et al., 2017).  These techniques vary in their computational 
complexity and the underlying assumptions made to use the techniques. 
Genomic control applies a scale factor, the genomic inflation factor (λ), to correct for the inflation 
of test statistics by population stratification.  The null hypothesis is that most SNPs have no effect 
on the phenotype.  Under the null hypothesis, when univariate logistic regressions are run for each 
SNP in the dataset, the calculated median Chi-squared statistic divided by the theoretical median 
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Chi-squared statistic, should be equal to one.  Deviations in the genomic inflation factor from one 
therefore represent population stratification (Devlin & Roeder, 1999).  In practise, population 
stratification is considered negligible below the commonly accepted level of 1.05 (Price, Zaitlen, 
Reich, & Patterson, 2010).  The genomic inflation factor makes assumptions which may not be met, 
i.e. that the impact of stratification is constant across the genome and the included SNPs are non-
causal (Devlin, Roeder, & Wasserman, 2001).  Genomic inflation can both under and over-represent 
the level of populations stratification and the value of lambda depends on the SNPs used in its 
calculation (Bouaziz et al., 2011; Kohler & Bickeboller, 2006).    Correction for population 
stratification by genomic controls is generally not used as it decreases the power to detect causal 
SNPs (Price et al., 2010).  However, it is commonly used to show that there is a reduction in the level 
of stratification i.e. a decrease in the genomic inflation factor from the application of population 
stratification techniques.  This is assumed to lead to improvements in the detection of causal SNPs, 
which has not been proven except for simulated data (Devlin & Roeder, 1999).  A better measure of 
the detection of causal SNPs, is their ability to identify who will develop a disease.  Genetic risk 
scores use the identified SNPs in a model to predicts the risk of colorectal cancer.  This provides an 
independent measure of the usefulness of the corrections for population stratification not 
previously used to assess population stratification corrections. 
Principal components analysis finds axes which represent the shared variation between samples.  
Principal components are included in genome-wide association studies to provide an estimate of 
the variation associated with shared population structures (Price et al., 2006).  They are included as 
fixed effects (i.e. they do not vary between variants) in logistic regressions calculated for each 
genetic variant.  The significance of each genetic variant is tested against the genome-wide 
significance level, corrected for multiple hypothesis testing, of 5x10-8 (for correlations less than 0.8 
and minor allele frequencies greater than 0.05.  These models and the associate probability 
thresholds assume that the effect of each genetic variant is independent (Fadista, Manning, Florez, 
& Groop, 2016).  Principal components reduce the impact of population stratification but have not 
significantly improved the ability of models to predict who will develop colorectal cancer. 
Linear mixed models were developed to account for the omission of causal variables, which could 
have interactions with the tested variables, in the logistic regressions.  In doing so, they also account 
for population structure and allow for multiple variants to be collectively important.  Linear mixed 
models include fixed and random effects terms.  Environmental/lifestyle variables are included as 
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fixed effects while the genetic relationship matrix, the genetic distance or correlation between 
individuals, is included as a random effect (Golan, Rosset, & Lin, 2017).  These models can be more 
successful compared to logistic regressions, but are computationally demanding to calculate and 
are not appropriate for case control data (Yang, Zaitlen, Goddard, Visscher, & Price, 2014).  This is 
because one of the key assumptions of the model is that the randomly sampled phenotype follows 
a normal distribution, which is not valid for case-control studies.  This leads to low power for the 
model to detect causal genetic variants (Golan et al., 2017).  Linear mixed models have not been 
applied to find genetic variants associated with the development of colorectal cancer (Google search 
of linear mixed models, colorectal cancer).  They are not examined in this thesis as no methods exist 
to adequately adjust for non-random sampling inherent in case-control studies. 
The inability to identify those who will develop complex diseases with SNPs identified using genomic 
control, principal component analysis and linear mixed models to correct for population 
stratification, means that corrections for population stratification are an area of active research.  
Zaidi and Mathieson (2020) recently proposed that principal components calculated with rare alleles 
(allele counts 2-5) may perform better than common alleles at identifying population stratification.  
Mutations in alleles develop at different times and then gradually spread throughout the population 
over generations as individuals with the mutation pass this mutation to their offspring.  Natural 
selection will increase the rate of spread of beneficial mutations and decrease the rate of spread or 
eliminate deleterious mutations but will have no effect on mutations that are neutral i.e. mutations 
that have no impact.  Despite the differences in the rate of spread, a generalisation can be made 
that common minor alleles represent mutations that have had more time to spread widely through 
a population and rare alleles represent mutations that are recent and have not had time to spread 
through a population.  Rare alleles (minor allele counts between 2 and 5) have been shown to better 
separate sub-populations with recent (last 2,500 years) population structure than common alleles, 
but this study was limited to white British subjects (Zaidi & Mathieson, 2020).  However, it has 
previously been shown that European samples are less well stratified by rare alleles (<0.05) than 
from a complete dataset (Heath et al., 2008).  A study of the 1000 genome data concluded that rare 
alleles (lowest bucket frequency of 0.01 to 0.001) performed worse than common alleles, as the 
proportion of variance explained was lower.  However, only the ability to distinguish continental 
groups was examined (Ma & Shi, 2020).  Analysis in animals also shows that rare alleles perform 
well at identifying populations, and more distinct groups are identified by principal component 
analysis with rare alleles (Linck & Battey, 2019).  Further assessments are therefore needed before 
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rare alleles can be used to correct for population stratification. 
Methods used for population stratification are generally assessed by the impact on the genomic 
inflation factor when the goal of the corrections are to allow the detection of causal genetic variants.  
This research instead assesses their effectiveness by improvements to models which predict the 
development of colorectal cancer, known as polygenic risk scores (PRS), as the impact of population 
stratification techniques on the accuracy of PRS has not been assessed.  The hypothesis for this 
chapter is that variations in parameters related to the use of principal components to correct for 
population stratification will improve the ability to detect genetic variants which can be used to 
predict the risk of developing colorectal cancer.  These parameters include the frequency of alleles 
from which the principal components are constructed, the number of principal components and the 
correlation of these principal components with the phenotype. 
Hypothesis 1 (H1):  The use of different methods to correct for population stratification with 
principal components will detect genetic variants that improve the performance of models to 
predict the risk of developing colorectal cancer. 
2.2  Results 
2.2.1  Number of Principal Components Which Contain Information About Population Structure 
The number of principal components (PCs) that contain information on population structure and 
the usefulness of rare alleles to detect population structure have not been definitively established.  
The 1000 Genomes data was used to assess these parameters as the presence of both continental 
and population level group labels allows visual assessment of the number of principal components 
that contain information about population structure for data with different allele counts. 
Tests for the number of principal components to use for the 1000 Genomes data for different allele 
counts selected varying numbers of principal components (see Table 2.1).  The scree plot results 
suggest 4-5 principal components.  The broken stick model suggests zero and one important 
principal component for the allele counts 2-5 and 6-10 plots respectively but otherwise suggests 
one less important principal component than the scree plots.  The Tracy-Widom test suggests high 
numbers of principal components, particularly for the allele counts 11-30 and 31-125 tests.  This 
may be due to the large genetic differences between populations, which is a known limitation of 














Number PCs  
Tracy-Widom 
2-5 604,568 3.812 4 0 13 
6-10 848,709 8.579 4 1 43 
11-30 1,011,047 21.780 4 3 112 
31-125 512,145 77.421 5 4 684 
2-250 1,378,438 35.435 4 3 44 
250+ 89,805 94.340 5 4 45 
Table 2.1:  The number of principal components recommended for the allele counts datasets by the 
scree plot, broken stick and Tracy-Widom statistic methods. 
Plots for the first four principal components by allele counts for the 1,000 Genomes data are shown 
in Figure 2.1.  The first four components separate the continental groups for all allele counts.  The 
lower allele counts plots (2-5 and 6-10) have greater separation between the continental groups on 
the first two principal components, then separate the African continental groups (purple) into 
populations on the fourth principal component.  The higher allele counts plots have difficulty in 
separating the American (blue), European (light green) and South-Asian(yellow) continental groups 
on the first two principal components but do separate these groups with principal components 
three and four. 
Separation of the continental groups into populations occurs on subsequent principal components 
for all allele counts, although this is not evident unless the principal components analysis results are 
Figure 2.1:  Graphs of the first two principal components for the 1000 Genomes data for different 




split by continent and labelled by population.  For example, in the left plot of figure 2.2 which shows 
PC15 and PC16, the unlabelled points show a central group with outliers, but when split by continent 
and labelled by population distinguish between populations for American, East-Asian, European and 
South-Asian continental groups (key omitted as irrelevant).  
   
For this study, the primary concern is the ability of rare alleles to identify populations within 
European samples (see Figure 2.4).  European populations are separated at all allele counts, with 
better definition of groups on the lower allele counts plots. The Italian (TSI, yellow), Spanish (IBS, 
green) and Finnish (FIN, blue) samples are all distinct groups.  The European-heritage from the USA 
samples (CEU, purple) overlap with the British samples (GBR, blue-green).  Less definition between 
groups was available on the allele counts 250+ plot (maf>0.05), although the groups remain 
separated. 
Plots of the data show that the first four principal components are important, but that there is 
further information about membership of population groups that is contained in principal 
components past the fifth principal component.  However, these are not evident unless the 
continental groups are separated.  When the samples are labelled by population and separated by 
continent, gradients between populations can be seen in ten to twenty principal components.  This 
suggests the number of principal components is greater than the 4-5 principal components 
suggested in the scree plot but less than the up to 700 suggested by the Tracy-Widom statistic.  
Figure 2.2:  Graph of principal components 15 and 16 for the 1000 Genomes data for allele counts 
greater than 250 i.e. maf>0.05.  The left graph shows the unlabelled plot while the graphs on the 




The whole genome colorectal cancer data used in this chapter does not have the same level of 
diversity as the 1000 Genomes data.  When the principal components are calculated on the 
European populations only (see Figure 2.4), there are similar degrees of separation between 
populations seen on all of the allele count graphs.  After the first two to three principal components, 
the subsequent principal components successively identified individuals as ‘unlike’ the remainder 
of the group, rather than identifying further groups in the data.  
The European only graphs suggest that the spread of points seen in the European samples from the 
pancontinental principal components for the alleles count 31-125 and 250+ datasets relate to SNPs 
which are shared between continental groups.  However, it is unknown which set of principal 
components best reflect the true level of population stratification, as the wider spread of points on 
the pancontinental graphs may more accurately reflect the relative relationships between 
individuals. 
 
Figure 2.3  European populations from the 1000 Genomes data shown on the principal 
components that best separate the populations for the different allele counts datasets.  




Figure 2.4:  The plots show the first two principal components for the 1000 genomes data with the 
European samples only, points are coloured by country of origin for each allele count dataset.  
CEU=European heritage in USA, FIN=Finland, GBR=Great Britain, IBS=Spain, TSI=Italy. 
2.2.2  Detection of Population Stratification 
The existence of population stratification was assessed with the genomic inflation factor (λ).  The 
genomic inflation factor of λ=1.141 for the build dataset for the whole genome colorectal cancer 
dataset showed that population stratification exists as it is above the commonly used threshold of 
1.05.  Therefore, a correction for population stratification is required for this dataset. 
Population stratification can also be assessed with a quantile-quantile plot as population 
stratification causes differences between the expected and observed distribution of probability 
values.  In Figure 2.5, it can be seen that overall, there is relatively little deviation from the expected 
distribution of probability values for the whole genome colorectal cancer dataset, which suggests 
that population stratification does not have a large impact on this dataset.  However, quantile-
quantile plots provide an overall assessment of population stratification effects and do not show 




Figure 2.5:  Quantile-quantile plot of the expected and observed probabilities for the whole genome 
colorectal cancer data for univariate logistic regressions with no principal components included. 
2.2.3  Polygenic Risk Score Model 
A polygenic risk score (PRS) for the whole genome colorectal cancer dataset was constructed from 
the significant SNPs and odds-ratios in (Law et al., 2019).  The AUC of 0.573 is lower than other 
recent studies, which have estimates of 0.609, 0.603, 0.622, 0.629  (Jia et al., 2020; Li et al., 2019; 
Tasa et al., 2020; Thomas et al., 2020).  These studies generally include a greater number of SNPs 
than are included here, although one study included a model with a similar number of SNPs which 
had an AUC of 0.608 (Tasa et al., 2020). 
When the whole genome colorectal cancer dataset is split into subsets by the source study and sex, 
the fit of the PRS varies between source studies and between sexes (see Table 2.2).  Stratification 
by study (NHS, WHI) and sex (female) can be seen by the poor fit of the models to the validation 
data.  The differences between the fit of the Male and Female models suggests that a separate 
model is required for females, although this is contradicted by larger studies which found that PRS 
models fit equally well to males and females (Tasa et al., 2020).  The differences between the AUCs 
for the build and validation datasets is due to variation between samples and the relatively small 










All 2340 0.576 552 0.564 
Study     
CPS-II 216 0.572 43 0.674 
DACHS 589 0.610 152 0.594 
HPFS 112 0.569 25 0.564 
NHS 176 0.530 45 0.519 
PLCO 493 0.576 123 0.582 
WHI 754 0.572 164 0.513 
Sex     
Male 864 0.587 211 0.631 
Female 1476 0.570 341 0.478 
Table 2.2:  Build and validation AUC for polygenic risk scores for the whole genome colorectal cancer 
dataset, and for subsets of the data by the originating study and sex. 
Different validation sample sets would result in a trade-off between the build and validation AUCs, 
as the samples with a poor model fit move between the build and validation datasets.  However, 
tests of different validation datasets did not alter the conclusions drawn about the relative fit of the 
models to the data. 
The fit of models specific to this dataset were also assessed i.e. the model coefficients were 
determined by the data (see Table 2.3).  A generalised logistic model (GLM) for the same SNPs fits 
better to the build dataset with an AUC of 0.637, but poorer fit to the validation data with an AUC 
of 0.545.  When only the significant SNPs are used for the GLM model (at p-value<0.05), the fit of 
the model to the build dataset deteriorates (AUC=0.598), but the fit to the validation dataset 
improves (AUC=0.559).  A cross-validated penalised logistic regression model (PLR) performs worse 
than either the PRS or the GLM model (build AUC of 0.565 and validation AUC of 0.543), as it cannot 
weight the SNP with the best predictive ability as strongly (rs6983267). 
Model SNPs Build AUC Validation AUC 
PRS 70 0.576 0.564 
GLM 70 0.637 0.545 
GLM (significant SNPs only) 12 0.598 0.559 
PLR 12 0.565 0.543 
Table 2.3:  The fit of polygenic risk score (PRS), generalised linear model (GLM) and penalised logistic 
regression models to the GWAS SNPs in the whole genome colorectal cancer dataset. 
Of the 70 SNPs that are significant and replicated in large GWAS, only one reaches significance after 
a Bonferroni correction for multiple hypothesis testing (rs6983267) in univariate logistic models, 
while a further ten SNPs are nominally significant directly or through linkage disequilibrium (r2>0.8).  
This is not surprising given the known difficultly in replicating GWAS results in small samples (Liu, 
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Papasian, Liu, Hamilton, & Deng, 2008).  There were also large differences in odds ratios between 
sexes, with differences greater than 0.20 for twelve SNPs.  For most of these SNPs (nine SNPs), the 
odds ratio was stronger for males than females, which explains the better model fit seen in the PRS 
for males.  For three SNPs, the SNP was strong enough in one sex that it caused the SNP to be 
nominally significant in the combined data, even though the SNP was not associated with colorectal 
cancer in the other sex. 
2.2.4  Corrections for Population Stratification with Rare Allele Principal Components and Different 
Numbers of Principal Components 
Principal components were calculated for rare alleles in the whole genome colorectal cancer data, 
with outliers removed based on Mahalanobis distance (Figure 2.6).  The principal components for 
the higher allele count datasets (allele counts 11-30, 31-125, 2-250 and 250+) show the DACHS study 
from Germany (dark blue) as a separate group from the other studies, while the lower allele count 
plots do not.  Cases and controls were not separated by any of the first twenty principal 
components.  The lack of groups in the data was expected given that the study participants all self-
identify as “white”. 
 
Figure 2.6: Plots of the first four principal components for the colorectal cancer data.  Case-control 
status and originating study are shown by shape and colour respectively. 
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The principal components were then used to: correct for population stratification in univariate 
logistic regressions; the univariate logistic regressions were used to select SNPs to build models; and 
models were built with these SNPs and the principal components.  This process is shown in Figure 
2.7.   
 
Figure 2.7:  The process used to build models with principal components.  Datasets with allele counts 
2-5, 6-10, 11-30, 31-125, 2-250 and 250+ were prepared in the first step and used to calculate 
principal components.  These principal components were then used in the third step, analyse 
common SNPs with principal components (PCs) and last step, to build a model. 
The number of principal components to use was selected based on the scree plot, Tracy-Widom 
statistic, first twenty principal components and correlated principal component rules.  Models with 
the number of principal components selected by the scree plot all performed poorly (see Table 2.4), 
as the validation AUC was less than the AUC of random allocation of sample (AUC=0.5).   












2-5 2 73 0.823 0.485 1.217 
6-10 3 71 0.817 0.472 1.186 
11-30 5 68 0.816 0.471 1.163 
31-125 7 70 0.818 0.481 1.106 
2-250 4 68 0.822 0.476 1.040 
250+ 6 73 0.820 0.471 1.099 
No PCs 0 70 0.738 0.480 1.141 
Table 2.4:  The AUC and genomic inflation factor for models built with population stratification 
corrections by the number of principal components selected by the scree plot method. 
The genomic inflation factor showed a decrease from the value calculated with no principal 
components (λ=1.141) for only the principal components from the allele counts 31-125, 2-250 and 
250+ data.  The allele counts 2−250 principal components had the lowest genomic inflation factor 
of λ=1.04 but this did not lead to any better performance for the model calculated with these 
principal components. 
The extra number of principal components used when the Tracy-Widom statistic was used to select 
principal components did not improve the models overall (see Table 2.5).  The use of principal 
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components from the allele counts 6-10 dataset gave a model that performs better than random 
chance, but the improvement is trivial.  Similar validation AUC and higher genomic inflation factors 












2-5 132 82 0.818 0.458 1.298 
6-10 68 90 0.814 0.513 1.207 
11-30 65 90 0.829 0.472 1.192 
31-125 14 67 0.810 0.468 1.121 
2-250 187 181 0.815 0.485 1.089 
250+ 6 73 0.820 0.471 1.099 
No PCs 0 70 0.738 0.480 1.141 
Table 2.5:  The AUC and genomic inflation factor for models built with population stratification 
corrections by the number of principal components selected by the Tracy-Widom method. 
Models with twenty principal components included (Table 2.6) performed similarly to the models 
with principal components selected by the scree plot and Tracy-Widom statistic.  The genomic 
inflation factor was higher for the allele counts 250+ dataset than it was for the lower number of 
principal components used under the scree plot and Tracy-Widom statistic rules.  Based on this 
analysis, there is no reason for the common use of 20 principal components to correct for population 












2-5 20 86 0.830 0.476 1.209 
6-10 20 81 0.824 0.461 1.210 
11-30 20 84 0.825 0.471 1.092 
31-125 20 67 0.809 0.471 1.140 
2-250 20 81 0.825 0.474 1.115 
250+ 20 74 0.816 0.462 1.159 
No PCs 0 70 0.738 0.480 1.141 
Table 2.6:  The AUC and genomic inflation factor for models built with population stratification 
corrections by the number of principal components selected by the 20 principal components (PCs) 
rule. 
The use of principal components that are correlated with the phenotype similarly had validation 
AUCs no better than random chance (Table  2.7).  The genomic inflation factor was low for the allele 
count 11-30 data when compared with the model with no principal components (λ=1.141), but this 
















2-5 22 98 0.850 0.462 1.164 
6-10 5 76 0.827 0.465 1.102 
11-30 9 77 0.831 0.482 1.034 
31-125 11 81 0.829 0.496 1.154 
2-250 10 82 0.832 0.450 1.184 
250+ 15 88 0.835 0.506 1.143 
No PCs 0 70 0.738 0.480 1.141 
Table 2.7:  The AUC and genomic inflation factor for models built with population stratification 
corrections by the number of principal components selected based on correlation to the phenotype.   
To assess whether the penalty applied by elastic net regression impacted the ability to build models 
that predict colorectal cancer, a generalised linear model (GLM) was run for twenty principal 
components from the allele counts 250+ dataset with the whole genome colorectal cancer data.  
The GLM model fit with a build AUC of 0.861 and validation AUC of 0.536, which compares 
favourably with the elastic net model with a build AUC of 0.816 and a validation AUC of 0.462.  This 
shows that the conservatism in the elastic net models reduces the validation AUC and suggests that 
there are a few SNPs highly weighted in the GLM model to give a better fit.  The conservatism in the 
elastic net does not affect the consistency of the results, as all the models are similarly penalised. 
Overall, neither the different numbers of principal components, nor the allele counts of the data 
from which the principal components made any difference to the ability to detect SNPs which could 
predict the development of colorectal cancer.   
2.2.5  Population Stratification in Principal Components from Continental Data 
The analysis of the 1000 Genomes data had shown that there is a different distribution of principal 
component scores for the European population depending on whether data from other continents 
was present, so the analysis in the previous section was rerun with the 1000 Genomes data merged 
into the allele count datasets to increase the variance in the data used to construct the principal 
components.  The principal components for the colorectal cancer data combined with the 1000 




Figure 2.8:  The 1000 genomes European populations plotted with the colorectal cancer dataset, for 
the allele count datasets.  The source study for the data is shown in colour and the case-control 
status is shown by shape.  CEU=European heritage in USA, FIN=Finland, GBR=Great Britain, 
IBS=Spain, TSI=Italy. 
On most plots (Figure 2.8), the colorectal cancer data is in a similar location to both the samples 
from Great Britain (EUR-GBR, light green) and Utah residents with European ancestry (EUR-CEU).  
The DACHS samples (purple) are not a separate group, as occurred in the colorectal cancer data at 
higher allele counts. 
The principal components calculated on the merged whole genome colorectal cancer and 1000 
Genomes datasets were then used to correct for population stratification in models to predict the 
development of colorectal cancer built from the whole genome colorectal cancer dataset, with the 
number of principal components selected by the same methods used in the previous section.   
The models with principal components selected by the scree plot method did not perform any better 
than random chance at identifying SNPs to use in models to predict the development of colorectal 
cancer (Table 2.8).  The genomic inflation factor also showed no benefit for the inclusion of the 1000 










Build AUC Validation AUC Genomic 
Inflation 
Factor λ 
2-5 6 68 0.823 0.466 1.121 
6-10 3 69 0.827 0.476 1.163 
11-30 4 75 0.833 0.491 1.096 
31-125 6 68 0.828 0.479 1.109 
2-250 4 67 0.818 0.464 1.121 
250+ 6 72 0.831 0.487 1.101 
No PCs 0 70 0.738 0.480 1.141 
Table 2.8:  The AUC and genomic inflation factor for models built with population stratification 
corrections by the number of principal components selected by the scree plot method.  Principal 
components were calculated on a dataset that combined the whole-genome colorectal cancer 
dataset and the European samples from the 1000 Genomes Project. 
The selection of principal components based on the Tracy-Widom statistic similarly performed no 
better than random chance (Table 2.9).  The use of the Tracy-Widom method to select the number 
of principal components caused a greater number of variables to be included in the models but 




Number of PCs 
Number of 
variables 




2-5 150 86 0.808 0.461 1.359* 
6-10 73 70 0.805 0.509 1.161 
11-30 59 78 0.825 0.474 1.108 
31-125 14 66 0.822 0.482 1.087 
2-250 193 88 0.810 0.470 1.222 
250+ 6 72 0.831 0.487 1.101 
No PCs 0 70 0.738 0.480 1.141 
Table 2.9:  The AUC and genomic inflation factor for models built with population stratification 
corrections by the number of principal components selected by the Tracy-Widom method.  Principal 
components were calculated on a dataset that combined the whole-genome colorectal cancer 
dataset and the European samples from the 1000 Genomes Project.*High variance inflation factor.   
Models with twenty principal components included performed similarly to the other models, with 
validation AUC values worse than random chance for most models (Table 2.10).  The models with 
principal components from the allele counts 31-125 and 250+ datasets had genomic inflation factors 
that showed improvements over the model with no principal components (λ=1.141), but this did 
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PCs 








2-5 20 72 0.831 0.484 1.153 
6-10 20 67 0.824 0.467 1.186 
11-30 20 74 0.828 0.475 1.111 
31-125 20 66 0.819 0.500 1.084 
2-250 20 75 0.830 0.459 1.157 
250+ 20 71 0.829 0.483 1.085 
No PCs 0 70 0.738 0.480 1.141 
Table 2.10:  The AUC and genomic inflation factor for models built with population stratification 
corrections by the number of principal components selected by twenty principal components rule.  
Principal components were calculated on a dataset that combined the whole-genome colorectal 
cancer dataset and the European samples from the 1000 Genomes Project. 
Principal components selected by their correlation with the phenotype gave models that performed 
similarly to the other sets of principal components (Table 2.11).  The validation AUC was no better 
than random chance for all sets of principal components.  The genomic inflation factor was low for 





Number of PCs 
Number of 
variables 




2-5 10 82 0.828 0.485 1.018 
6-10 11 79 0.833 0.514 1.123 
11-30 8 72 0.822 0.475 1.103 
31-125 19 82 0.836 0.488 1.132 
2-250 8 82 0.845 0.464 1.248 
250+ 10 78 0.829 0.482 1.032 
No PCs 0 70 0.738 0.480 1.141 
Table 2.11: The AUC and genomic inflation factor for models built with population stratification 
corrections by the number of principal components selected by correlation with the phenotype.  
Principal components were calculated on a dataset that combined the whole-genome colorectal 
cancer dataset and the European samples from the 1000 Genomes Project. 
The use of principal components that were calculated with both the whole genome colorectal 
cancer dataset and the 1000 Genomes Project dataset did not improve the performance of models 
to predict the development of colorectal cancer with any of the methods or datasets used to select 
principal components.  This is the same result as for the principal components that were calculated 
on the whole genome colorectal cancer data on its own, so the inclusion of the 1000 Genomes 
Project samples in the data used to calculate the principal components made no differences to the 
performance of the models. 
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2.2.6  The Impact of Principal Components Corrections 
The failure of the different datasets and methods used to calculate principal components to produce 
a model that predicted the development of colorectal cancer suggested that the impact of principal 
components on the odds ratios needed to be investigated.  The odds ratio for each SNP with and 
without the inclusion of twenty principal components were compared using the principal 
components were from the allele count 250+ dataset.  Figure 2.9 shows the results of this analysis.   
The plot of the odds ratio difference against the minor allele frequency (left side of Figure 2.9) shows 
that the largest differences to the odds ratio from population stratification adjustments occur in the 
minor alleles with the lowest frequencies.  This is likely to be related to the sample size, as the low 
number of samples which have minor alleles means that the phenotype of each sample makes a 
larger contribution to the odds ratio for that SNP.  For most of the SNPs, the odds ratio varies by 
less than 0.05 due to the population stratification correction, so makes negligible difference.  
Therefore, most of the models tested in the previous sections are very similar to each other.  When 
the differences to the odds ratio from population stratification are examined by the size of the odds 
ratio, it can be seen (right side of Figure 2.9) that none of the largest odds ratios are greatly altered 
by population stratification adjustments, although the ranked order of the SNPs is slight altered. 
Figure 2.9:  The left plot shows the difference made to the odds ratio by minor allele frequency 
for the inclusion of 20 principal components calculated on the dataset with a minor allele counts 
of 250+.  The right plot shows the difference to the odds ratio by the size of the odds ratio when 
no principal components are included. 
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The impact of principal components on the SNPs selected to build models was assessed.  When the 
SNPs selected for the scree plot models (the models in Table 2.4) were compared with the SNPs 
selected when no principal components were used, eighteen out of the twenty SNPs with the 
highest univariate odds ratios were used in all models and thirty-eight out of fifty SNPs were used 
in all models.  This pattern continued when more principal components were used in the univariate 
logistic regressions, with forty-one out of fifty SNPs selected in common by univariate logistic 
regressions when no principal components and twenty principal components were used when 
selecting SNPs.  This shows that the models are substantially the same irrespective of the principal 
components used to select SNPs. 
2.3  Discussion 
Population stratification corrections with principal components were examined to determine 
whether rare allele principal components, correlated principal components, high variance principal 
components or different number of principal components could improve the construction of models 
to predict the development of colorectal cancer.  Population stratification was present in the data 
and the corrections for population stratification resulted in a reduction in the genomic inflation 
factor for some of the sets of principal components.  The impact of the corrections for population 
stratification were inconsistent across the different allele count data, even though the analysis of 
principal components for the 1000 genomes project data suggests that the different rare allele 
count datasets all summarise population structure in a similar manner.  All of the models 
constructed performed worse than the polygenic risk score model constructed from the results of a 
large genome-wide association study (35,000 cases and 71,000 controls).  This disproves the 
hypothesis for this chapter, that the use of different methods to correct for population stratification 
with principal components will detect genetic variants that improve the performance of models that 
predict the risk of developing colorectal cancer. 
The poor performance of the models constructed in this chapter is not unexpected.  Small sample 
sizes (as used here) are underpowered to detect lead SNPs with small odds ratios (less than 1.2) 
such as found in colorectal cancer genome-wide association studies (Hong & Park, 2012).   However, 
the use of whole genome data meant that it was possible that true causal SNPs with high odds ratios 
would be directly detected, rather than indirectly detected through imputed SNPs with low odds 
ratios.  Odds ratios above 1.5 were found for SNPs in the data and the involvement of these SNPs in 
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the development of colorectal cancer was plausible when investigated.  But this did not feed 
through to models which predicted the development of colorectal cancer in the validation dataset.   
The poor performance of the models may also result from incorrect assumptions made in the use 
of logistic regression models.  The use of logistic regressions without interaction terms assumes that 
there are no interactions.  This cannot be assumed to be true, when we know that proteins interact 
within pathways where the available substrates for each successive step depend on the successful 
completion of the previous steps.  Studies of yeast suggest that interactions within pathways and 
between pathways are important (Fang et al., 2019).  Analysis of SNPs found to be significant in 
genome-wide association studies for cancer also suggest that these pathways are important, as 
significant SNPs in GWAS can to influence the expression of many genes in a biological pathway 
(Fagny, Platig, Kuijjer, Lin, & Quackenbush, 2020).  For colorectal cancer, sets of genes associated 
with three pathways are important (TGF-β, MYC, chromosome integrity and DNA repair) (Law et al., 
2019).  Ideally, the impact of biological pathways on colorectal cancer would be tested with a model 
for these pathways and then the SNPs would be identified (the reverse of finding SNPs in GWAS and 
then identifying pathways).  This is currently beyond our capabilities as it is difficult to predict gene 
expression levels from genetic variants (Alpay, Demetci, Istrail, & Aguiar, 2020; Bien et al., 2019; 
Vervier & Michaelson, 2016).  An alternative to models which explicitly model gene expression is to 
allow interactions between SNPs to capture the potential for multiple SNPs to act together to impair 
a particular pathway, or to impair two genes or pathways which would otherwise be able to 
compensate for each other (Parrish et al., 2020).  The usefulness of interactions within risk models 
was investigated in Chapter 5. 
The assumption that there is one set of adverse alleles that act multiplicatively to increase the risk 
of developing colorectal cancer may also be incorrect.  For Breast cancer, this appears to be the 
case, as the risk associated with a SNP depends on the cancer subtype (whether the cancer is 
positive for the estrogen receptor or not) and SNPs may have opposite effects in different subtypes 
(Mavaddat et al., 2019).  The idea that cancer may be more genetically heterogenous than other 
diseases is also supported by the success of polygenic risk scores in other diseases, as polygenic risk 
scores for other diseases, able to achieve higher predictive accuracy, e.g. coronary artery disease 
has an AUC of 0.806 against the best colorectal cancer model with an AUC of 0.654 (Khera et al., 
2018; Thomas et al., 2020).   
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2.4  Conclusion 
Population stratification exists within the dataset for colorectal cancer analysed in this chapter, but 
principal components are not able to correct for this population stratification.  As principal 
components have been shown to summarise local population structure, the inability of principal 
components to adjust for population structure is likely to stem from incorrect assumptions about 
the correct model for the development of colorectal cancer.  These include that the action of each 
SNP can be measured in isolation and that colorectal cancer is a homogenous disease. 
The subsequent chapters of this thesis investigate some of these assumptions to determine whether 
analysis of the genetic data which already exists can be reanalysed to identify SNPs which can be 
used to predict the development of colorectal cancer.  Chapters 3 and 4 examined whether the 
performance of models can be improved through recognition of subtypes of colorectal cancer.  
Chapter 5 examined whether the inclusion of interactions between SNPs improves the performance 
of models, which is a step towards the incorporation of gene pathways.  
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3.  Identification of Colorectal Cancer Subtypes 
3.1  Introduction 
Polygenic risk scores for colorectal cancer are below the level of accuracy required for the scores to 
provide accurate predictions for individuals of their risk of developing colorectal cancer or to be cost 
effective for health systems to conduct (Naber et al., 2019).  One possible reason for the low 
predictive accuracy may be the use of data which aggregates different subtypes of colorectal cancer 
which have different genetic causes together.  If this were true, the aggregation of different 
subtypes of colorectal cancer into one model would lead to poor predictive accuracy across all 
subtypes of colorectal cancer, as SNPs which were important for one subtype of colorectal cancer 
acted as confounding variables for another subtype of colorectal cancer where the SNP had no 
effect. 
Evidence that different sets of SNPs exist for different subtypes of cancer exists for breast cancer.  
When genome-wide association studies for breast cancer are analysed by whether the cancer 
patient has estrogen receptor positive or negative cancer (with a prevalence of 73% and 27% 
respectively), the single nucleotide polymorphisms which are significant by estrogen receptor status 
are altered when compared with the combined dataset (Mavaddat et al., 2019).  Subtype analysis 
has also identified SNPs which have opposite effects in different subtypes of breast cancer, which 
are not detected in analyses of the combined data (H. Zhang et al., 2020).  This suggests that an 
analysis of the SNPs associated with different subtypes of colorectal cancer may be useful and that 
the common method of pruning and thresholding to reduce the dimensionality of the data may be 
removing SNPs which have opposite effects in different subtypes of cancer. 
For colorectal cancer, subtypes exist in the literature on both the types of genetic abnormalities 
seen in the DNA in cancer cells and for Consensus Molecular Subtypes which are assigned by a 
combination of genetic abnormalities and alterations in gene expression (Guinney et al., 2015; 
Menter et al., 2019).   There is also evidence that the location within the colon has an affect (right 
versus left side) as there is a difference in gene expression signatures (Peng et al., 2018).  However, 
there are no studies which examine the importance of SNPs in models to predict the development 
of cancer by these subtypes.  The reason for this is likely to be the lack of clear separation of 
colorectal cancer into subtypes, as the simple delineation of breast cancer into clinically useful 
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subtypes with the expression level of the estrogen and progesterone receptors does not occur in 
colorectal cancer.   
The three recognised genetic abnormalities for colorectal cancer are Chromosomal Instability (CIN),  
Microsatellite Instability pathway (MSI), and CpG Island Methylator Phenotype (CIMP)  (Mármol, 
Sánchez-De-Diego, Pradilla Dieste, Cerrada, & Rodriguez Yoldi, 2017).  Chromosomal Instability (CIN) 
is the most common genetic alteration in colorectal cancer (60-85%) and is characterised by 
inherited or acquired mutations in genes for chromosomal segregation, telomere stability and DNA 
repair (Mármol et al., 2017; Pino & Chung, 2010).  Microsatellite Instability (MSI) is less common 
(15-20%) and is characterised by inherited or acquired mutations or methylation alterations in DNA 
mismatch repair (MMR) genes.  These mutations and alterations cause sections of DNA with 
repeated nucleotides (microsatellites) to accumulate errors (Vilar & Gruber, 2010).  CpG Island 
Methylator Phenotype (CIMP) is characterised by abnormal DNA methylation patterns and may 
overlap with the CIN type (Mármol et al., 2017). 
The Consensus Molecular Subtypes (CMS) for colorectal cancer use the genetic abnormalities seen 
in colorectal cancer as an input into their categorisation.  CMS1 is associated with both MSI and 
CIMP, CMS2-4 are all CIN.  CIN type cancers can be distinguished by the number of gene copy 
number alterations (CMS2 and CMS4), expression of WNT and MYC (CMS2), KRAS mutations (CMS3) 
and TGF-β activation (CMS4) (Guinney et al., 2015).  The detection of these pattern in colorectal 
cancer samples suggests that there may be different underlying genetic profiles or cellular processes 
which lead to the development of colorectal cancer. 
In conclusion, there is evidence from analysis of colorectal cancers that there are different subtypes 
of colorectal cancer.  These subtypes may be caused by inherited genetic variation.  The conjecture 
for this chapter is that subtypes of colorectal cancer can be detected in genetic data. 
Second Hypothesis (H2):  A model for subtypes of colorectal cancer performs better than a case-
control model to predict the development of colorectal cancer. 
3.2  Results 
3.2.1  Replication of GWAS Results 
The SNPs found to be significant in large genome−wide association studies were assessed to 
determine whether they are significant in the whole genome colorectal cancer dataset.  Univariate 
logistic regressions were calculated for the data and the results for selected SNPs are shown in Table 
42 
 
3.1.  None of the SNPs in the dataset are significant at the threshold for genome−wide significance 
of 5x10-8.  SNPs that are in linkage disequilibrium with the lead SNPs (LD SNPs) are also not significant 
at a genome−wide significance level.  The LD SNPs are within 26,000 base pairs (bp) except for lead 












































4.96 x10-07 1.14 0.0536 rs34530130 1.15 3.01 x10-02 
Table 3.1:  Replicated lead SNPs from a large study by Law et al. (2019) and the coefficient and 
probability values obtained for the whole genome colorectal cancer data.  The logistic equations 
include sex and six principal components as co-variates.  The SNPs in linkage disequilibrium (LD) with 
the lead SNP have an r2>0.75 with the lead SNP. 
3.2.2  Unsupervised Clusters for Significant SNPs in GWAS 
The number of clusters recommended for Ward’s method and K-means by the different methods 
for assessments of the numbers of clusters are shown in Table 3.2.  When the cases and controls 
are analysed together, the most commonly recommended number of groups is two.  The larger 
values reported are suspected to be an inability to report a one cluster solution, for example the 
prediction of twenty-five clusters for k-means with all of the data.  This conclusion is supported by 
the Gap statistic, which recommends one cluster using the first maximum in the Gap statistic. 
When the two-cluster solutions are analysed (by any of these methods), the two clusters do not 
separate cases and controls, despite the use of the significant SNPs from GWAS.  For example, the 
two-cluster solution recommended by the CH method for k-means has proportions of cases in each 
cluster of 0.641 and 0.680. These proportions are not significantly different from the proportion of 
cases in the data of 0.660, as these proportions could occur by chance by taking a random sample 
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(based on a 90% confidence interval for a cluster of that size).  The seven and twelve cluster solutions 
recommended by the BIC for Ward’s D and k−means respectively could also occur by chance.  
Similarly, the twenty-five clusters recommended by the silhouette method with k-means form 
clusters (with a size of 45-108) that have a proportion of cases more/less than a random sample 
(based on 90% confidence interval) for four out of twenty-five clusters which is not statistically 
significant (p=0.236 based on a binomial distribution). 
Clustering Method Cluster Number Method All Cases Controls 
Wards Silhouette 2 2 37 
 CH 2 2 2 
 Gap 1 1 1 
 BIC 7 2 1 
Complete Silhouette 2 2 2 
 CH 15 4 3 
 Gap 1 1 1 
 BIC n/a n/a n/a 
K-means Silhouette 25 39 50 
 CH 2 2 2 
 Gap 1 1 1 
 BIC 12 10 10 
Model-based BIC 1 1 1 
OPTICS Reachability 1 1 1 
Table 3.2:  Cluster numbers identified in each clustering method by the cluster number methods 
shown.  For the model-based and OPTICS methods only one cluster number method was available. 
The cases were clustered separately (to ensure that clusters in the cases are detected without 
confounding by the variation in the controls).   The number of recommended clusters and the fit of 
the penalised logistic regression models are shown in table 3.3.  The model-based and OPTICS data 
is not included as only one cluster was identified in the cases and controls, so the solution is the 
same as the base model.  When the data is split for clustering, the number of recommended clusters 
is generally less than or equal to the number of clusters for the cases and controls together.  The 
application of discriminant analysis to the clusters identified in the data does not identify any 
improved ability to predict the development of colorectal cancer compared with the polygenic risk 











Build AUC Validation AUC 
Wards Cluster then split 2→4 0.490 0.539 
 Split then cluster 2+2=4 0.499 0.516 
Complete Cluster then split 2→4 0.512 0.478 
 Split then cluster 2+2=4 0.497 0.522 
 Split then cluster 4+3=7 0.507 0.490 
K-means Cluster then split 2→4 0.488 0.516 
 Split then cluster 2+2=4 0.503 0.548 
Table 3.3:  The performance of models as measured by the AUC when SNPs that are significant in 
large GWAS are clustered and then split into case/control groups or split into case/control groups 
and then clustered. 
3.2.3  Supervised Clusters for Significant SNPs in GWAS 
3.2.3.1  Gradient Boosted Trees 
The best performing gradient boosted trees models are shown in Table 3.4, along with selected 
models from Chapter 2.  Most of the models have validation AUCs better than the PRS and best GLM 
or PLR models from Chapter 2.  The fit of the models for the dataset that consists of significant 
GWAS SNPs replicated in large datasets (70 SNP) is better than the fit of the models from the larger 
dataset (562 SNPs) that also includes GWAS SNPs identified in small datasets and/or that have not 
been replicated.  The models from the larger dataset have lower validation AUCs for the same model 
depth.  A comparison of the models constructed from the two datasets show that some of the 
signals detected in the 70 SNP dataset are also detected in the 562 SNP dataset.  For example, 
rs6983267 is included in five of the models and all six models use rs12682374 which is in high LD 
with it (r2>0.8). 
The model from the 70 SNP dataset with a depth of five and minimum leaf size of ten has the highest 
validation AUC, but is likely to be overfitted, as there is a large difference between the model build 
and validation AUCs.  The models from the 70 SNP dataset with a depth of three and nineteen trees, 
and from the 70 SNP dataset and a depth of five with a minimum leaf size of twenty, both have build 
AUCs closer to their validation AUCs and use less variables than the model with the highest AUC.  
Both of these models have higher validation AUCs that the highest generalised logistic model (GLM 
with significant SNPs only), with the AUC for the model with a depth of three higher by 0.028 and 
the model with a depth of five higher by 0.033.  The differences between these models and the 










Build AUC Validation AUC 
GBT - 70 SNPs 1 30 30 24 40 0.618 0.568 
 2 30 90 48 20 0.710 0.574 
 3 19 133 48 40 0.705 0.597 
 5 16 496 71 10 0.879 0.602 
 5 8 248 49 20 0.734 0.593 
GBT - 562 SNPs 1 40 40 40 80 0.673 0.540 
 2 2 6 6 20 0.596 0.557 
 3 4 28 14 40 0.628 0.576 
 5 8 248 170 1 0.959 0.583 
 9 6 3066 122 10 0.863 0.584 
 10 6 6138 124 10 0.864 0.581 
PRS  - - 97 - 0.576 0.564 
GLM  - - 97 - 0.637 0.545 
GLM  
(significant SNPs) 
 - - 6 - 0.589 0.569 
PLR  - - 13 - 0.565 0.543 
Table 3.4:  The best performing gradient boosted tree (GBT) models for the 70 SNP dataset 
(significant GWAS SNPs replicated in large datasets)  and 562 SNP (70SNPs plus significant GWAS 
SNPs identified in small datasets and/or that have not been replicated).  The polygenic risk score 
(PRS), generalised logistic regression models (GLM) and penalised logistic regression (PLR) models 
from Chapter 2 are also shown for comparison. 
Separate models for each sex were also assessed, given the difference in the fit of the PRS model to 
males and females seen in Chapter 2 (see Table 3.5).  The validation AUC was higher for both sexes 
when the data was split by sex, but this is likely to be due to overfitting of the models given the 
small numbers of samples in each group.  The overlap in the models by sex is relatively low, with 
only six variables in common.  The variables that appear in only one sex-based model have strong 
univariate odds ratios for one sex but not the other, which may be from sex-based differences but 
is more likely to be due to sampling variation. 
Tree models can be used assess the impact of additive alleles in the GLM/PRS models and identify 
potential interactions between SNPs.  With the same six SNPs, the GLM model has a higher 
validation AUC than the best GBT model, with validation AUCs of 0.569 and 0.558 respectively (see 
Table 3.6).  This suggests that an additive model better specifies the relationship between alleles 
than the splits used by the GBT model.  However, the GBT models are constrained to split as either 
zero alleles vs one and two alleles or zero and one alleles versus two alleles, so two trees are needed 
to contain the same information as one variable in the GLM model.  When the number of trees is 
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increased to twelve, a GBT model can achieve an AUC similar to the GLM model of 0.568, with five 
of the six SNPs repeated as expected (one is present thrice). 










GBT - male 2 4 12 11 1 0.674 0.622 
GBT - female 4 3 45 27 5 0.713 0.594 
GBT - male and female 3 19 133 48 40 0.705 0.597 
PRS  - - 97 - 0.576 0.564 
GLM  - - 97 - 0.637 0.545 
GLM (significant SNPs 
only) 
 - - 6 - 0.589 0.569 
PLR  - - 13 - 0.565 0.543 
Table 3.5:  The best model for each sex from the significant GWAS SNPs dataset.  The best model 
was selected to have a high validation AUC and a relatively low gap between the build and validation 
AUC values.  The polygenic risk score (PRS), generalised logistic regression models (GLM) and 







Vars Build AUC Validation AUC 
GBT 1 40 6 6 6 0.582 0.558 
 1 40 12 12 6 0.591 0.568 
 2 40 7 21 6 0.598 0.577 
 3 40 4 28 6 0.602 0.576 
 5 40 3 93 6 0.600 0.571 
PRS  - - - 97 0.576 0.564 
GLM  - - - 97 0.637 0.545 
GLM (significant 
SNPs only) 
 - - - 6 0.589 0.569 
PLR  - - - 13 0.565 0.543 
Table 3.6:  Gradient boosted tree models (GBT) for the significant GWAS SNPs dataset with the 
number of variables limited to six and a minimum leaf size of forty.  The polygenic risk score (PRS), 
generalised logistic regression models (GLM) and penalised logistic regression (PLR) models from 
Chapter 2 are also shown for comparison. 
The weights on alleles in the GBT model can be used to assess whether an additive model is 
appropriate for each SNP (adding weights where they appear in the model more than once).  In the 
GBT model with twelve trees, an additive model is valid for some SNPs (e.g. rs3184504) but not for 
others (e.g. rs6983267 for which a double minor allele is more protective than twice the value of a 
single minor allele).  This suggests that for the SNPs in the models assessed, the assumption that 
two minor alleles have twice the effect of one minor allele may not be valid for some SNPs, but that 
the fit of a linear model is not greatly impaired. 
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Interactions between SNPs may occur when the tree depth is greater than one.  With the same six 
SNPs used to compare the effect of additive alleles, a model with a depth of two performs slightly 
better than a linear model, with validation AUCs of 0.577 and 0.569 respectively.  The validation 
AUC for the GBT model with a depth of two is also greater than the GBT model with a depth of one 
but twelve trees (validation AUC of 0.568), so there is an additional benefit in the model with a 
depth of two, above the benefit of specifying each allele separately.  This suggests that some SNPs 
have a different impact on the risk of developing colorectal cancer when another SNP is present.  
Models for depths of three and five are shown in Table 3.6, but with only six SNPs in the model there 
is no additional benefit for any interactions between three or more SNPs. 
The analysis of the gradient boosted tree models suggests that a gradient boosted tree with the 
correct parameters may outperform a polygenic risk score based on a logistic model.  The model 
chosen to develop supervised clusters is the gradient boosted tree model with a minimum leaf size 
of forty, a depth of three and nineteen trees as this model has a relatively high validation AUC of 
0.597 and the minimum leaf size means that it will find groups that apply to groups of a meaningful 
size.  This model was used for the following analysis. 
3.2.3.2 Clustering based on SHAP Values for the Best Gradient Boosted Tree Model 
The features in the best gradient boosted tree model (with a minimum leaf size of forty, a depth of 
three and nineteen trees) have varying levels of importance based on SHAP values.  The varying 
levels of conditional contributions can be seen in figure 3.1, where each point shows the SHAP value 
of one sample by SNP.  The mean SHAP value is shown on the left of the figure.  The weight applied 
to each allele varies depending on the tree branch(es) which contribute to the score for that sample, 
with negative SHAP values representing a decrease in the risk of developing colorectal cancer, and 
positive values an increase in the risk of developing colorectal cancer.  The dispersion of samples is 
greater for SNPs that were used multiple times within the trees.  The SHAP scores for SNPs range 
from -0.515 (protective) to 0.391 (adverse) and the net SHAP scores for samples range from -2.19 
to 2.54 with a mean of 0.055.  
The SHAP values show that there is a wide variation in the conditional contribution of a SNP to the 
final predicted probability of developing colorectal cancer from the gradient boosted tree model.   
For example, two minor alleles of rs6983267 can be strongly protective against colorectal cancer, 
but this effect only occurs in the presence of specific SNPs (coefficient -0.51) and can be reduced by 
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other specific SNPs (coefficient -0.10).  The highest contributions are made by relatively few SNPs, 
although the strength of these SNPs is conditional on the presence of the remainder of the SNPs in 
the model.  The gradient boosted tree and logistic models agree about which SNPs are most 
important, as the top five SNPs from the GBT model are the same as five of the six SNPs in the best 
performing GLM model.   The sixth SNP from the GLM model (rs73208120) is fourteenth in the 
gradient boosted tree model.  This SNP is important to the fit of the GLM model, as the validation 
AUC drops from 0.569 to 0.557 when it is excluded.  
 
Figure 3.1:  SHAP values by SNP for the gradient boosted tree model for the significant GWAS SNPs 
dataset, with a depth of three, nineteen trees and a minimum child weight of forty. 
Clustering methods were applied to the SHAP data to determine whether groups of samples 
clustered together (see Table 3.7).  The clusters identified are not considered to be useful, as there 
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are no SNPs which are characteristic of a particular group.  The clustering solutions are also unstable, 
with differences in the SNP signature of the clusters when the validation data is added. 
None of the results were conclusive so the clustering solution for Ward’s D was examined visually 
(Figure 3.2).  This figure shows the SHAP values by sample for the 15 SNPs with the highest SHAP 
values, with the order of the samples determined by clustering with the Ward’s D method.  The 
graph shows no obvious groups.  To improve the ability to visualise possible clusters, the figure was 
divided into six parts (Figure 3.3).  Parts 1 and 2 show no particular patterns and do not discriminate 
on risk, although there is a section of part 1 where two minor alleles of rs6983267 are protective 
which would be clustered separately if more clusters were used.  The samples in part 3 have an 
increased risk of cancer, with rs3184504, rs6983267, rs704017 and the “rest of the variables“ 
category all contributing to the increased risk level (rs3184504, rs6983267 are a branch on the first 
tree and rs3184504 and rs704017 are a branch on the third tree).  The increased risk for samples in 
part 4 is from one or two minor alleles of rs1035209 and is offset in some individuals by rs3184504.  
The cluster around order 500 in Figure 3.2 is shown in part 5 of Figure 3.3, where most of the 
samples have a reduced risk of developing colorectal cancer due to two minor alleles of rs1810502.  
This SNP only appears once in the model at the start of the third tree and has a strong protective 
effect on its own.  The samples in part 6 have an increased risk associated with one or two minor 
alleles of rs73208120, which also appears once in the model at the start of the fourth tree and 
increases the risk of developing colorectal cancer. 
Clustering Method Cluster Number Method Number of Clusters 
Ward’s D Silhouette 2 
 CH 2 
 Gap 2 
 BIC 24 
Complete Silhouette 2 
 CH 2 
 Gap 9 
 BIC n/a 
K-means Silhouette 2 
 CH 2 
 Gap 3 
 BIC 26 
Model-based BIC 17 
OPTICS Reachability 1 
Table 3.7:  The number of clusters in the SHAP values data for the best model (70 SNP dataset, depth 




Figure 3.2:  SHAP values by observation for the gradient boosted tree model for the significant GWAS 
SNPs dataset with a depth of three, nineteen trees and a minimum child weight of forty. 
 
Figure 3.3:  SHAP values for the gradient boosted tree model with a depth of three, nineteen trees 
and a minimum child weight of forty, split by cluster. 
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3.2.3.3  Analysis of the best performing Gradient Boosted Tree Model 
The best gradient boosted tree model (70 SNP dataset, a minimum leaf size of forty, a depth of three 
and nineteen trees, see Table 3.8) shows that there are particular combinations of SNPs that are 
either beneficial or adverse.  The combinations with the largest effect (leaf beta) are shown in Table 
3.8, where the leaf beta column is the weight applied to that particular combination in the logistic 
equation for the gradient boosted trees.  The combinations identified have coefficients that are 
different from those used in a GLM model (the sum for that SNP combination) and can differ in 
effect direction. 
Tree Combination of SNPs and Alleles 
Leaf 
Beta 
Logistic Model Beta 
0 rs6983267(aa), rs4919687(Aa,aa) -0.452 -0.282/-0.018 
0 rs6983267(AA,Aa), rs1078643(AA), rs3184504(AA,Aa) 0.259 -0.282/-0.109/-0.176 
0 rs6983267(AA, Aa), rs1078643(Aa,aa), SEX(M) -0.319 -0.282/-0.109/0.167 
1 rs3802842(AA), rs72013726(aa) -0.390 0.189/-0.08 
1 rs3802842(AA,Aa), rs2295444(AA,Aa), rs1391441(AA) 0.379 0.189/-0.13/-0.1 
2 rs1810502(AA,Aa), rs704017(AA), rs1321311(Aa,aa) 0.442 -0.135/-0.165/0.162 
3 rs73208120(AA), rs6983267(AA), rs9929218(AA) 0.300 0.28/-0.282/-0.149 
4 rs3184504(AA), rs1800469(AA) 0.380 -0.176/0.018 
5 rs2450115(AA), rs10774214(AA) -0.277 -0.124/0.097 
6 rs10161980(Aa,aa), rs10849432(Aa,aa) -0.296 -0.14/0.03 
7 rs6906359(AA), rs4444235(Aa,aa), rs4360494(aa) 0.326 -0.194/-0.016/-0.008 





13 rs704017(AA,Aa), rs812481(AA), rs2423279(AA) 0.290 -0.165/-0.011/0.037 
15 rs1957636(AA), rs6691170(AA) 0.302 0.007/-0.037 
18 rs10161980(AA,Aa), rs961253(AA), rs1078643(Aa,aa) 0.315 -0.14/0.103/-0.109 
Table 3.8:  Interactions present in the model with a leaf beta (coefficient in the logit model) of greater 
than ±0.25.  The Alleles for each SNP are shown as A for a major allele and a for a minor allele.  The 
logistic model beta values are the coefficients for the SNPs in a univariate logistic regression. 
The interactions on the first tree were further investigated.  For the interaction between rs6983267 
and rs4919687 (see the yellow box in Figure 3.4), two minor alleles (TT) of rs6983267 (intron of 
CASC8/non-coding transcript variant of CCAT2) protects against the development of colorectal 
cancer, with an increase in protection when there are one or two minor alleles (AG or AA) of 
rs4919687 (intron of CYP17A1).  These two SNPs interact, as rs4919687 has a main effect close to 
zero (coefficient of −0.02 in the GLM model).  The impact of this interaction can be seen in Table 
3.9, where there is variation in the odds ratio for two minor alleles of rs6983267 (TT) when the 




Figure 3.4:  The first tree (called Tree 0 in xgboost) of the best model  (70 SNP dataset, depth of three, 
nineteen trees and a minimum child weight of 40).  The yellow box shows an increasing interaction.  
The blue box shows a sex specific interaction (1=male).  The green box shows a reducing interaction. 
Odds Ratios 
rs4919687 
AA AG or GA GG 
rs6983267 
GG 1.000 1.064 0.749 
TG or GT 0.816 0.907 0.871 
TT 0.725 0.560 0.592 
Table 3.9:  The odds ratios for the interaction between rs6983267 and rs4919687 in the combined 
build and validation datasets.  The major alleles are GG and AA respectively, this is the reference for 
the odds ratios.  Values shown in bold are significant with p-value<0.05 in a likelihood ratio test. 
The protective interaction of rs6983267 TT with rs4919687 AG/GA is overrepresented in the 
controls (noting that controls are selected to not have colorectal cancer) and underrepresented in 
the cases (based on frequency for these alleles in European populations in Hardy-Weinberg 
equilibrium).  This pattern is present in both the build and validation datasets.  The likelihood ratio 
test (on the combined build and validation data due to the small number of samples with minor in 
the validation dataset) shows that the interactions are significant (p=0.00363), with none of the 
main effect significant without the interactions.  This interaction would not be detected with 
commonly used tests based on allele counts or regression-based significance tests (p=0.617 for fast-
epistasis, p=0.569 for epistasis, p= 0.364 for boost commands in PLINK1.9). 
The top branch in the first tree (see the green box in Figure 3.4) includes rs6983267, rs1078643 and 
rs3184504.   At least one major allele of rs6983267, two major alleles of rs1078643 and at least one 
major allele of rs3184504 are adverse (coefficient 0.259).  But when two minor alleles of rs3184504 
are present, then the risk posed by major alleles of rs6983267 and rs1078643 is reduced (coefficient 
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−0.092).  This interaction is significant when tested with the likelihood ratio test (p= 0.000951).  
When the coefficient for the adverse tree branch (0.259) is compared with the coefficients from the 
GLM model for these SNPs, it shows that there is a reducing interaction between these SNPs.  Even 
though all three sets of major alleles are adverse, the collective impact is not as bad as the additive 
impact of the coefficients of the GLM model would suggest. 
The gradient boosted tree models also have the ability to account for differential effects of SNPs by 
sex.  The importance of this can be seen in Figure 3.4 (blue box), where the combination of at least 
one major allele of rs6983267 (GG) and at least one minor allele of rs1078643 (GA or GG, missense 
variant in TMEM238L) is protective for males (coded 1) but not females (coded 2).  When this 
interaction is tested with a likelihood ratio test, it is significant at a 0.05 level (p= 0.0442).  A large 
difference seen in the full LRT model coefficients between sexes for two major alleles of rs6983267 
with two minor alleles of rs1078643 (males -3.7263, females 2.1706), with both coefficients 
significant (p-value <0.01).  This sex difference is generally not accommodated within polygenic risk 
scores (PRS) or generalised linear regressions.  Sex is generally only included in as a covariate, which 
assumes that sex effects are constant across all SNPs, when it would need to be included as an 
interaction to detect a sex specific interaction. 
SHAP values can also be used to assess interactions between SNPs by decomposing the effect of an 
interaction into the main effect of each SNP and the incremental effect of the interaction.  
Interactions between SNPs on the first tree of the gradient boosted tree model (as shown in Table 
3.8) are shown in Figure 3.5.  The SHAP interaction values are calculated for the model, so a spread 
of points occurs on the graphs when the variable appears multiple trees.  On the graphs, a horizontal 
line at zero would indicate that there are no interactions.  For all pairs of SNPs, it can be seen that 
the interaction size varies by genotype, with either two major alleles or two minor alleles varying in 
the direction of their impact from the other points.  This provides visual support for the interactions 
found to be significant by the likelihood ratio test. 
The analysis of the best gradient boosted tree model (70 SNP dataset, depth of three, nineteen 
trees, minimum child weight of forty) showed that interactions between SNPs are likely to 
contribute to variations in the level of colorectal cancer risk between people.  Based on the model 
analysis, it appears that main effects or interactions between SNPs are the cause of differences in 




Figure 3.5:  The size of the interaction (in SHAP values) between the pairs of SNPs within the best 
gradient boosted tree model (70 SNP dataset, depth of 3, nineteen trees, minimum child weight 40).  
For each interaction, it can be seen that the interaction SHAP value differs between genotypes (no 
interaction gives points that are in a horizontal line at zero). 
3.3  Discussion 
The identification of subtypes of colorectal cancer which are caused by genetic differences would 
aid in the identification of those at risk of developing colorectal cancer and improve models to 
predict the development of colorectal cancer.  This study used single nucleotide polymorphisms 
(SNPs) shown in genome-wide association studies (GWAS) to have a significant effect on the risk of 
developing colorectal cancer to examine whether subtypes exist for colorectal cancer.  
Unsupervised clustering methods were unable to identify clusters within the GWAS data which 
could be used to identify subtypes of colorectal cancer.  Supervised clustering methods, i.e. 
clustering methods applied to data which was weighted by its contribution to the best gradient 
boosted tree model, were also unsuccessful in identifying subtypes of colorectal cancer.  The lack of 
success of clustering reflects the difficulty of replicating GWAS results in relatively small samples.  
None of the assessed SNPs (or SNPs in high linkage disequilibrium with them) reached a probability 
of 1x10-5 for their univariate logistic regressions, with nine significant at a probability of 0.05.   Across 
all SNPs found to be significant in GWAS, only ~40% are replicated with a probability of at least 
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1x10−5, with high proportions replicated at less stringent thresholds (Marigorta, Rodríguez, Gibson, 
& Navarro, 2018).  Even in a sample of almost 35,000 colorectal cancer cases, the rediscovery rate 
was 78%, when the SNP needs to exceed a threshold of at least 1x10-5 to be replicated (Law et al., 
2019).   
The gradient boosted tree models built for the supervised clustering showed that gradient boosted 
tree models can improve the performance of polygenic risk scores.  The best gradient boosted tree 
model outperformed the best linear model, with validation AUCs of 0.597 and 0.569, respectively.  
Although the difference in the validation AUC was not statistically significant, the increase in the 
AUC of 0.028 is a meaningful improvement given that the models were built from the same set of 
SNPs and samples.  The difference in performance relates to the ability to specify the weight of 
combinations of up to three SNPs by alleles in the gradient boosted tree model instead of the 
additive weights used in the linear model (i.e. two minor alleles have twice the effect of one minor 
allele).  Gradient boosted trees and linear models performed equally built with the same SNPs and 
a depth of two for the trees, with validation AUCs of 0.568 and 0.569.  The improvement in 
performance from a validation AUC of 0.568 to 0.596 occurs when the depth of the gradient boosted 
trees increases from two to three (i.e. three SNPs are used to allocate a risk weight to a sample), 
despite the restriction applied within the model that limits the minimum size of the group at the 
end of each branch.  This suggests that the risk of developing colorectal cancer increases when at 
least three adverse SNPs are present. 
The use of a gradient boosted tree model uses more of the information available in the data than a 
linear model.  The gradient boosted tree model with a depth of three includes more SNPs in the 
model, as it uses forty-eight SNPs.  The additional SNPs included tend to have lower odds ratios in 
GWAS, e.g. rs1810502 has an odds ratio of 1.07.  Although the odds ratio for these SNPs are 
relatively low across the population, the impact for the section of the population which have this 
variant is relatively high.   The beneficial effects of this SNP only occur when there are two minor 
alleles (17.6% of the sample, minor allele frequency of 0.453), and the conditional SHAP scores for 
two minor alleles range from -0.214 to -0.515 (the SHAP values for this model range from -0.515 to 
0.391, positive values are adverse).   The variation in the effect of two minor alleles varies depending 
on the other SNPs present in a genotype.  This cannot be accounted for by a linear model with 
additive SNPs and causes the improvement in the performance of the gradient boosted tree model. 
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The results of this analysis suggest that further investigation of the use of gradient boosted tree 
models to predict the development of colorectal cancer.  The analysis here was limited by the size 
of the dataset, with many SNPs that were significant in large GWAS unable to be replicated.  The 
ability to test findings for significance was also limited, such as the significance tests for interactions 
that were conducted on the combined dataset, as the validation dataset was too small to expect 
any result other than not significant.  The lack of benefits seen in the cluster analysis of the genetic 
data suggests that different methods are needed to identify clusters in genetic data, so that 
inherited genetic similarities can be distinguished from genetic similarities that are associated with 
colorectal cancer.  However, clustering will not be able to detect the impairment of pathways that 
contribute to colorectal cancer, which may be a more promising way to look at patterns in the 
genetic causes of colorectal cancer. 
3.4  Conclusion 
There are no identifiable subtypes of colorectal cancer present in single nucleotide polymorphisms 
identified by genome-wide association studies.  This conclusion may change if a larger set of single 
nucleotide polymorphisms is used to construct models or if samples were separated prior to analysis 
based on the expression signature of the colorectal carcinomas that develop.  The use of a gradient 
boosted tree model found single nucleotide polymorphisms that deviate from the additive alleles 
model commonly used for polygenic risk scores.  The ability to model non-additive alleles in gradient 





4.  Identification of Colorectal Cancer Locations 
4.1  Introduction 
Polygenic risk scores for colorectal cancer are below the level of accuracy required for the scores to 
provide accurate predictions for individuals of their risk of developing colorectal cancer.  In the 
previous chapter, the existence of different subtypes of colorectal cancer with different genetic 
causes was examined, but there were no identifiable genetic subtypes.  This assumed that a 
genotype predisposed to colorectal cancer can develop cancer at any point in the colon or rectum.  
However, the environment within the colon and rectum is not homogenous, as the level and type 
of bile acids and microbiome composition vary from the start of the colon through to the rectum.  
Experimental evidence shows that there are differences between cancers that develop at different 
locations in the colon, with differences in gene expression between cancers that begin on the right 
or left side of the colon (Peng et al., 2018). 
Bile acids are produced from cholesterol in the liver and stored in the gall bladder.  Cholic acid (CA) 
and chenodeoxycholic acid (CDCA) are the major bile acids and account for 70% of bile produced.  
Bile acids make dietary lipids and lipid soluble vitamins (A, D, E) soluble, digestible and absorbable 
in the small intestine (Ridlon, Kang, & Hylemon, 2006).   The amount of bile produced increases with 
increasing fat in the human diet, and higher bile levels are correlated with an increased incidence 
of colorectal cancer (Liu et al., 2019; Ridlon, Kang, Hylemon, & Bajaj, 2014). 
Bile acids affect the concentration of bacteria in the digestive system (gut microbiome), with higher 
levels of bacteria and different local compositions of species within the microbiome the further you 
are from the bile duct (Liu et al., 2019; Ostaff, Stange, & Wehkamp, 2013).  The composition of 
species in the gut microbiome is thought to be important in the development of colorectal cancer, 
as the gut microbiome differs between colorectal cancer patients and controls (Ahn et al., 2013; Liu 
et al., 2019; Louis, Hold, & Flint, 2014; Wang et al., 2012).  Alterations in the microbiome appear to 
speed the progression of colorectal cancer.  The use of broad-spectrum antibiotics (reducing the 
diversity of the microbiome), by patients with advanced colorectal cancer, reduced survival rates to 
24 months, versus 89 months for those who did not receive antibiotics (Ahmed et al., 2018; 
Dethlefsen & Relman, 2011).  Dysregulation of the microbiome leads to increased inflammation and 
promotes the development of cancer (Chen & Vitetta, 2018; Ostaff et al., 2013). 
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Bacteria in the colon can indirectly contribute to the development of cancer through their actions 
on bile acids.  Bacteria (e.g. Clostridium spp. Lachnoclostridium spp., and Eggerthella spp.) can 
deconjugate, oxidise and dehydroxylate bile salts to forms the secondary bile acids deoxycholic acid 
(DCA) and lithocholic acid (LCA) (Heinken et al., 2019; Ridlon et al., 2014).  Secondary bile acids 
damage endothelial cell membranes at high concentrations and are carcinogenic in animal models.  
In humans, high levels of secondary bile acids are associated with colorectal cancer (Ajouz, Mukherji, 
& Shamseddine, 2014; Bernstein et al., 2011; Makishima et al., 2002).  DCA is thought to damage 
DNA and activate genes known to be involved in carcinogenesis, including β-catenin, JNK1, EGF 
(Makishima et al., 2002; Ridlon et al., 2006). 
Bacteria in the microbiome may also directly cause colorectal cancer.  Fusobacterium spp., 
Bacteroides fragilis and enteropathogenic Escherichia coli have all been implicated in the 
development of colorectal cancer (Mármol et al., 2017; Purcell et al., 2017).  F. nucleatum and some 
strains of B. fragilis both produce proteins which promote the development of colorectal cancer.  F. 
nucleatum and B. fragilis produces produce proteins (FadA and BFT) which both damage E-cadherin 
and activate β-catenin signalling (Louis et al., 2014; Rubinstein et al., 2013; Sears, Geis, & Housseau, 
2014).  B. fragilis also induces the oncogene c-MYC and produces high levels of polyamines, which 
are toxic and associated with the development of cancer (Louis et al., 2014).  Adherent-invasive E. 
coli have been shown to adhere to the colonic mucosa, which reduces the ability of the epithelial 
cells of the colon to produce anti-microbial peptides and mucins.  The close contact between 
epithelial cells of the colon and E. coli also allows bacterial products, such as colibactin, to enter the 
cells and cause double stranded breaks in DNA (Nougayrède et al., 2006; Secher, Samba-Louaka, 
Oswald, & Nougayrède, 2013). 
Beneficial bacteria may also prevent colorectal cancer.  Indigestible intestinal fibre and resistant 
starches such as cellulose, lignan and pectin are fermented in the colon to produce short fatty acids 
e.g. acetate, propionate and butyrate.  Short fatty acids provide energy to colonocytes (which 
promotes cell growth), reduce intestinal permeability, reduce inflammation, increase apoptosis and 
decrease the proliferation of cancerous cells, and increase commensal bacteria (Ahn et al., 2013; 
Chen & Vitetta, 2018; Louis et al., 2014; Wang et al., 2012).  Butyrate produced by Ruminococcus 
spp. and Bifidobacterium spp. has been identified as the key substance which protects against 
colorectal cancer, as it causes the activation and maturation of T-reg cells, inhibits histone 
acetyltransferase, enhances the expression of mucin genes, induces the expression of anti-microbial 
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proteins and reduced the levels of oncogenic miR-92a (Chen & Vitetta, 2018; O'Keefe, 2016).  
Butyrate increases the phosphorylation of SMAD3, which protects against cancer through the 
induction of differentiation and cell cycle arrest (Daniel, Schröder, Zahn, Gaschott, & Stein, 2004; 
Daniel et al., 2007; Gaschott & Stein, 2003). 
The literature on bile acids and the microbiome shows that differences in the microbiome are 
associated with the development of colorectal cancer.  Therefore, different genotypes may be 
susceptible to the development of colorectal cancer at different locations within the colon and 
rectum through the impact of genetic variation on the gut environment.  The hypothesis for this 
chapter is the same as in Chapter 3 (the second hypothesis for this thesis), except in this chapter the 
subtypes of colorectal cancer are assigned by the location of the cancer within the colon or rectum, 
rather than through the identification of clusters within the data by statistical analysis. 
Second Hypothesis (H2):  A model for subtypes of colorectal cancer performs better than a case-
control model to predict the development of colorectal cancer. 
4.2  Results 
4.2.1  Univariate Logistic Regression Analysis 
The dataset was examined for population stratification with a quantile-quantile plot (see Figure 4.1).  
Without principal components included, there is evidence of population stratification.  However, as 
the SNPs are on a panel array where SNPs were selected for their potential impact on disease, the 
increased number of SNPs with low probabilities is not unexpected.  The reduction seen in the 
Figure 4.1:  Quantile-quantile plots of the probabilities from univariate logistic regressions for the 




deviation from the expected distribution of probabilities with the addition of twenty principal 
components (right) may therefore be removing SNPs that are associated with colorectal cancer.   
The number of SNPs in the dataset needed to be reduced to ensure that a unique solution existed 
for the linear discriminant analysis.  The SNPs with the highest probabilities in their univariate 
logistic regression were selected to build models, with univariate logistic regressions calculated for 
all locations of colorectal cancer combined and for each location separately (left colon, right colon 
and rectum against the controls).  The results are shown in Table 4.1.  The SNPs that are significant 
in the all-location regressions have a consistent effect (protective or adverse).  There is generally a 
stronger effect in one location in the colon than in the other locations.  The rectum location has less 




















rs6574553 0.86 4.31x10-06 0.83 1.34 x10-04 0.86 1.46 x10-03 0.90 0.0608 
rs900171 0.86 4.95 x10-06 0.81 2.44 x10-05 0.89 0.0149 0.90 0.0502 
rs12290790 1.24 7.11 x10-06 1.36 7.43 x10-06 1.25 1.07 x10-03 1.11 0.191 
rs1938736 1.19 8.93 x10-06 1.33 4.57 x10-07 1.10 0.0826 1.14 0.0478 
rs414031 0.85 1.12 x10-05 0.81 1.31 x10-04 0.88 0.0131 0.86 0.0144 
rs1357797 0.83 1.55 x10-05 0.83 2.31 x10-03 0.88 0.0400 0.80 2.86 x10-03 
rs615916 1.19 1.70 x10-05 1.22 7.33 x10-04 1.14 0.0245 1.22 4.02 x10-03 
rs865379 0.80 2.13 x10-05 0.82 0.0125 0.78 1.36 x10-03 0.82 0.0356 
rs6701062 1.15 2.17 x10-05 1.17 1.23 x10-03 1.14 6.41 x10-03 1.12 0.0372 
rs7081384 0.85 2.25 x10-05 0.83 8.35 x10-04 0.86 6.69 x10-03 0.87 0.0251 
Table 4.1:  The SNPs with the highest significance in the build dataset that contains all locations 
(right/ascending, transverse, left/descending, rectum).  Results for the transverse colon are omitted 
due to the small number of cases available. 
4.2.2  Prediction of the Location of Colorectal Cancer 
The SNPs with the highest significance in either the all-location or individual location univariate 
regressions were used to perform linear discriminant analysis (see Table 4.2 for the results).  Overall, 
the best validation AUC of 0.542 (95% confidence interval: 0.5135-0.5717) for a model to predict 
the location of a cancer is lower than polygenic risk score AUCs achieved in recent studies of 0.603 
to 0.654 (Jia et al., 2020; Li et al., 2019; Tasa et al., 2020; Thomas et al., 2020).  The relatively low 
AUC achieved by this model is not surprising as only 33 of the 70 significant and replicated GWAS 
SNPs for colorectal cancer (as used in Chapter 3) are included in the dataset or represented by SNPs 
with high linkage disequilibrium (r2>0.75).  Analysis of this model showed that the categorisation of 
colorectal cancers to a particular location by genetic variation is unstable, with the actual location 
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of the colorectal cancer not well detected by the models (see Table 4.3).  The accuracy of the 
classification of cases to the correct location is only 2.64%, with most incorrectly classified as cases.   
The best model to predict the location of cancer has the largest difference in the validation AUC of 
0.028 (for the all locations with p−value<1x10-3 dataset), but this is not statistically significant (p-
value=0.102).   
Models that were built from SNPs selected from the entire build dataset performed better than 
models that used SNPs selected for a particular location.  Analysis of the significant SNPs specific to 
particular locations showed that these SNPs were not predictive in the validation dataset.  Based on 
this analysis, there is no need to identify SNPs specific to a location within the colon and rectum. 
SNP Selection Data SNPs Prediction Build AUC Validation 
AUC 
Each location separately, 
p−value<1x10-3 
610 Location 0.712 0.510 
Case-Control 0.684 0.521 
All locations and each location 
separately, p−value<1x10-3 
766 Location 0.734 0.498 
Case-Control 0.715 0.508 
All locations, 
p−value<1x10-3 
219 Location 0.688 0.542 
Case-Control 0.662 0.514 
All locations, 
p−value<1x10-2 
2204 Location 0.839 0.521 
Case-Control 0.827 0.513 
Penalised Logistic Regression 219 Case-Control 0.688 0.525 
Table 4.2:  The performance of models built with linear discriminant analysis to predict the location 
of the development of colorectal cancer or to predict the development of colorectal cancer 
irrespective of location.  A penalised logistic regression model (LASSO) for the all locations with 
p−values<1x10-2 is provided for comparison. 







Rectum Misc. Total 
Control 2,133 71 1 17 58 2 2,282 
Right Colon 509 21 0 6 26 0 562 
Transverse Colon 81 4 0 4 4 0 93 
Left Colon 625 19 0 9 20 0 673 
Rectum 402 20 1 6 18 1 448 
Misc. 36 2 0 0 1 0 39 
Total 3,786 137 2 42 127 3 4,097 
Table 4.3: The movement of validation samples between categories for the linear discriminant 
analysis by location model with 219 SNPs.   
Models to predict the development of colorectal cancer by location were also built with gradient 
boosted trees, as these can use the full dataset without variable selection to build models.  The 
results are shown in Table 4.4.  The model that predicts locations performs better than the model 
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that predicts phenotype.  The validation AUC for the location model of 0.625 (95% confidence 
interval: 0.608−0.642) is better than the case-control model AUC of 0.597 (95% confidence interval: 
0.580−0.615) at a significance level of 0.05 (p-value=0.022).  However, the location model still has 
difficulty in distinguishing between the different locations within the colon and rectum for cases 
(Table 4.5).  The ability of the model to classify cases to locations within the colon and rectum is 
improved compared with the linear discriminant model but remains relatively low with only 9.31% 
of cases assigned to the correct location.   
Prediction SNPs Build AUC Validation AUC 
Location 38 0.651 0.625 
Case-Control 26 0.634 0.597 
Table 4.4:  The performance of models built with gradient boosted trees to predict the location of 
the development of colorectal cancer or to predict the development of colorectal cancer irrespective 
of location.  The location and the case-control models both have the same parameters except for the 
dependent variable.  The location model AUC is calculated by assigning samples as controls if the 
probability they are controls is greater than 0.5, and all other samples to cases. 







Rectum Misc. Total 
Control 1,931 155 0 149 47 0 2,282 
Right Colon 406 82 0 55 19 0 562 
Transverse Colon 68 15 0 8 2 0 93 
Left Colon 501 81 0 73 18 0 673 
Rectum 335 53 0 46 14 0 448 
Misc. 34 0 0 5 0 0 39 
Total 3,275 386 0 336 100 0 4,097 
Table 4.5: The movement of validation samples between categories for the gradient boosted tree 
model for location model. 
The gradient boosted tree model for case-control status is the best model after the parameters of 
the model were optimised.  As the model is optimised, it could be overfitted to both the build and 
validation datasets, as the fit to the validation dataset was used to choose between the models 
developed on the build dataset.  There are a number of reasons why this is not thought to have 
occurred.  There is a relatively small gap between the build and validation AUCs.  The optimised 
models with a depth of one have a similar fit to the best linear discriminant analysis model, which 
was not optimised, with AUCs of 0.538 and 0.542 respectively.  The worst of the case-control models 
has only six variables yet performs better than the best linear discriminant analysis model, with an 
AUC of 0.553.  The optimisation process also includes parameters that limit the use of SNPs that 
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only apply to small groups of samples, as these SNPs are more likely to reflect differences in genetic 
heritage rather than disease related differences.   
The results for the gradient boosted trees are significantly better than the results of the linear 
discriminant analysis models despite being built on the same dataset (p-value=1.35x10-6).  However, 
this is not a direct comparison, as the cases for the gradient boosted tree models are identified on 
the probability that the sample is not a control (probability they are a control of less than 0.5), rather 
than the assignment of samples to the location with the highest probability.  If the gradient boosted 
tree model was assessed based on the categories assigned based on the category with the highest 
probability, all cases would be predicted to be controls. 
4.3  Discussion 
The actions of bile and bacteria within the colon suggested that different sets of genetic variants 
may be associated with the development of colorectal at particular locations within the colon and 
rectum.  Both linear discriminant analysis and gradient boosted trees showed that models to predict 
the location in the colon or rectum may improve the ability to predict the development of colorectal 
cancer.  The improvement from the prediction of the location in the colon and rectum was 
significant for the gradient boosted trees but not for the linear discriminant models.  However, the 
differences seen between predicted and actual locations at which colorectal cancer developed 
suggests that there are no identifiable patterns of genetic variants that cause colorectal cancer to 
develop at a particular location within the colon or rectum.  The conflict between these two sets of 
result may be from subtypes of colorectal cancer present in the data that are associated with 
location to some degree and are therefore imperfectly identified.   
The patterns detected in the location models may relate to the different type of polyps that can 
develop in the colon and rectum.  Different types of polyps are more likely to be found in particular 
locations in the colon (Shussman & Wexner, 2014).  The patterns related to location may also be 
present but affected by environmental factors, especially diet.  Fat in the diet increases bile levels, 
which is associated with the development of colorectal cancer (Liu et al., 2019; Ridlon et al., 2014).  
Dietary fibre increases the level of short fatty acids in the colon and rectum, which have been shown 
to have beneficial effects that may protect against the development of cancer (Ahn et al., 2013; 
Chen & Vitetta, 2018; Louis et al., 2014; Wang et al., 2012).  The unmeasured variability from these 
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environmental effects would make the genetic patterns difficult to detect, as environmental 
variables are not included in the models.   
The key limitation of this study is the size of the groups for each of the locations of the carcinomas 
in the colon and rectum, which limits the power to detect SNPs associated with location within the 
colon.  The limited group size for the transverse colon meant that impact of inherited genetic 
variation was unable to be assessed for this location.  It also meant that a more granular analysis of 
the association between inherited genetic variation and the location of a carcinoma in the colon and 
rectum was not possible (for example for the cecum or rectosigmoid junction).  Linear discriminant 
analysis by location does provide a greater ability to detect differences by location but the use of 
linear models may not fit the real relationship between location and colorectal cancer well and may 
therefore miss location related genetic variation.  Future research into the relevance of genetic 
variation to the location at which colorectal cancer develops may benefit from the use of non-linear 
models, from the use of a larger dataset and from the incorporation of environmental variables.  It 
would be interesting to see if other cancer types also find that explicitly modelling cancer subtypes 
provides no benefit for prediction of the development of cancer.   
4.4  Conclusion 
There is no evidence to suggest that inherited genetic variation is associated with the location at 
which colorectal cancer develops.  Linear discriminant models to predict the development of 
colorectal cancer perform better when the location at which colorectal cancer developed is explicitly 
modelled, but this difference is not statistically significant and is an improvement over a poorly 
performing model.  Models that predicted the development of colorectal cancer by location were 
also unable to reliably assign samples to the carcinoma location even where they were correctly 
identified as likely to develop cancer.  Therefore, the location at which colorectal cancer develops 
may be the result of environmental factors, the interaction between genetic variation and 
environmental factors or the result of random chance.    
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5. Interactions Within Models to Predict the Development of Colorectal 
Cancer 
5.1  Introduction 
The search for genetic variants which cause disease has proven to be more difficult than expected 
at the time the human genome was first sequenced.  Genome-wide association studies (GWAS) have 
found sets of single nucleotide polymorphisms (SNPs) which achieve statistical significance after 
corrections for multiple hypothesis testing but have not proven useful to identifying those people 
who are susceptible to developing complex diseases such as cancer.  This has led to the development 
of different techniques to identify disease susceptibility. 
The ability to detect SNPs with an effect on the phenotype of interest depends on the size of the 
effect and the size of the dataset.  SNPs with larger effects are more readily detected than SNPs with 
smaller effects, as the less samples are required to distinguish the effect of the SNP from effects 
which stem from sampling variation.  For colorectal cancer, most variants have relatively small 
effects as the average reported odds ratios for SNPs is 1.14 (range 1.06 to 1.53).  There is also a 
relatively high variability in the estimated odds ratios between studies, as the odds ratios for a SNP 
can increase by 0.24 or decrease by 0.51 (average change in the odds ratio is a decrease of 0.06) 
when tested in a replication study (Law et al., 2019).  The size of the datasets increases the likelihood 
that SNPs with small contributions to disease states will be detected as statistically significant.  For 
colorectal cancer, the number of SNPs detected as statistically significant has increased from 10 to 
approximately 100 as the dataset size has increased from 4,000 to 125,000 (Huyghe et al., 2019; 
Tenesa & Dunlop, 2009). 
This ability to identifying those people who are susceptible to colorectal cancer with SNPs identified 
in GWAS can be assessed by the construction of a polygenic risk score (Kooperberg, Leblanc, & 
Obenchain, 2010).  Polygenic risk scores for colorectal cancer built with 140 GWAS identified SNPs 
have an AUC of 0.629 (Thomas et al., 2020).  However, an AUC of 0.629 remains below the threshold 
needed for population screening to be financially viable of a minimum AUC of 0.65 (Naber et al., 
2019).   In an effort to improve the performance of polygenic risk scores, models have also included 
SNPs below the threshold for statistical significance for multiple hypothesis testing to improve the 
performance of models.  For colorectal cancer, when the number of SNPs used in the polygenic risk 
score model is increased from 140 to 1.2 million, the AUC increases from 0.629 to 0.654 (Thomas et 
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al., 2020).  This AUC is above the minimum threshold for population screening to be financially 
viable, but the performance of the model would still lead to large numbers of false positive and false 
negative polygenic risk scores. 
Polygenic risk scores are constructed as linear models, where the effect of each allele of a SNP is 
added to (or subtracted from) the cumulative score for an individual (Kooperberg et al., 2010).  
However, a linear model may not fit the biological relationship between SNPs where there are 
interactions between SNPs, known as epistasis (Zuk et al., 2012).  When interactions occur, the 
presence of a SNP modifies the effect of the other SNP, increasing or decreasing the risk relative to 
the impact of each SNP on its own (Wright, Ziegler, & König, 2016).  For example, when two SNPs 
have main effects on their own (i.e. each SNP is correlated with the phenotype) but interact to have 
a much greater effect when both SNPs are present (see Figure 5.1).  The results of Chapter 3 of this 
thesis suggest that adverse and beneficial combinations of SNPs determine whether someone will 
develop colorectal cancer, i.e. interactions between SNPs.  Interactions cannot be adequately 
modelled by the linear models used in polygenic risk scores, as the change in the impact of a SNP 
due the presence or absence of another SNP is not included. 
The relevance of interactions between SNPs for complex diseases is intuitively appealing but the 
identification of interactions in humans is difficult.  The role of biological interactions is plausible as 
the actions of a particular protein can depend on the availability of precursor molecules, signalling 
molecules, co-factors required for actions to occur, transporters across cell membranes and the 
speed of degradation of molecules.  Biological interactions between SNPs have been demonstrated 
in model organisms including yeast and bacteria, but have not conclusively been shown in humans 
due to the complexity of human biology (Moore & Williams, 2005; Zuk et al., 2012).  Statistically 
significant interactions are more readily found but can be difficult to replicate, even in large samples 
(Johnsen, Riemer-Sørensen, Dewan, Cahill, & Langaas, 2021). 
For colorectal cancer, only two studies could be identified that systematically examined interactions 
between SNPs for colorectal cancer (Dorani, Hu, Woods, & Zhai, 2018; Jiao et al., 2012).  Other 
studies have examined interactions between selected genes with known cancer related pathway 
although often in relatively small samples (Kim, Yum, Kang, & Kang, 2016).  The examination of 
statistical interactions between SNPs for genome-wide data is limited by the large number of 
interactions that need to be examined to comprehensively examine all combinations (Niel et al., 
2015).  For example, to examine all possible three-SNP combinations of one thousand SNPs requires 
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166 million combinations to be examined.  Therefore, techniques which reduce the set of 
interactions to be examined are required.  The methods used to reduce the set of interactions to be 
examined include the selection of significant SNPs in GWAS, the selection of important SNPs in 
Random Forests and the use of Gradient Boosted Trees to select the best set of SNPs. 
 
Figure 5.1:  Different type of two SNP interactions that may be present in genetic data.  Interactions 
are present where the effect of two SNPs together (shown in grey) is greater than the combined 
individual effects (shown in blue and orange).  A main effect is when a SNP has an individual effect 
on the phenotype i.e. an odds ratio different from one. 
The use of significant GWAS SNPs to test for interactions limits the number of SNPs to be assessed 
in combinations but will miss SNPs that do not have a main effect.  In the figure above (Figure 5.1), 
only an interaction with two main effects is likely to be detected.  The interaction with no main 
effect SNPs is unlikely to be detected as neither SNP will be included in the dataset, and the 
interaction with one main effect is also unlikely to be detected, as only one of the SNPs will be 
included in the dataset.  Therefore, other methods are required to detect SNPs that interact without 
main effects. 
Random Forests reduce the computational burden to assess combinations of SNPs and can detect 
interactions.  Each tree in the random forest successively selects the best available SNPs from a 
random sample of SNPs, which in effect samples the space of all possible interactions for 
interactions most likely to be relevant (Breiman, 2001).  SNPs which interact with each other are 
likely to occur in the same tree as the inclusion of one of the interaction SNPs increases the 
likelihood that the other SNPs in the interaction will be the best available SNP in a subsequent 
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random sample (Dasgupta, Sun, König, Bailey-Wilson, & Malley, 2011).  The selection of SNPs by the 
Random Forest therefore indicates that the SNP either has a main effect or interaction, although 
interactions where none of the SNPs involved have main effects are unlikely to be detected (Wright 
et al., 2016).  As Random Forests are constructed from random samples of SNPs, they may include 
SNPs that were the best available SNP but are not causal.  The SNPs which are most useful make a 
greater impact on the accuracy of the trees, which can be measured with the variable importance 
score.  This can be used to select SNPs with main effects and/or interaction effects for use within 
models. 
Gradient Boosted Trees also reduce the computational burden to assess combinations of SNPs and 
can detect interactions.  Gradient Boosted trees are similar to Random Forests except that they 
select the best SNP available for each node from the entire set of SNPs instead of a random sample.  
When a SNP that occurs in an interaction is included in the tree, SNPs with interactions become 
more likely to be included in subsequent branches of the tree.  The interactions that can be included 
are limited to those where at least one of the SNPs has a main effect that is the best available SNP 
at a particular node, so will miss interactions where the SNPs have no main effects. 
Pairwise and three-way interactions have been examined for colorectal cancer with random forests 
and gradient boosted trees.  However, the interactions were not assessed for replicability and the 
ability of the significant interactions to identifying those people who at risk of developing colorectal 
cancer was not examined (Dorani et al., 2018).  The addition of these two criteria would increase 
the probability that the interactions detected represent biological interactions rather than statistical 
associations that have no real world meaning.   
In conclusion, the inclusion of interactions between SNPs may improve the performance of 
polygenic risk models.  However, interactions are difficult to detect due to the large number of 
interactions which would need to be examined to assess all possible interactions of three or more 
SNPs.  Random forests and gradient boosted trees can both be used to find interactions between 
SNPs, although they may miss interactions where none of the SNPs have detectable main effects.  
The rationale for this chapter (the third hypothesis for this thesis) is that the inclusion of interactions 
will improve the performance of models that predict the development of colorectal cancer.   
Third Hypothesis (H3):  A model that includes interactions performs better than a model without 




5.2  Results 
5.2.1  Selection of SNPs by Random Forest Importance Scores 
The gradient boosted trees models for various combinations of numbers of trees and sample 
selection proportions are shown in Table 5.1.  All of the results (those shown and those not shown) 
are consistent in their performance, with a range in the test AUC of 0.595 to 0.625.  The number of 
trees in the random forest does not alter the AUC achieved by the random forest although a lower 
sampling rate or a minimum child weight of eighty led to lower test AUC values.  A lower sampling 
rate combined with a smaller number of trees mean that not all possible combinations can occur 
and leads to a lower test AUC.  The minimum child weight restricts the use of SNPs that identify 
samples instead of cancer related patterns, but when the minimum child weight is eighty, it also 
appears to restrict the use of SNPs associated with cancer as the test AUC is lower.   
Minimum Child Weight Depth 
1,000 Trees 10,000 Trees 
r=0.01 r=0.1 r=0.01 r=0.1 
20      
 2 0.612 0.622 0.611 0.620 
 3 0.614 0.623 0.613 0.623 
 5 0.615 0.625 0.615 0.625 
40      
 2 0.612 0.622 0.612 0.623 
 3 0.612 0.623 0.613 0.624 
 5 0.614 0.625 0.614 0.625 
80      
 2 0.603 0.611 0.602 0.611 
 3 0.599 0.612 0.601 0.613 
 5 0.599 0.615 0.600 0.614 
Table 5.1:  The test AUC for random forests built with different combinations of the minimum child 
weight, depth, trees and sampling ratio (r).   
The contribution of each SNP to each random forest was measured with importance scores.  When 
the SNPs selected by the random forest are compared with the results of univariate logistic 
regressions, two patterns are apparent (see Figure 5.2):  the SNPs selected by the random forest 
include some of the SNPs that are selected by the highest probabilities in univariate logistic 
regressions but exclude many of the SNPs with the highest univariate probabilities; and the set of 
SNPs selected includes many SNPs that have low probabilities in a univariate logistic regression.  The 
cause of the different SNPs selected by the results of the univariate logistic regression probabilities 
and the random forest importance scores is the different methods by which the two figures are 
calculated.  The univariate regression probabilities measure how different the odds ratio of the SNP 
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is from one, when only that SNP and standard covariates (sex, study, twenty principal components) 
are included.  The random forest importance scores measure the impact of a SNP on the correct 
classification of samples in the complete model.  Therefore, the SNPs that are not important for a 
random forest may be good proxies for more than one SNP that are not included in the model, 
rather than associated with colorectal cancer in their own right.  For example, if the minor allele of 
SNP A with a minor allele frequency of 0.5 and the minor allele of SNP B with a minor allele frequency 
of 0.2 interact, the interaction (at least one minor allele of A and at least one minor allele of B) would 
have a frequency of 0.27 (assuming Hardy-Weinberg equilibrium).  If the interaction was highly 
correlated with another SNP, that SNP could seem important in a univariate logistic regression, but 
it would actually be an imperfect substitute for the two interacting SNPs when they are both present 
in a model. 
 
Figure 5.2:  Comparison of the SNPs selected by univariate logistic regressions and random forest 
importance scores.  Differences in the SNPs selected occur when different depths of trees are used in 
the random forest. 
The SNPs selected by random forests importance scores from random forests of different sizes and 
different depths select the same SNPs.  The SNPs selected with different sampling rates select a 
different set of SNPs (see Figure 5.3).  The same SNPs are selected for the highest ranked SNPs i.e. 
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the top twenty-five SNPs for this data, but with a lower sampling rate (0.01), SNPs that are 
unimportant with a lower sampling rate (0.1) become more important. 
 
Figure 5.3:  Random Forest importance scores for SNPs from forests with different sampling rates. 
5.2.2  Gradient Boosted Tree Models for Colorectal Cancer 
The gradient boosted tree (GBT) models with the highest validation AUC for each variable selection 
method is shown in Table 5.2, along with the results from the models built from the same dataset 
with LDA and GBT in Chapter 4.  The gradient boosted tree model to predict location (AUC=0.625) 
performed better than all of the other gradient boosted tree models but the difference between 
best model built with random forest importance scores was not significantly different 
(p−value=0.418).  All of the gradient boosted tree models performed better than the LDA models 
from Chapter 4, with a significant difference in the AUC between the top model to predict the 
phenotype of 0.615 (95% confidence interval:  0.597-0.632) and the best LDA model to predict 
location with an AUC of 0.542 (95% confidence interval: 0.5135-0.5717), a difference of 0.073 (p-
value=1.83x10-5).  The gradient boosted tree model from univariate SNPs (AUC=0.580, confidence 
interval: 0.5629-0.598) was also significantly better than the best LDA model (p-value=0.0258).   
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There were relatively minor differences in the validation AUC between models with different two 
sampling rates used to select variables with random forest importance scores.  The models built 
with variables from random forest importance scores with a sampling rate of 0.01 had slightly higher 
validation AUCs but not by a significant amount.  The similarity between the scores is not surprising 
as the SNPs that are most important in the models are the same in both datasets, it is only the SNPs 
that are less important that differ.   
Method - Variables Selection 
Minimum 
Leaf Size 
Depth Trees Build AUC 
Validation 
AUC 
GBT - top 219 SNPs in 
univariate logistic regressions 
(p−value<1x10-3) 
1 3 5 0.622 0.580 
5 3 5 0.622 0.580 
10 3 5 0.622 0.580 
20 4 20 0.612 0.580 
40 3 5 0.622 0.580 
80 5 50 0.642 0.581 
GBT - top 500 SNPs in random 
forest with sampling rate of 
0.1 
1 4 20 0.699 0.604 
5 1 50 0.657 0.601 
10 4 13 0.727 0.602 
20 1 50 0.657 0.601 
40 3 18 0.645 0.603 
80 2 12 0.633 0.600 
GBT - top 500 SNPs in random 
forest with a sampling rate of 
0.01 
1 4 19 0.692 0.610 
5 5 18 0.730 0.615 
10 4 20 0.689 0.609 
20 4 18 0.671 0.610 
40 2 50 0.659 0.607 
80 4 19 0.659 0.604 
GBT - no selection 
(i.e. the full dataset) 
1 4 20 0.745 0.599 
5 3 20 0.669 0.597 
10 3 20 0.668 0.601 
20 3 20 0.664 0.602 
40 2 10 0.633 0.601 
80 3 10 0.627 0.598 
LDA location model 
(p−value<1x10-3) 
- - - 0.688 0.542 
LDA case-control model 
(p−value<1x10-3) 
- - - 0.662 0.514 
GBT location model  
no selection 
40 2 10 0.651 0.625 
Table 5.2:  The gradient boosted tree models with the highest validation AUC for sets of variables 
selected by random forests.  The build dataset is 75% of the samples and the validation datasets is 
25% of the samples.  The LDA location and case-control models from Chapter 4 is shown for 
comparison (split of data of build 75%, validation 25%). 
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The models built with SNPs selected by random forest importance scores perform significantly 
better than the models build with the variables selected by univariate logistic regressions.  The 
validation AUC of the top model built from random forest importance scores of 0.615 (95% 
confidence interval:  0.597-0.632) is significantly better (p-value=1.28x10-5) performs better than 
the validation AUC for the model built with univariate SNPs (depth of three and five trees with a 
minimum child weight of forty) of 0.580 (95% confidence interval:  0.563-0.597).  However, the 
model from univariate SNPs used twenty-eight variables while the best model with variables from 
random forests used 250 variables.  A simpler model with variables from sampling rate 0.01 random 
forest (with a depth of  two, eleven trees and a minimum child weight of forty), uses twenty-six 
variables for a validation AUC of 0.604 (95% confidence interval:  0.5864-0.6209).  The simplicity of 
this model combined with the small difference in performance suggests that this model is better 
than the models shown in Table 5.2.  The simpler model remains significantly better than the 
univariate model (p-value=0.00265).  The number of variables in the models suggests that they are 
similar but there is only one SNP in common to both models.   
5.2.3  Analysis of Gradient Boosted Tree Models 
In XGBoost, one a SNP has been chosen to split a node, the samples with missing values are expected 
to be directed down the one branch that best fits their phenotype as this will maximise the “gain” 
for the model (Chen & Guestrin, 2016).  However, examination of the GBT models as diagrams found 
that missing values were treated as their own group.  This was evident as the number of alleles on 
the split of some nodes was to less than 4.00000095 (see Figure 5.4), which does not make sense 
when you have a maximum of two minor alleles unless it represents missing values.  A sample of 
ten models based on random forest importance scores was checked, and it was found that all ten 
models include at least one node where the split uses a missing value category. 
The impact of missing values was investigated for the “simple” model (sampling rate of 0.01 for 
random forest, a depth of  two, eleven trees and a minimum child weight of forty).  This model splits 
on the missing category on eight out of eleven trees.  The impact of different values applied to the 
missing allele counts showed that value applied modifies the fit of the validation AUC in different 
ways (Table 5.3).  The match between AUC values for the default method and the separate group 
missing values that were applied (-1 and 3) supports the idea that the missing values are treated as 
a separate group, The difference between the AUC for these values is due to the treatment of SNP 




Figure 5.4: The forth tree (called Tree 3 in XGBoost) of the “simple” model showing splits on values 
that do not represent allele counts (i.e. 4.00000095).  The “simple “model had a sampling rate of 
0.01 for random forest, a depth of  2, 11 trees and a minimum child weight of 40.   
Missing Value 
Applied 
SNPs Build AUC Validation AUC 
Default 26 0.632 0.604 
-1 25 0.628 0.605 
0 27 0.620 0.562 
1 26 0.622 0.572 
2 27 0.633 0.595 
3 26 0.633 0.604 
Table 5.3:  The impact on a gradient boosted tree model of different treatments of missing values.  
All models were built with the dataset of SNPs selected with a random forest sampling rate of 0.01, 
a depth of 2, 11 trees and a minimum child weight of 40.   
Investigation of the SNPs that have the highest importance scores in the simple model (sampling 
rate of 0.01 for random forest, a depth of  two, eleven trees and a minimum child weight of forty) 
shows that the samples with missing values have a different profile than the rest of the samples.  
This pattern was evident in all ten of the SNPs examined.  An example of this is one of the branches 
on the forth tree of the model, that has both SNPs in a branch split on missing values (see Figure 5.3 
and Table 5.4).  The missing allele counts for rs11941136 indicate a lower risk of developing 
colorectal cancer for samples with missing allele counts.  The odds ratio of 0.446 shows a beneficial 
effect for missing alleles that is not seen for zero, one, or two minor alleles.  For rs12595642, the 
risk of developing colorectal cancer is greatly increased when there are missing allele counts, with 
an odds ratio of 1.77 well above any of the odds ratios when samples are genotyped.  The differential 
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between the risk for the missing values and the risk for the genotyped values suggests that the 
missing values are not at random and are underpinned by some causal process. 
SNPs rs11941136 and rs12595642 have 521 and 510 missing allele counts and proportion of missing 
allele counts of 3.51% and 3.09% respectively.  This is consistent across the variables selected by the 
model which have an average proportion of allele counts missing of 3.04%.  The distribution of the 
number of missing genotypes is shown in Figure 5.4.  The number of missing alleles in the SNPs used 
in the model is higher than the average number of missing alleles in the entire dataset of 51.7 
(standard deviation 104).  The number of missing alleles is not expected to cause the selection of 
these SNPs as the XGBoost selects SNPs based on the non-missing data.   
Relative Risk 
 rs12595642     
Alleles 0 1 2 N/A Total 
rs11941136 
0  1.00   1.02   0.88   1.69   1.02  
1  1.01   1.01   1.04   1.88   1.04  
2  0.99   1.00   0.86   2.70   1.01  
N/A  0.41   0.47   0.52   -     0.45  
Total  0.98   1.00   0.92   1.77   1.00  
Number of samples Alleles 0 1 2 N/A Total 
rs11941136 
0 4,207 4,143 1,101 309 9,760 
1 2,302 2,378 619 177 5,476 
2 316 338 90 21 765 
N/A 225 232 61 3 521 
Total 7,050 7,091 1,871 510 16,522 
Table 5.4:  The relative risk of developing colorectal cancer and number of samples for the different 
allele counts for the SNPs from a tree with missing values as splits (the fourth tree, as shown in Figure 
5.3).  The relative risk uses 0 minor alleles of the two SNPs as the reference. 
To assess whether the missing alleles could be determined, the genotype totals were compared with 
the expected allele frequencies under Hardy-Weinberg equilibrium for European samples (Table 
5.5).  Both SNPs are in Hardy-Weinberg equilibrium (p-value>0.05).  For rs11941136, the missing 
genotypes appear to be TT genotype, as there are too few TT genotypes and too many TC and CC 
genotypes in both the cases and controls.  For rs12595642, there was no obvious genotype that the 




Figure 5.4:  The distribution of number of missing genotypes for each SNP for the GECCO consortium 
dataset. 
rs11941136 Controls Cases 
Expected under H-W 
equilibrium 
TT  0.612   0.608  0.628 
TC  0.340   0.345  0.329 
CC  0.048   0.048  0.043 
rs12595642 Controls Cases 
Expected under H-W 
equilibrium 
CC  0.440   0.440  0.436 
CT  0.440   0.447  0.448 
TT  0.120   0.113  0.115 
Table 5.5:  Genotype frequencies for rs11941136 and rs12595642 to determine the likely genotype 
for the samples with missing genotypes.  The Expected frequencies are calculated from European 
allele frequencies. 
5.2.4  Interactions in Gradient Boosted Tree Models 
The univariate SNP model with the highest AUC (depth of three and five trees with a minimum child 
weight of 40), the “simple” model (sampling rate of 0.01 for random forest, a depth of two, eleven 
trees and a minimum child weight of forty) and the gradient boosted tree with no sampling (depth 
of two, ten trees and a minimum child weight of forty) were analysed to determine whether they 
contained interactions with SHAP values.  For the univariate model, twenty-three interactions 
between SNPs were detected out of a possible 325 interactions.  The strongest interaction was 
between rs1938736 and rs2691269 but this was not significant in either the build or validation 
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dataset when tested with the likelihood ratio test (build: p-value=0.317, validation:  p-value=0.458).  
This may indicate that the interaction is more complex than a two-way interaction, as rs6592215 
has non-zero interaction values with both of these SNPs.  Two SNPs showed interactions with sex 
and seventeen SNPs showed interactions with the age indicator.   
For the “simple” model, there were twelve interactions between SNPs out of a possible 276.  The 
strongest interaction was between rs1413849 and rs2078478, which is significant in the build 
dataset when tested with the likelihood ratio test (p-value=1.32x10-15) but was not significant in the 
validation dataset (p-value=0.110).  Again, the interactions may be more complex than can be 
modelled with a two-way interaction, as rs1938736 and rs10773777 both have small interactions 
with rs2078478.  Two SNPs showed interactions with sex and seven SNPs showed interactions with 
the age indicator.   
For the model with no variable selection, there were twelve interactions between SNPs out of a 
possible 253.  The strongest interaction was between rs2322095 and rs7800092, which was 
significant in the build dataset when tested with the likelihood ratio test (p-value=5.56x10-6) but 
was not significant in the validation dataset (p-value=0.159).  One SNP showed an interaction with 
sex and seven SNPs showed interactions with the age indicator.   
The interactions with sex and age in the models may indicate different effects by sex or age, but it 
is more likely that they are related to population stratification, as female samples are younger than 
male samples on average (see Table 5.6).   
Average Age F M Total 
Cases 65.8 65.9 65.9 
Control 62.9 64.3 63.5 
Table 5.6:  Average age of the cases and controls by sex. 
5.3  Discussion 
Models built with gradient boosted trees do perform better than linear models, with both models 
built from SNPs selected by univariate logistic regressions and models built from SNPs selected by 
random forest importance scores outperforming linear models built from the same datasets.  
However, when the SNPs that were identified as interactions with SHAP values were tested in the 
validation data, none of the highest interactions in any models were significant.  This suggests that 
the improved fit of the gradient boosted tree models relates to the ability to weight combinations 
of SNPs, rather than the inclusion of interactions between SNPs.  This is not to say that interactions 
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are not important, just that they are unable to be detected with random forests, with or without 
variable selection by random forest importance scores. 
The use of missing genotypes within the gradient boosted tree models means that the improved 
performance of the models may be due to the different use of the SNPs rather than a better ability 
to model genetic relationships than linear models.  The detection of the missing genotypes with 
different rates of colorectal cancer was a surprise.  The missing genotypes were able to be detected 
as the decision was made not to impute them, as the SNPs most of interest were unlikely to be 
successfully imputed and because gradient boosted trees are able to deal with missing genotypes.  
This meant that their association with colorectal cancer was able to be detected in the models.  The 
difference in the prevalence of colorectal cancer for missing genotypes suggests that there is some 
factor related to colorectal cancer which causes the genotypes to be missing, particularly when the 
overall genotyping rate for the samples is good.  Possible reasons for the genotype to be missing for 
particular samples are the presence of a variant within the binding region that prevents binding to 
probe sequences, the presence of methylation, or secondary DNA structures (Shestak, Bukaeva, 
Saber, & Zaklyazminskaya, 2021; Stevens, Taylor, Pearce, & Kennedy, 2017; Tomaz, Cavaco, & Leite, 
2010; Ward et al., 2006).  These issues have all been identified as related to the use of polymerase 
chain reaction (PCR) rather than the bead chips used for this data but provide possible explanations 
for why the missing genotypes are correlated with the phenotype. 
The difference in performance of the gradient boosted tree models over the linear models for the 
univariate dataset suggests that gradient boosted tree models are more suitable for building 
polygenic risk scores than logistic regression models.  With a dataset that includes more of the lead 
SNPs found to be significant in GWAS, it may be possible to improve the performance of polygenic 
risk scores for colorectal cancer above their current level of a validation AUC of 0.65 (Khera et al., 
2018; Thomas et al., 2020).  There may also be further benefits to the use of gradient boosted tree 
models where SNPs are selected with random forest importance scores although this is much more 
computationally intensive than the use of univariate logistic regressions to select SNPs. 
The analysis here did not find any evidence of interactions for SNPs selected by random forests and 
used in gradient boosted trees.  These may become apparent when models with a larger number of 
variables included are assessed or when random forests with smaller sampling rates (e.g. 0.001) are 
used.  Alterations in the sampling rate would require a greater number of trees in the random forest 
as otherwise the random sampling of SNPs may mean that important interactions do not get a 
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chance to occur.   The depth of the random forests could also be extended to determine whether 
deeper trees capture useful interactions or simply increase the level of overfitting of the model.  
This would require a dataset with more samples, as the number of samples at the each of branch 
would be lower with a greater depth so would be more likely to detect individual variation rather 
than cancer related variation. 
There are three key limitations for this chapter, the inability to impute significant GWAS SNPs, the 
size of the dataset and the potential impact of population stratification.  The inability to impute the 
GWAS SNPs was limited by the gaps in the coverage of one of the arrays used for most samples and 
can be addressed by the use of newer arrays that offer more complete coverage.  This would 
improve the ability to model the development of colorectal cancer but would lose the ability to 
analyse the impact of missing genotypes.  The size of the dataset limited the ability to detect 
interactions between less common variants, particularly interactions between more than three 
SNPs, due to the choice to require a minimum leaf size (minimum child weight) in proportion to the 
strength of the association with colorectal cancer (i.e. “too good to be true” combinations could not 
occur).  A larger dataset would allow more interactions to be detected but is likely to always be an 
issue in detecting interactions between less common SNPs as the number of people that have these 
interactions is likely to always be low in datasets where the samples are random selection of possible 
genetic variation (a key exception is groups that are genetically interrelated).  The choice to use raw 
allele frequencies rather than allele frequencies adjusted for population stratification means that 
the gradient boosted trees may be detecting population stratification rather than interactions 
between SNPs.  However, the use of population stratification adjustments clouds the interpretation 
of the tree, as a SNP minor allele score of 1.24 could represent a heterozygous genotype adjusted 
upwards or homozygous minor alleles adjusted downwards (or both at the same time).  Population 
stratification may exist within the model, but the use of a validation dataset as an outcome measure 
is expected to ensure that models influenced by population stratification are not accepted, 
assuming that the population stratification is not consistent across both the build and validation 
datasets. 
5.4  Conclusion 
Gradient boosted tree models may significantly improve the ability to predict the development of 
colorectal cancer.  This improvement appears to be due to the ability to weight combinations of 
SNPs, as none of the identified interactions were significant.  The unexpected discovery that missing 
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genotypes may be associated with colorectal cancer indicates that further work is needed to analyse 
the causes of missing genotypes.  This merits further investigation, as missing SNPs are generally 




6.  Summary, Conclusions and General Discussion          
Genetic models that currently exist to predict the development of colorectal cancer perform below 
the level required for genetic screening to financially viable.  They would also generate a relatively 
high number of false positives and false negatives, which could have severe consequences for those 
who received wrong estimates for their risk of developing colorectal cancer.  Improved models are 
needed for the full benefits of personalised medicine to be unlocked.   
This thesis hypothesised that improvements in the performance of models to predict the 
development of colorectal cancer could be obtained through addressing some of the assumptions 
and limitations within the methods currently used to build models.  These are: that corrections for 
population stratification adequately adjust for population stratification; the assumption that all 
colorectal cancer patients have the same causal genetic background; and that there are no 
interactions between genetic variants or between genetic variants and other model variables (such 
as sex or age).  The results from tests of each of these assumptions are discussed in the following 
sections. 
6.1  Summary of Population Stratification Corrections in Colorectal Cancer Models 
Sets of principal components that varied by the number of principal components, the level of 
correlation with the phenotype and the frequency of the alleles used to construct the principal 
components did not improve the ability of models to predict the development of colorectal cancer.  
None of the methods assessed were ineffective at identifying SNPs that improved the performance 
of models in a dataset of 1,927 cases and 965 controls.  Most models performed worse than random 
allocation of samples to cases or controls, i.e. the validation area under the receiver operating curve 
(AUC) was below 0.50.  The validation AUC for the best models with principal components 
(AUC=0.514) performed better than the model with no principal components (AUC=0.480) but was 
still performed worse that the polygenic risk score for the same dataset (AUC=0.564).   Analysis of 
the impact of the inclusion of principal components on the univariate logistic regression odds ratios 
showed that the odds ratios for each SNP was altered by a relatively small amount (most odds ratios 
were within ±0.05), except for a few SNPs with relatively low minor allele frequencies.   
The lack of improvement in the fit of the models with principal components to correct for population 
stratification was surprising, as the genomic inflation factor suggested that population stratification 
was likely to be present and there was a reduction in the genomic inflation factor with the use of 
82 
 
some sets of principal components.  The cause of the models’ inability to predict who will develop 
colorectal cancer is likely to be the relatively small sample sizes used to assess this hypothesis.  It 
would be useful if future research could show in a larger dataset that principal component 
corrections for population stratification do improve the ability of models to predict the development 
of colorectal cancer, given the widespread use of principal components.   
6.2  Summary of Identification of Colorectal Cancer Subtypes 
The possibility that subtypes or subgroups of colorectal cancer could have different sets of SNPs 
associated with each subtype was investigated for data with no known groups and for data grouped 
by the location within the colon and rectum.  Both assessments were unable to find any evidence 
to show that the identification of subtypes was important to include in models to predict the 
development of colorectal cancer.  Clustering of data with hierarchical, model-based and density 
methods did not identify any clusters that were able to predict who would develop colorectal 
cancer.  The clusters that were found performed no better than could have been obtained by the 
random assignment of samples to clusters.  Clustering of data transformed by the use of SHAP values 
similarly did not identify any meaningful clusters but did suggest that some of the SNPs identified in 
genome-wide association studies interact to cause cancer.  These interactions were significant when 
tested with the likelihood ratio test (p-value<0.05).  Models built with linear discriminant analysis 
to predict the location of colorectal cancer performed better than models that predicted the 
phenotype (validation AUCs of 0.542 and 0.514 respectively), but this difference was not considered 
to be conclusive due to the poor performance of the models that predicted case-control status.  
These results indicate that there are likely to be few benefits for the development of models for 
different subtypes of colorectal cancer, although this will need to be confirmed in a larger dataset 
given the small size of some of the carcinoma location groups. 
6.3  Summary of Interactions and Predictions of the Development of Colorectal Cancer 
To test whether interactions are important for models to predict the development of colorectal 
cancer, models were built with gradient boosted trees from variables that were selected by 
univariate logistic regression, random forest importance scores and with no selection applied.  The 
models built with gradient boosted trees performed better than linear models built with the same 
datasets.  There was a significant improvement in the validation AUC of 0.072 (p-value=1.83x10-5), 
between the best gradient boosted tree model built with SNPs selected with random forest 
importance scores (AUC=0.615, 95% confidence interval:  0.597-0.632) and a linear discriminant 
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analysis model based on SNPs that are significant in univariate logistic regressions (AUC=0.542, 95% 
confidence interval: 0.5135-0.5717).  However, when selected models were examined in more 
detail, it was found that the performance improvements in the gradient boosted tree models were 
not from interactions.  None of the strongest interactions within the models were significant when 
tested in the validation datasets.  The cause of the improvement in the models was the use of 
missing alleles in the gradient boosted tree models to split data into groups.  An examination of 
these SNPs found that the odds ratios for some of the missing SNPs were highly favourable or 
unfavourable for colorectal cancer (odds ratios of 0.446 and 1.77).  These SNPs existed in the dataset 
because it was decided to not use imputation to increase the number of SNPs available.  The 
unexpected discovery of these strong odds ratios merits further investigation as the missing SNPs 
may lead to rare variants, short tandem repeats or methylation differences that improve the 
predictive abilities of models for the development of colorectal cancer.   
6.4  Limitations of the Study/Investigation 
The ability to investigate the hypotheses within this thesis was limited by the availability of data.  
The level of variability between the genomes of individuals means that relatively large datasets are 
required to distinguish between differences between individuals that stem from this variability, and 
differences between individuals that stem from genetic variation that causes disease.  The two 
datasets used here have different strengths, but the limitations within those datasets mean that 
genetic variation that causes disease is difficult to identify.  The whole genome colorectal cancer 
dataset has all SNPs genotyped, but the dataset is too small to identify SNPs associated with disease.  
Therefore, none of the models in Chapter 2 were able to perform better than random chance.  The 
GECCO consortium dataset is larger and avoids the inability to distinguish between individual 
genetic variation and disease related variation but was sequenced ten years ago on a panel array 
which targets selected areas of the genome rather than providing a broad coverage of the genome.  
As a consequence, the coverage of some SNPs that are associated with colorectal cancer in large 
studies were unable to be imputed and included within the analysis here.  The cost of sequencing 
more samples more comprehensively would cost millions of dollars and is beyond all but the largest 
global funding agencies.  
The genetic diversity of the datasets used was also limited to European heritage samples.  This limits 
the applicability of the results to groups of other genetic heritages and also limits the ability to 
distinguish between SNPs that are causal and those that are statistically correlated with disease.  It 
84 
 
is unlikely that a SNP that is rare in one group but common in another group is a disease-causing 
variant unless the incidence of disease varies in proportion to the different frequency of the SNP 
between groups (De La Vega & Bustamante, 2018; Kim, Patel, Teng, Berens, & Lachance, 2018; 
Lachance & Tishkoff, 2013).   
6.5  Future Research Directions 
To address the limitations of this thesis, future research could use increased sample sizes of whole 
genome data for more genetically diverse groups to examine the same topics.  This applies across 
all of the chapters of this thesis.  However, the use of whole genome data for a large number of 
samples would require the use of high-performance computing facilities to gain sufficient memory 
and software developed to cope with big data. 
The lack of success of rare-allele principal components to adjust for population differences to allow 
the identification of SNPs associated with colorectal cancer in Chapter 2 suggests that better 
methods for adjusting for population stratification are required.  Ideally, a good adjustment method 
would mean that smaller sample sizes would be required to identify causal SNPs, which would assist 
with the identification of SNPs for diseases that are rarer than colorectal cancer.   
The potential exists for interactions between SNPs to play an important role in the development of 
disease and the results of Chapters 3 and 5 show hints that interactions may be important.  
However, interactions are difficult to identify and the evidence that exists to support the role of 
interactions in disease is limited.  Further research is needed to be able to readily identify 
interactions and prove that interactions between SNPs cause effects in cells that can cause cancer.  
These answers may be found through work on the role of genetic variants in determining protein 
expression levels or analysis of the examination of colorectal cancer related pathways, where SNPs 
may interact to cause measurable effects (Bien et al., 2019; Parrish et al., 2020).   
The unexpected result that missing genotypes have a risk of developing colorectal cancer that differs 
from that of the genotyped SNPs warrants further investigation to determine whether there is a 
underlying cause for these genotypes to be missing.  There may be specific feature such as 
methylation, rare minor alleles, short tandem repeats or other structural features of the 
chromosomes that cause colorectal cancer but are undetected as the signal provided by missing 
genotypes was overlooked when the missing genotypes were imputed.  Given the time elapsed since 
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the samples in the GECCO Consortium data were genotyped, it would also be interesting to see 
whether samples that have been genotyped recently on a similar platform show the same patterns. 
The wider question of how to identify those at risk of developing colorectal cancer remains to be 
answered.  This thesis was focussed on the genetic origins of colorectal cancer so did not include 
any environmental variables but identifying the genetic causes of colorectal cancer may require the 
inclusion of environmental variables (such as alcohol intake, micronutrients, or gut composition) in 
order to be able to identify genetic variants that cause cancer when certain environmental 
exposures occur.  Other forms of genetic variation such as variation in the number of copies of 
genes, variation in short-tandem repeat sequences, and methylation and other DNA or RNA 
modifications is not yet established so the investigation of multi-omics and new sequencing 
technologies may provide answers about how to identify those who will develop colorectal cancer.   
6.6  Conclusion 
Models to predict the development of colorectal cancer with corrections for population 
stratification with rare allele principal components and the use of subtypes of colorectal cancer did 
not outperform polygenic risk scores built from SNPs with the highest significance in univariate 
logistic regression models.  These methods are ineffective at improving the performance of models 
to predict the development of colorectal cancer.  Models that used gradient boosted trees to predict 
the development of colorectal cancer were significantly better than linear models built from the 
same data but could not be compared to a polygenic risk score model due to data limitations.  
Interactions between SNPs were not significant in these models.  Of the methods assessed, the use 
of gradient boosted trees warrants further investigation to improve the performance of models to 




7.  Data Sources and Methodology 









7.1  Data     
1000 Genomes Project Samples ✓    
Whole Genome Colorectal Cancer Data ✓ ✓   
GECCO Consortium Colorectal Cancer Data   ✓ ✓ 
Data Preparation and Quality Control ✓ ✓ ✓ ✓ 
Principal Component Analysis ✓ ✓ ✓  
Population Stratification Assessments ✓  ✓  
7.2  Linear Models     
Logistic Regressions ✓  ✓  
Polygenic Risk Score Models ✓ ✓   
Penalised Logistic Regression Models ✓  ✓  
Linear Discriminant Analysis   ✓  
7.3  Decision Tree Models     
Gradient Boosted Tree Models  ✓  ✓ 
SHAP Values  ✓   
Random Forests    ✓ 
Random Forest Variable Importance    ✓ 
7.4  Cluster Analysis  ✓   
7.5  Area Under the Receiver Operating Curve  ✓ ✓ ✓ ✓ 
Table 7.1:  An outline of the data and methods used in each chapter of this thesis. 
Best practice in prediction model studies is outlined in the Transparent Reporting of a Multivariable 
Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) checklist.  This study is a type 2a 
case-control study where a random split-sample was used for model development and validation.  
The TRIPOD guidelines have been followed throughout this thesis (Moons et al., 2015). 
For all software, the default parameters were used, unless otherwise stated. 
All figures are rounded to three significant figures, unless otherwise stated.   
Principal component analysis, random forest models, gradient boosted tree models and cluster 
analysis (for the Gap statistic) were computed on the Research Compute Cluster (RCC) facilities at 
the University of Canterbury, on a Linux server with 32 CPUs (Intel(R) Xeon(R) E5-2683 @2.1Gz) and 





7.1  Data 
Genomic data can be obtained as either whole genome sequencing or as panel array data with 
imputation of the ungenotyped SNPs.  Panel array data is more prevalent in GWAS studies as its 
relatively low cost allows larger samples to be used to increase the power of the study, but can have 
errors in its imputed SNPs of 3-7% and be biased in the SNPs selected for the arrays (Guan & 
Stephens, 2008; Kim et al., 2018; Marchini & Howie, 2010).  Whole genome sequencing does not 
include imputation errors but can be prohibitively expensive to obtain a sample sufficiently large to 
have power to detect SNPs associated with disease (Höglund et al., 2019).   
7.1.1  1000 Genomes Project Samples 
Whole genome sequencing data from the 1000 Genomes Project was chosen for its known 
population structure.  The 1000 Genomes Project sequenced DNA samples from serum for 
representative populations from each continent (The 1000 Genomes Project Consortium, 2015).  
Phase 3 of the 1000 Genomes Project was the final phase and has higher quality data as the 
sequencing was completed on one platform, uses longer reads and was constructed with a more 
mature variant calling pipeline.  This data contains samples from twenty-six populations across five 
continents.  This data was used to analyse the ability of low frequency alleles to identify populations. 
1000 Genomes phase 3 data was obtained from the PLINK2 website (Chang et al., 2015). The data 
was screened to eliminate low quality data with the following criteria used to remove samples:  
more than 50% of calls missing, a minimum quality score below 30% and Hardy-Weinberg 
equilibrium probabilities of less than 1x10-4  (Danecek et al., 2011).  Screening was completed in 
PLINK1.9 (Chang et al., 2015). 
7.1.2  Whole Genome Colorectal Cancer Samples 
Whole genome sequencing data for colorectal cancer was chosen as it is a relatively large dataset 
(for whole genome sequencing) and contains low frequency minor alleles.  The size of the dataset 
means that it is underpowered to detect SNPs with small effect sizes (e.g. an odds ratio of 1.2) but 
has sufficient power to detect larger effects (i.e. 82.5% power for an odds ratios greater than 1.5 
and a minor allele frequency of 0.05 in the build dataset) (Purcell, Cherny, & Sham, 2003).  The use 
of whole genome data also means that the true causal SNP is more likely to be detected than a SNP 
in high linkage disequilibrium with the causal SNP. 
Huyghe et al. (2019) sequenced the whole genome for selected participants in six studies related to 
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colorectal cancer, with DNA samples obtained from serum.  The studies included are the Prostate, 
Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial; Nurses’ Health Study (NHS); Health 
Professionals Follow-up Study (HPFS); Cancer Prevention Study II (CPS-II); Women’s Health Initiative 
(WHI) study; and Darmkrebs: Chancen der Verhütung durch Screening (DACHS).  Five studies 
(excluding DACHS) are longitudinal cohort studies in the United States of America and DACHS is a 
longitudinal cohort study in Heidelberg, Germany.  Both DACHS and PLCO are interventional studies 
which screen for colorectal cancer.  Cases of colorectal cancer are confirmed by medical records.   
Further details of the methodologies used are in the papers for each study (Belanger, Hennekens, 
Rosner, & Speizer, 1978; Brenner, Chang-Claude, Seiler, Stürmer, & Hoffmeister, 2006; Calle et al., 
2002; Gohagan, Prorok, Hayes, & Kramer, 2000; Rimm et al., 1992; The Women’s Health Initiative 
Study Group, 1998) or on the relevant websites. 
The whole genome sequences were made available to researchers under code phs001554.v1.p1 on 
the NHI sponsored database of Phenotypes and Genotypes (dbGaP).  This data contains 1,927 cases 
and 965 controls.  All samples were genotyped at the same location and passed through the same 
processing pipeline.  Details of the genotyping to the human genome reference (GRChr37) and 
quality control processes can be found in the methodology for Huyghe et al. (2019).  Key statistics 
for this dataset are shown in Table 7.2. 
Study CPS-II DACHS HPFS NHS PLCO WHI Total 
Participants (n) 259 741 137 221 616 918 2892 
Cases 173 495 91 153 406 609 1927 
Controls 86 246 46 68 210 309 965 
Percentage female (%) 51.7 38.9 0 100 41.6 100 62.8 
Average age (years) 69.1 68.7 65.7 59.2 64.4 65.8 66.0 
Table 7.2:  Key statistics from the whole genome colorectal cancer dataset. 
For Chapter 2, two subsets of this data were used.  The first GWAS dataset consists of 70 SNPs that 
have been identified and replicated in large studies (Huyghe et al., 2019; Law et al., 2019).  This is 
the same data used to calculate the polygenic risk score in chapter 2.  The second, larger GWAS 
dataset consists of 562 unique SNPs listed as significant under colorectal cancer (EFO:0005842) in 
the Experimental Factor Ontology section of EMBL-EBI with minor allele frequencies greater than 
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0.05.  EFO:0005842 combines 85 studies of colorectal cancer published between 2007 and 2021 
which cover the development and progression of cancer, progression and disease free survival, 
SNPxSNP and environmental factors interactions (European Bioinformatics Institute, 2021).   
The power to detect an increase in risk for this dataset was calculated using the Genetic Power 
Calculator (Purcell et al., 2003).  This study has 94% power based on inputs of a heterogenous odds 
ratio of 1.5, a multiplicative risk model, a risk allele frequency of 0.05 in a case control study with a 
significance level of 0.05.  The power drops to 74% if the input heterogenous odds ratio drops to 1.4 
and 26% if the odds ratio drops to 1.2. 
7.1.3  GECCO Consortium Data 
Microarray data for 16,522 samples from the Genetics and Epidemiology of Colorectal Cancer 
Consortium (GECCO) was used for Chapters 4 and 5.  This consists of samples collected as part of 
the following studies:  ASTERISK, DACHS, DALS, HPFS, MEC, NHS, PHS, PLCO, VITAL and WHI.  The 
participants in these studies have European heritage, are located in the United States of America, 
France (ASTERISK) or Germany (DACHS) and were from longitudinal or interventional (screening for 
colorectal cancer in DACHS and PLCO) studies.  Further details can be found in Peters et al. (2013). 
The samples were genotyped on the Illumina CytoSNP v12.2 and the Illumina OmniExpress12v1 
chips (Peters et al., 2013).  The raw data was called on the Illumina Array Analysis Platform (IAAP) 
command line software and BCFtools add-in gtc2vcf, then combined in BCFtools (Genovese, 2021; 
Li, 2011).  The data was aggregated with the previously genotyped data provided by some studies 
and only SNPs that were present from both chip types was kept.  The data was then screened with 
PLINK1.9 (Chang et al., 2015).   After linkage disequilibrium was reduced (see section 7.1.4), the final 
dataset contained 192,303 SNPs, with a genotyping rate of 0.996895.  Key statistics for this dataset 
are shown in Table 7.3.  Of note, the controls have a younger age on average than the cases, 63.5 
vs 65.9 respectively.  This difference is greatest for females, with a difference in the average age of 
2.96 years for females and 1.67 years for males. 
The primary locations of the carcinomas were collected by the studies participating in the GECCO 
consortium.  This consisted of International Classification of Diseases v10 site codes:  for the right 
colon of C18.0, C18.2, C18.3; for the transverse colon of C18.4; for the left colon of C18.5, C18.6, 
C18.7, C19.0, C19.9; for the rectum of C20.0, C21.0, 21.1, C21.8; and unspecified locations classified 










Rectum Misc. Total 
Study        
ASTERISK 985 222 37 411 281  1936 
DACHS 2253 660 112 816 835 7 4683 
DALS 468 179 32 185  16 880 
HPFS 1125 121 22 164 62 2 1496 
MEC 357 68 16 70 31  542 
NHS 2064 200 44 196 84 9 2597 
PHS 405 110 17 173 52 48 805 
PLCO 516 235 39 165 147 13 1115 
VITAL 300 128 23 97 48 10 606 
WHI 1036 364 58 253 146 5 1862 
Age        
Average 63.5 67.0 66.2 65.3 65.4 62.5 64.5 
Sex        
Female 5173 1282 227 1156 689 37 8564 
Male 4336 1005 173 1374 997 73 7958 
Sample 
Allocation 
     
Build 4810 1125 211 1255 827 52 8280 
Validation 4699 1162 189 1275 859 58 8242 
Total 9509 2287 400 2530 1686 110 16522 
Table 7.3:  Key statistics in the GECCO dataset. 
The benefits of imputation were assessed for the SNPs most likely to be useful to impute, i.e. the 
SNPs found to be significant that have been replicated in large GWAS (the same set as above) 
(Huyghe et al., 2019; Law et al., 2019).  As linkage disequilibrium between an array SNP and the 
desired SNP is one of the key determinants of imputation accuracy, a threshold of r2>0.75 was 
required for these SNPs to be accurately imputed (where imputation accuracy is a correlation of 
greater than 0.80 between the measured genotype and the imputed genotype) (Liu et al., 2015).  
For the 70 SNPs found in large GWAS (see section 7.2.2 on polygenic risk scores), only 33 of these 
SNPs had SNPs present in the dataset with linkage disequilibrium higher than the threshold of 
r2>0.75 (based on the whole genome data from a subset of the same studies, as used in Chapters 2 
and 3).  The decision was therefore made not to impute any SNPs as the accuracy of the imputed 
SNPs for the SNPs most likely to be of interest was below 0.80. 
The power to detect an increase in risk for this dataset was calculated using the Genetic Power 
Calculator (Purcell et al., 2003).  For a genotyped SNP, this study has 100% power based on inputs 
of a heterogenous odds ratio of 1.5, a multiplicative risk model, a risk allele frequency of 0.05 in a 
case control study with a significance level of 0.05, 94% power if the input heterogenous odds ratio 
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drops to 1.2.  However, if the SNP is not genotyped and is in linkage disequilibrium with a genotyped 
SNP at r2=0.80, the power is 100% and 80% for odds ratios of 1.5 and 1.2 respectively. 
7.1.4  Data Preparation and Quality Control 
Outliers in the data can occur from high levels of relatedness of individuals e.g. siblings and can 
affect the construction of principal components.  Kinship-based Inference for Genome-wide 
association studies (KING) calculates kinship estimates without the assumption of no population 
stratification.  This calculation does not rely on population allele frequencies, as the KING-robust 
estimates measure the number of shared genotypes (Manichaikul et al., 2010).  KING-robust kinship 
estimates were calculated in PLINK2 with the --make-king-table command (Chang et al., 2015).  The 
results were assessed to determine whether they were above the threshold for third-degree 
relatives of 0.044 Manichaikul et al. (2010).  Duplicate samples (KING-robust kinship estimates=0.5) 
were removed from the data, close relatives were removed if they were both cases or both controls. 
Data screening waw completed in BCFtools and PLINK(v1.9) (Chang et al., 2015; Li, 2011).  The data 
was screened for low quality data with the following criteria used to eliminate samples: more than 
50% of calls missing or a minimum quality score below 30% (Danecek et al., 2011).  Hardy-Weinberg 
equilibrium probabilities for the controls are generally used to eliminate SNPs with genotyping 
errors.  However, with the controls selected to be free of colorectal cancer, and from different 
continental populations, the assumptions of random mating and alleles at population frequencies 
are not met.  Therefore, controls were screened for SNPs with Hardy-Weinberg equilibriums below 
1x10-50, rather than against a more stringent threshold (Abramovs, Brass, & Tassabehji, 2020).   
Genetic variants in whole genome data are highly correlated, which is known as linkage 
disequilibrium.  Correlations are generally highest between genetic variants located close to each 
other on a chromosome (Reich et al., 2001).  The level of correlations in whole genome data needs 
to be reduced, as many statistical procedures are unable to cope with high levels of correlations 
between variables, known as multicollinearity.  Linkage disequilibrium (i.e. correlation) is commonly 
reduced to within ±0.70, but this may remove causal genetic variants where the variation occurs in 
the uncorrelated samples.  Therefore, a maximum correlation threshold of ±0.95 was used for 
assessment of genetic variants in univariate logistic regressions.  Uncorrelated SNPs (r2<±0.1) were 
used in principal component analysis, as otherwise principal component analysis would detect the 
correlated SNPs as a key source of variation between samples.  PLINK’s indep-pairwise command at 
the required r2 threshold was used to exclude SNPs in high linkage disequilibrium.  For the 
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indep−pairwise command, a window of 50,000 SNPS, and step of 5,000 SNPs were used as there are 
very few SNPs in linkage disequilibrium that are not detected at these settings (Calus & Vandenplas, 
2018). 
For the colorectal cancer datasets, the variable for age was coded into three groups, below 65, 65 
to 75 and above 75 as tree models are known to prefer variables that can be split at multiple points 
over variables with fewer groups (such as SNPs coded by the number of minor alleles) (Strobl, 
Boulesteix, Zeileis, & Hothorn, 2007). 
The samples in the two datasets were randomly allocated to either the build dataset or the 
validation dataset.  For the whole genome colorectal cancer samples dataset, the split between the 
build and validation dataset was 80%/20%.  For the GECCO consortium dataset, the split between 
the build and validation datasets was 75%/25%.  For Chapter 5 only, the build dataset was split into 
a build dataset and a test dataset, so the split of the GECCO consortium dataset between build, test 
and validation was 50%/25%/25%, with the validation set the same as the previously. 
7.1.5  Principal Component Analysis 
Principal component analysis summarises the variation present in the dataset.  To ensure that the 
variation identified corresponds to population stratification rather than kinship, related individuals 
are excluded (Price et al., 2010).  There are multiple methods to determine the number of principal 
components to use summarise the data but there is no accepted best method.  The number of 
principal components included is generally set at ten, although principal components identified as 
significant by the Tracy-Widom statistic may perform better than the rule of thumb value (Patterson 
et al., 2006; Zhao, Mitra, Kanetsky, Nathanson, & Rebbeck, 2018).  The number of principal 
components is classically determined by the curve in a scree plot, but principal components which 
are correlated with the phenotype may also prove useful (Jackson, 1993; Lee, Wright, & Zou, 2011).  
The standard rule, Tracy-Widom statistic, scree plot and correlation methods are assessed and 
compared in this chapter. 
Principal component analysis is sensitive to outliers in the data.  It will allocate a principal 
component to identify outlier(s), when variance between the outlier and the main group in the data 
is high.  To correct for this, two methods were used.  Firstly, outliers were identified with the 
Mahalanobis distance, which sums the distances of points from the mean on each principal 
component (Privé, Luu, Blum, McGrath, & Vilhjálmsson, 2020).  Secondly, the 1000 Genomes Project 
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and colorectal cancer data were merged for the construction of the principal components, to 
decrease the relative variance between points in the colorectal cancer data and to increase the 
number of control samples.  The 1000 Genomes samples were then excluded from the eigenvector 
data before it was used in the univariate logistic regressions and regression models. 
The inclusion of principal components in the models to predict the development of colorectal cancer 
means that the validation data needs to be projected onto the principal components calculated for 
the model build data.  When projections are made from the principal components to new data, 
shrinkage occurs in the estimates for the new data.  This can be corrected for with an online 
augmentation, decomposition, and Procrustes (OADP) transformation, which rescales the estimates 
for the validation data to match the model build data (Zhang, Dey, & Lee, 2020). 
Principal component analysis and the projection of these principal components for the validation 
data was completed in the R package bigsnpr, which removes outliers based on robust Mahalanobis 
distances, calculates the principal components and then applies OADP to obtain the validation data 
principal components (Privé et al., 2020).  Scree plot bend points were assessed in Excel by an 
increase in the eigenvalue of more than 1%.  The significance of the principal components for 
approximate Tracy-Widom statistics was calculated in EIGENSOFT:SMARTPCA with command 
twstats (Patterson et al., 2006).  Correlations with the dependent variable were assessed based on 
the significance of the coefficient for first two hundred principal components in a generalised linear 
model calculated in R with a significance level of 0.05.  The significant principal components were 
then serially assessed for importance in R with anova with Chi-squared significance tests as a 
significance level of 0.05. 
7.1.6  Population Stratification Assessments 
For a correction for population stratification to be required, population stratification must be 
present.  The most common method for assessments of the level of population stratification are the 
use of the genomic inflation factor (λ).  A set of 100-500 uncorrelated SNPs, that are not causally 
related to the outcome, are selected (Hellwege et al., 2017).  The genomic inflation factor is 
calculated from the results of univariate tests of significance for the SNPs, which generates Chi-
squared test statistics.  The genomic inflation factor is then equal to the median Chi-squared statistic 
divided by the median of the Chi-Squared distribution with one degree of freedom (0.456) (Devlin 
et al., 2001).  A genomic inflation factor of less than 1.05 after correction for population stratification 
is desirable (Hellwege et al., 2017). 
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Population stratification can also be assessed with the use of quantile-quantile plots of the expected 
distribution of probability values for univariate logistic regressions (see section 7.2.1) against the 
observed probability values.  Where there is a deviation from the expected distribution, this is 
evidence that population stratification is present (Clarke et al., 2011). 
A set of 416 uncorrelated SNPs distributed across all chromosomes was identified by selecting every 
hundredth SNP from a set of SNPs with linkage disequilibrium below 0.05.   The genomic inflation 
factor was calculated for these SNPs in PLINK1.9 with command “--logistic --adjust gc”. 
Quantile-quantile plots were prepared in R with the qqman package (Turner, 2018). 
7.2  Linear Models 
7.2.1  Generalised Logistic Regressions 
Logistic regressions fit a model to the data which predicts the dependent variable on a set of 
independent variables, so that the errors in the model’s prediction of the dependent variable are 
minimised.  Logistic regressions are less reliable when the variables are highly correlated (i.e. there 
is multicollinearity) as the coefficients may be inflated and the standard errors will increase 
(Vatcheva, Lee, McCormick, & Rahbar, 2016).  Logistic regressions also assume that the model of 
association between alleles is multiplicative (unless the data is binary coded), so if the SNP alleles 
act in an additive, dominant or recessive manner then a logistic regression will poorly model the 
data (Clarke et al., 2011). 
Logistic regression models are the most used analysis technique for genome-wide association 
studies, as the dimensionality of the data means that it is difficult to use other modelling techniques.  
Logistic regression models are estimated for each SNP in turn (i.e. univariate logistic regressions), 
with variables included for sex to adjust for sex related differences and principal components to 
adjust for populations stratification.  These regressions are used to determine the size (odds ratio) 
and significance (probability) that the SNP is statistically linked to the dependent variable.  The 
results of the logistic regression models are assessed against a probability threshold corrected for 
multiple hypothesis testing of 5x10-8.   
Univariate logistic regressions are used to select variables for inclusion in other models.  The number 
of variables selected to build a model needs to be appropriate for the number of samples within the 
dataset.  A commonly used rule is ten samples per variable, but this is a rule of thumb rather than a 
statistically justified requirement.  The model build method influences the number of samples 
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required, with fewer samples needed for penalised regression methods (e.g. Elastic Net, Ridge).  The 
proportion of the cases/controls in the dataset is also important (Van Smeden et al., 2019).  For the 
Elastic Net regression method (described in the penalised logistic regression models section), an 
events per variable ratio of five has been shown to provide a stable AUC measure (Pavlou, Ambler, 
Seaman, Maria, & Omar, 2015).  The number of SNPs selected to use in penalised logistic regression 
models was limited to one hundred, so that the number of events per variable would at least five 
after varying numbers of principal component variables were included in the models. 
For the linear discriminant analysis, variable selection was performed with univariate logistic 
regressions with sex and twenty principal components included as covariates.  The univariate logistic 
regressions were calculated on the entire build dataset and on subsets of the data which consisted 
of all of the controls plus one of the colorectal cancer locations e.g. controls plus left colon samples.  
The results of these regressions were then ordered by the probability associated with the odds ratio, 
and the SNPs with probabilities less than 1 x 10-3 (1 x 10-2 was also used for the combined build 
dataset) were selected to use in the linear discriminant analysis.  At this step, any highly correlated 
SNPs (r2 were also removed). 
Univariate logistic regressions (to assess each SNP separately) were performed in PLINK(v2.0) using 
the --glm command with --vif 5 to limit multicollinearity (Chang et al., 2015).  Logistic models that 
included more than one SNP (GLM models) were calculated in R with the glm command (from base 
R). 
7.2.2  Polygenic Risk Scores 
Polygenic Risk Scores (PRS) measure the impact of risk SNPs on the probability of developing a 
disease.  Individual SNP odds ratios (or relative risk) from a reliable GWAS meta-study are used to 
weight the SNPs from a new dataset to calculate risk scores (Janssens, 2019).  The predictive ability 
of the model can then be determined by the AUC (see below).  Where the PRS model for the sample 
has a lower or higher ability to predict the development of colorectal cancer than in the population 
model, the sample is either less or more like the population, which is evidence of population 
stratification in the samples for the genetic variants used in the polygenetic risk model.  PRS can also 
provide a baseline comparison to assess whether models with different specifications are 
improvements on the PRS model. 
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The PRS was calculated for the significant SNPs (p−value<5x10-8) in common to the studies by 
Huyghe et al. (2019); Law et al. (2019).   This provided a list of 75 SNPs for inclusion in the model, of 
which 70 were present in the datasets and were used to construct models.   Odds ratios were 
obtained from Law et al. (2019) as these estimates are the largest available (on approximately 35 
thousand cases and 71 thousand controls), have a similar genetic heritage and are independent of 
the data used in this study.  PRSice was used to calculate risk scores with principal components 
(maf>0.05) as a covariate (Choi, Mak, & O’Reilly, 2020; Choi & O'Reilly, 2019).   
7.2.3  Penalised Logistic Regression Models 
Penalised linear regression models (e.g. Elastic Net) are a modified form of a linear regression, 
where the coefficients of the variables in the model are restricted based on penalty added to the 
loss function used in ordinary least squares (Pavlou et al., 2015).  Support Vector Machines are a 
special case of the Elastic Net model that are also used for genetic data (Huang, Chen, Lin, Ke, & 
Tsai, 2017; Huang et al., 2018; Zhou et al., 2015).  Elastic Net regressions combine the limitation on 
the size of the coefficients from Lasso regression models with the propensity to set variables with 
very low weights to zero from Ridge regression models.  Elastic net methods perform well in the 
presence of multicollinearity, as they reduce the weight on one of the correlated variables (Pavlou 
et al., 2015).    Therefore, Elastic Net regression methods were used to construct models in this 
study. 
Elastic Net regressions were implemented in R software using package glmnet with command 
cv.glmnet (Friedman, Hastie, & Tibshirani, 2010).  The alpha parameter was set at 0.5 and the 
lambda value was calculated by the software.  Once the base model was calculated, alternative 
values of alpha were tested but none were found to improve the model fit. 
7.2.4  Linear Discriminant Analysis 
Linear discriminant analysis (LDA) is a supervised machine learning technique which finds linear 
combinations of variables that discriminate between groups.  It maximises the variance between 
groups relative to the variance within a group (Hastie, Tibshirani, & Friedman, 2009).  LDA assumes 
that the classes are normally distributed and have the same covariance matrices but is not sensitive 
to class imbalances (e.g. different numbers of control, left colon, right colon and rectum samples) 
(Hastie et al., 2009; Xue & Titterington, 2008).  However, LDA is not able to fit models that have 
more variables than samples, so variables need to be selected before LDA is used.   
97 
 
To assess the assignment of cases to locations, the number of correct classifications out of the total 
number of cases was calculated. 
Linear discriminant analysis was undertaken in R software with packages MASS command lda and 
caret (https://CRAN.R-project.org/package=caret) for ten-fold cross-validation and variable 
standardisation (Ripley, 2002).   
7.3  Decision Tree Models 
7.3.1  Gradient Boosted Tree Models 
Gradient Boosted Trees model an outcome by a linear combination of the scores generated by the 
end leaf of multiple decision trees, where the combination of trees is optimised to reduce the loss 
function of the model i.e. the gradient of the loss function (Chen & Guestrin, 2016).  When Gradient 
Boosted Trees were compared to thirteen other machine learning methods across one hundred and 
sixty-five datasets, Gradient Boosted Trees were found to perform best, outperforming linear 
regression models in 78% of datasets (Olson, Cava, Mustahsan, Varik, & Moore, 2018).  Gradient 
Boosted Tree models also have the desirable property that when non-linearity is present in the data 
that weight attributed incorrectly to variables and the error in the model do not depend on the 
amount of non-linearity, in comparison to logistic regression which does incorrectly weight variables 
and increase the error rate (Lundberg et al., 2020).  Extreme Gradient boosted trees (XGBoost) were 
chosen to model the relationship between colorectal cancer and genetic data as they are able to 
include interactions between SNPs (as each branch is the outcome of a specific combination of 
alleles), are able to cope with missing data without the need to exclude samples and provide a more 
parsimonious model than other similar techniques, such as random forests (Chen & Guestrin, 2016).   
Methods based on decision trees have been shown to overfit the data or be unstable when the 
number of samples per variable is less than two hundred, but the study which observed this gave 
no information on the parameters used in the model (Van Der Ploeg, Austin, & Steyerberg, 2014).  
In XGBoost, both gamma and the minimum child weight can be used to limit overfitting and improve 
performance.  Gamma restricts individual branches by requiring a minimum improvement threshold 
to be surpassed to add a new variable to the tree.  Minimum child weight restricts individual 
branches from selecting variables that perform amazingly for a few samples.  Different values of 
gamma and minimum child weight were assessed to determine the values that provided the best 
performance in the test dataset. 
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Gradient boosted trees were run in R with package xgboost (Chen & Guestrin, 2016).  All models 
used the “gbtree” booster.  The objective that was optimised was “binary:logistic” for models to 
predict phenotypes and “multi:softprob” for the models for location within the colon and rectum.  
To compensate for the 2:1 ratio of cases to controls in the data, scale_pos_weight=0.5 was used for 
the whole genome colorectal cancer data.  The data used was coded on the number of alleles and 
treated as a numeric variable as this is a requirement of XGBoost.  Dummy variables (e.g. one-hot 
encoding) were not used due to the size of the datasets. 
The parameters within the models were optimised to ensure that the best model was identified.  
The parameters which can be optimised in XGBoost are the minimum child weight, eta, gamma, the 
maximum tree depth and the number of trees (nrounds).  Minimum child weight is the sum across 
all samples of the estimated probability, p, times one minus the probability, p(1-p), known as 
“cover” in XGBoost or the minimum sum of the Hessian.  Eta (range 0 to 1) determines the weight 
applied to the scores in each tree for the calculation of probabilities and the number of trees needs 
to be more than 1/eta.  Gamma is a regularisation parameter applied to the logloss function and 
reduces the complexity of the models i.e. limits the addition of new leaves.  Table 7.4 shows the 
parameters that were optimised and the values which were assessed for each parameter.   
Parameter Possible Values Values Used 
Minimum Child Weight 1-∞ 1, 5, 10, 20, 40, 80 
Eta 0-1 0.01, 0.1, 0.5, 0.9, 1 
Gamma 0-∞ 0, 0.5, 1, 1.5, 2, 5 
Tree Depth 1-∞ 1, 2, 3, 4, 5, 10 
Number of Trees 1-∞ 2,5,10,20,50,100 
Table 7.4:  Parameters assessed for gradient boosted tree models. 
7.3.2  SHAP Values 
The way that gradient boosted tree models calculate model predictions can be difficult to explain.  
The variables that are used for each sample will depend on the branches taken in each tree, which 
is difficult to summarise.  Shapley Additive Explanations (SHAP) provide an explanation for the 
importance of variables in complex models such as gradient boosted trees.  They calculate the local 
importance of each SNP in the prediction for a sample, and then add together the results of all 
samples to give a SHAP value for each variable within the model.  SHAP values are useful as the 
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weight of a variable will be zero if it is not useful for predictions.  SHAP values is a computationally 
efficient way to calculate global Shapley values (the importance of a SNP in the model), which are 
otherwise difficult to calculate (Lundberg et al., 2020).  In genetics, SHAP values have been shown 
to identify SNPs that are associated with obesity and potential interactions (Johnsen et al., 2021).  
As SHAP values are a new technique, they are underutilised used for the prediction of colorectal 
cancer but have been used for models to predict the survival of colorectal cancer patients (Sundrani 
& Lu, 2021; van den Bosch et al., 2021).      
For Chapter 3, the genetic data was transformed to weight the SNPs according to their contribution 
to predictions of the phenotype for each individual.  The data was transformed in a two-step 
process: first, a model to predict the development of colorectal cancer was developed with gradient 
boosted tree(s); second, the SHAP values for each SNP were calculated (Lundberg et al., 2020).  The 
SHAP values were then used as an input to clustering methods. 
For Chapter 3 and Chapter 5, interactions were detected with SHAP values.  The interaction values 
have the desirable property that they can separate the main effect of a variable from the interaction 
effect (Lundberg et al., 2020).  They are also easy to interpret, as interaction values are zero when 
there is no evidence for an interaction.   
SHAP values were calculated in R with package xgboost and analysed with SHAPforxgboost 
(https://CRAN.R-project.org/package=SHAPforxgboost) (Chen & Guestrin, 2016).  In xgboost, SHAP 
values can be calculated with the predict command and predinteraction = TRUE.  Graphs of SHAP 
values were prepared in SHAPforxgboost with commands shap.prep.stack.data and 
shap.plot.force_plot. 
There are many methods to test the significance of interactions between SNPs (Ueki & Cordell, 
2012).  Tests based on alleles potentially miss the impact of double recessive alleles, so a test based 
on genotypes was chosen.  The test was conducted on the difference between genotypes using the 
saturated model shown in equation 7.1 (equation 2 in Ueki and Cordell (2012)).   This tests the 
significance of the interaction terms (𝛿11, 𝛿12,  𝛿21, 𝛿22) for the genotypes for two SNPs (x1 and x2) 
which have either one or two minor alleles (𝐼 is an indicator variable for the number of minor alleles) 
and main effects (𝛽1, 𝛽2, 𝛾1,  𝛾2).  The null hypothesis is that 𝛿11 = 𝛿12 =  𝛿21 =   𝛿22 = 0 .  The 






= 𝛼 +  𝛽1 𝐼(𝑥1 = 1) +  𝛽2 𝐼(𝑥1 = 2) +  𝛾1 𝐼(𝑥2 = 1) +  𝛾2 𝐼(𝑥2 = 2)
+ 𝛿11𝐼(𝑥1 = 1)𝐼(𝑥2 = 1) + 𝛿12𝐼(𝑥1 = 1)𝐼(𝑥2 = 2) + 𝛿21𝐼(𝑥1 = 2)𝐼(𝑥2 = 1)
+ 𝛿22𝐼(𝑥1 = 2)𝐼(𝑥2 = 2) 
Equation 7.1:  The saturated model used to test the significance of interactions, with a null hypothesis 
that 𝛿11 = 𝛿12 =  𝛿21 =   𝛿22 = 0 .  Equation 2 in Ueki and Cordell (2012).   
The significance of interaction terms was calculated in R with the command glm (base R) and 
package lmtest (https://CRAN.R-project.org/package=lmtest) with command lrtest. 
7.3.3  Random Forests 
Random Forests build multiple decision trees based on a randomly selected set of variables 
(Breiman, 2001; Strobl, Boulesteix, Kneib, Augustin, & Zeileis, 2008).  They have been shown to 
outperform logistic regressions in a variety of datasets (Levy & O’Malley, 2020).  Random Forests 
assess variables in combination with other variables, as each branch in each tree in a random forest 
represents a dependent path, where variables towards the end of the branches are only selected 
when the variables before them in the branch are selected (Dasgupta et al., 2011).  In theory this 
increases the chance that interactions are present, but practise random forests may miss 
interactions, depending on the type of interaction, size of the effects, methodology used and 
parameter settings (Wright et al., 2016).  For genetic data (multiple sclerosis and obesity), it has 
been shown that the variables selected by Random Forests overlap to a large degree with the 
variables found to be significant in genome-wide association studies (Goldstein, Hubbard, Cutler, & 
Barcellos, 2010; Johnsen et al., 2021).  Random forests were selected to use in this thesis as they 
are expected to detect SNPs that interact.  However, the ability of Random Forests to detect 
interactions is difficult to confirm, as test data with known interactions is difficult to obtain.   
Random Forests are constructed with a number of parameters able to be varied.  The sampling rate 
(mtry) randomly selects a number of columns from which to select the variable to use at each node.  
The default sampling rate is often set at the square root of the number of variables (√𝑝), however, 
the sampling rate is dependent on the number of noise variables in the dataset (Breiman, 2001). For 
genetic data, sampling rates of 0.1 were found to perform best in a dataset of approximately 
300,000 SNPs, while a sampling rate of was  0.21 in a dataset of approximately 529,000 SNPs to 
ensure pairs of SNPs had a probability of appearing together in one of 50 subsets of 0.9 (Goldstein 
et al., 2010; Johnsen et al., 2021).  Ultimately, the sampling rate needs to be appropriate for the 
chance of detecting interactions i.e. two SNPs occur in the same tree and the proportion of SNPs 
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(and any SNPs in linkage disequilibrium) which are associated with colorectal cancer, which may be 
as low as 0.003 (Thomas et al., 2020).  A variety of values for the sampling rate were assessed, which 
ranged from 0.01, where SNPs with small main effects are more likely to be selected, to 0.1, where 
two or more SNPs are more likely to interact.  The parameter for the number of trees in the forest 
is generally expected to converge with a few hundred trees (including with genetic data) (Goldstein 
et al., 2010).  However, a larger number of trees provides more opportunities for SNPs which 
interact to occur in the same tree i.e. be detected at the cost of possible correlation between trees 
in the random forest, which also depends on the sampling rate.  Therefore, a variety of values for 
the number of trees were assessed, which ranged from 1,000 to 10,000. 
The proportion of variables selected at each node (colsample_bynode) needs to be large enough 
that informative variables are included in each selection but small enough that the benefit of a large 
number of variables can be assessed.  Previous studies which use random forests on genomic data 
suggest that a proportion of 0.1 is optimal, with no loss of information when linkage disequilibrium 
is reduced to a maximum r2 of 0.90 (Goldstein et al., 2010).  However, models build with LDpred find 
that the best models occur when the proportion of causal variables is between 0.01 and 0.001 
(Thomas et al., 2020).  Therefore, a range of sampling rates were tested within the range of 0.01 to 
0.1. The number of trees in the random forest (num_parallel_tree) needs to be large enough that 
all variables have a chance to be included in the forest, so the minimum number of trees is inversely 
proportional to the sampling rate.   
Random Forests were calculated in R package xgboost, as this package was able to handle large 
datasets.  Random Forests were implemented with the parameters eta=1, nrounds=1, 
num_boost_round=1.  The parameters within the models were optimised to ensure that the best 
model was identified.  The parameters which can be optimised are the minimum child weight, eta, 
gamma, the maximum tree depth, the number of SNPs in the random sample for each node 
(colsample_bynode)  and the number of trees (num_parallel_tree).  Table 7.5 shows the parameters 
that were optimised and the values which were assessed for each parameter. 
Parameter Possible Values Values Used 
Minimum Child Weight 1-∞ 20, 40, 80 
SNP in Random Sample 0-1 0.01, 0.1 
Gamma 0-∞ 0, 1, 2 
Tree Depth 1-∞ 2, 3, 5 
Number of Trees 1-∞ 1000, 10000 
Table 7.5:  Parameters available in xgboost for random forests and the options assessed. 
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7.3.4  Random Forest Importance Scores 
The importance of each variable within a random forest can be assessed with a variable importance 
score.  This calculates the increase in the accuracy of the classification of samples from the inclusion 
of the variable to the model (a Gini coefficient).  The variables with the highest importance scores 
can then be selected to build models.  Importance scores are unbiased estimators of variable 
importance when collections of random trees are grown to be fully developed i.e., they use all 
possible variables, but this is not practical in many circumstances.  When sampling of variables is 
used, the variable importance scores are biased, as the strongest variables mask the effect of 
weaker variables.  The masking of relevant variables is reduced by the presence of irrelevant 
variables, with the impact dependent on the proportion of causal variables and the proportion of 
variables selected (Louppe, Wehenkel, Sutera, & Geurts, 2013). 
Variables with more categories have higher variable importance scores based when the importance 
score is calculated using the Gini coefficient (which is equal to twice the AUC less one), as the 
number of categories increases the likelihood that a favourable split can be identified by chance 
(Strobl et al., 2007).  To ensure all of the variables have the same number of categories, age was 
split into the same number of categories as are present for SNPs (0, 1,or 2 risk alleles), with three 
age groups of below 65, 65 to 75 and above 75.  SNPs with higher minor allele frequencies are also 
more likely to be selected using variable importance scores based on Gini coefficients.  This leads to 
uninformative SNPs with high minor allele frequencies masking informative SNPs with low minor 
allele frequencies.  Importance scores based on permutation do not show the bias seen in 
importance scores based on Gini scores, but are computationally impractical for big data 
(Boulesteix, Bender, Lorenzo Bermejo, & Strobl, 2012).   Permutation importance scores are also 
less likely to detect interactions than Gini importance scores (Wright et al., 2016).  Importance 
scores are also biased when SNPs have high linkage disequilibrium (Strobl et al., 2008). The 
importance score of correlated SNPs is inflated by their degree of correlation with causal SNPs.  The 
degree of inflation depends on the value chosen as the proportion to sample at each node, with a 
low value more likely to lead to correlated SNPs with importance scores greater than uncorrelated 
causal SNPs.  Inflation of importance scores can be corrected by using conditional importance scores 
(which are conditioned on correlated variables (Strobl et al., 2008).  However, conditional 
importance scores are computationally unfeasible in high dimensional data.  Meng, Yu, Cupples, 
Farrer, and Lunetta (2009) show (in figure 3) that provided there are enough SNPs included in the 
list of top SNPs, that correlated SNPs do not exclude uncorrelated causal SNPs. 
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7.4  Clustering methods 
There are multiple methods to allocate samples within a dataset into clusters, with more than forty 
different methods available (Rodriguez et al., 2019; Xu & Wunsch, 2010).  Most of these methods 
are unsupervised (the phenotype is not used).  Unsupervised methods for clustering (i.e. 
information about the phenotype is not included) are generally classified into four broad categories 
of hierarchical, partitional, model-based and density-based, although other categories and 
categorisation schemes exist (Rodriguez et al., 2019; Xu & Wunsch, 2010).  Studies which compare 
these methods show that some methods are generally more successful, and that the success of the 
method depends on the data being analysed (Dalton, Ballarin, & Brun, 2009; Jay et al., 2012; Milligan 
& Cooper, 1985).  However, there is no consensus about which method is best, either overall or for 
genetic data. 
Hierarchical clustering successively adds/divides the data into groups that are like/unlike each other 
based on a rule set by the selected method.  This results in a dendrogram which shows the 
relationships of the groups in the data to each other.  A variety of methods exist to measure the 
distance between the groups and find the closest/furthest groups, including Euclidean and 
Manhattan distances (Clifford, Wessely, Pendurthi, & Emes, 2011).  Ward’s method minimises the 
within cluster sum-of-squares and can be sensitive to outliers (Xu & Wunsch, 2010).  It can also be 
used to initialise the cluster locations for k-means (see below) (Steinley & Brusco, 2007).  Ward’s 
method was selected as it performed best in larger datasets in classifying gene expression data (Jay 
et al., 2012). 
Partitional clustering randomly assigns starting points for the required number of clusters and then 
associated the remaining samples to belong to those clusters.  The mean point for each cluster is 
then updated and the samples are reassigned iteratively until no changes in cluster membership 
occur (Xu & Wunsch, 2010).  This can force outliers to join clusters they do not fit well with, which 
alters the mean centroid of the cluster.  K-means is one of the most used partitional clustering 
methods and was selected for use on this basis.  It requires the number of clusters to be specified 
and then forms this number of clusters around the mean point of each cluster.  The initial cluster 
starting points can be randomly generated but this may lead to suboptimal solutions.  As principal 
component analysis is equivalent to the optimal solution to k-means, the optimal solution can be 
obtained by principal component analysis followed by k-means on the principal components (for 
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the first n-1 principal components where n is the number of clusters)  (Shen, Olshen, & Ladanyi, 
2009). 
Model-based approaches cluster samples based on mixed models by Expectation Maximisation 
(EM).  Mixed models apply a mixture of distributions (commonly Gaussian) to the clusters i.e. each 
cluster has its own distribution.  Then at each iteration of the Expectation Maximisation algorithm, 
the probability a sample belongs to each cluster is determined (Expectation) and the distribution 
parameters for the clusters are calculated.  This continues until the fit of the distributions to the 
data by as set criteria (such as the log-likelihood) is maximised (Maximisation).   Model-based 
approaches require the correct distribution to be specified.  The benefit of model-based approaches 
is that samples are assigned probabilities of belonging to a cluster i.e. soft clustering. 
Density methods cluster points with other points within their neighbourhood (defined by a set 
distance, epsilon), provided the number of neighbours is greater than the minimum density 
threshold.  With the DBSCAN method, the clusters extends until there are no other points meet the 
minimum density threshold (Ester, Kriegel, Sander, & Xu, 1996).  Alternatively, with the OPTICS 
method, all points can be assigned to clusters by varying the epsilon parameter and the clusters can 
be determined by the reachability (epsilon) of the samples (Ankerst, Breunig, Kriegel, & Sander, 
1999).  Density methods are robust to outliers and can succeed in situations where hierarchical and 
partitional clustering can fail, due to their tendency to form spheroid structures (Xu & Wunsch, 
2010).  Density methods do not require the specification of the number of clusters, but the 
determination of epsilon has a similar impact on the number of clusters. 
The optimum clustering algorithm to use depends on the structure of the data being analysed.  
Performance varies between different algorithms and different distance measures (where these are 
available) (Clifford et al., 2011; Ultsch & Lötsch, 2017).  Therefore a variety of clustering algorithms 
were used, with complete and Wards method selected to represent hierarchical methods, k-means 
to represent partitional methods, Expectation Maximization for model-based methods and DBSCAN 
and OPTICS for density methods.  These methods all contain parameters that can be set by users 
that can improve the performance of the clustering method (Rodriguez et al., 2019).  Parameters 
(e.g. number of iterations) were varied to find optimal solutions where applicable with a focus on 
the stability of the final solution. 
There are also multiple methods to determine the number of clusters present in a dataset, with over 
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thirty different metrics available that claim to identify the number of clusters in a dataset (Charrad, 
Ghazzali, Boiteau, & Niknafs, 2014).  These methods are based on distance measures e.g. Euclidean 
distance.  The three main groups of methods are variance based, structure based and stability 
approaches (Chiang & Mirkin, 2010).  Variance based methods find the minimum within cluster 
variance subject to a criterion and include the Calinski and Harabasz (CH) psudo-F and Gap statistic 
(Caliński & Harabasz, 1974; Tibshirani, Walther, & Hastie, 2001).  Structure methods compare the 
cohesion within clusters and the differences between clusters, such as the silhouette method or 
density-based methods (Ankerst et al., 1999; Rousseeuw, 1987).  Hierarchical methods assess the 
incremental impact on the distance to the cluster centroids, such as the Duda and Hart (DH) ratio, 
which can only be used with hierarchical methods (Duda & Hart, 1973). 
The relative merits of each clustering method in identifying the real number of clusters in the data 
can be examined with simulated data where the correct number of clusters is known.  None of these 
methods is accepted as the best method and all may under- or over-estimate the number of clusters 
in the data in simulated datasets.   Different conclusions are reached about the best method 
depending on the simulated dataset used, with different performances for cluster separation, 
unequal cluster sizes and overlapping clusters (Islam et al., 2015; Milligan & Cooper, 1985; Tibshirani 
& Walther, 2005).  For this reason a variety of methods were selected to assess the number of 
clusters, with CH, Gap, BIC and Reachability used (where available and appropriate for the clustering 
method). 
Clustering algorithms were all run in R software.  Clusters and numbers of clusters were determined 
with the packages NbClust (command nbclust), cluster (command clusGap, https://CRAN.R-
project.org/package=cluster), adegenet (command find.clusters), MClust (command mclust) and 
DBSCAN (command optics) (Charrad et al., 2014; Hahsler, Piekenbrock, & Doran, 2019; Jombart, 
2008; Scrucca, Fop, Murphy, & Raftery, 2016).  The method used for each clustering type and 
number of clusters is shown in Table 7.6.   
Clustering 
Method 
Number of Clusters 
CH Gap BIC Reachability 
Wards NbClust cluster adegenet n/a 
Complete NbClust cluster n/a n/a 
K-means NbClust cluster adegenet n/a 
Model-based n/a n/a mclust n/a 
OPTICS n/a n/a n/a DBSCAN 
Table 7.6:  The R packages used for each combination of clustering method and assessment of the 
number of clusters. 
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7.5  Area Under the Receiver Operating Curve 
A receiver operating curve is a graph of the trade-off between the specificity of a model (disease 
predictions that were true) against the sensitivity of a model (predictions of no disease that were 
true).  The area under the receiver operating curve is the space between the plotted line and the x-
axis.  Concordance scores (AUC) measure the ability of a model to accurately predict cancer status 
on a scale between 0.5 and 1, where 0.5 is the performance of a random variable, above 0.75 is 
considered a useful level of discrimination and 1 is a perfect ability to predict whether someone will 
develop colorectal cancer (Alba et al., 2017). 
AUC was chosen to compare the performance of models for two reasons.  It is valid to compare 
models constructed from different datasets with different methods with the AUC.  The AUC also 
measures the performance of a model relative to the performance of a randomly assigned variable 
in the proportions in the dataset, so the level of the AUC is not altered by the use of different ratios 
of cases and controls in the dataset (Alba et al., 2017).  To compare models, the significance of the 
difference in AUCs was tested with a bootstrap test.  A bootstrap test was chosen as the loss of 
power for DeLong’s test for the difference in AUCs with the addition of a variable to a model 
suggests that it may also lose power when different model designs are tested on the same dataset 
(Demler, Pencina, & D'Agostino, 2012). 
To assess the ability of LDA to correctly assign samples to locations with the AUC, all samples 
predicted to be at a colorectal cancer location were classified as cases and then the AUC was 
calculated on the predicted phenotype.   
AUC was calculated in R package pROC with command roc,  95% confidence intervals were 
calculated with command ci.auc and the bootstrap option and the significance of the difference 
between two AUC values was calculated with roc.test and the bootstrap option.  The bootstrap 




Aaltonen, L., Johns, L., Järvinen, H., Mecklin, J.-P., & Houlston, R. (2007). Explaining the Familial 
Colorectal Cancer Risk Associated with Mismatch Repair (MMR)-Deficient and MMR-Stable 
Tumors. Clinical Cancer Research, 13(1), 356-361. doi:10.1158/1078-0432.ccr-06-1256 
Abramovs, N., Brass, A., & Tassabehji, M. (2020). Hardy-Weinberg Equilibrium in the Large Scale 
Genomic Sequencing Era. Frontiers in Genetics, 11(210). doi:10.3389/fgene.2020.00210 
Ahmed, J., Kumar, A., Parikh, K., Anwar, A., Knoll, B. M., Puccio, C., . . . Lim, S. H. (2018). Use of broad-
spectrum antibiotics impacts outcome in patients treated with immune checkpoint 
inhibitors. Oncoimmunology, 7(11), e1507670-e1507670. 
doi:10.1080/2162402X.2018.1507670 
Ahn, J., Sinha, R., Pei, Z., Dominianni, C., Wu, J., Shi, J., . . . Yang, L. (2013). Human Gut Microbiome 
and Risk for Colorectal Cancer. JNCI: Journal of the National Cancer Institute, 105(24), 1907-
1911. doi:10.1093/jnci/djt300 
Ajouz, H., Mukherji, D., & Shamseddine, A. (2014). Secondary bile acids: an underrecognized cause 
of colon cancer. World Journal of Surgical Oncology, 12(1), 164. doi:10.1186/1477-7819-12-
164 
Alba, A. C., Agoritsas, T., Walsh, M., Hanna, S., Iorio, A., Devereaux, P. J., . . . Guyatt, G. (2017). 
Discrimination and Calibration of Clinical Prediction Models. JAMA, 318(14), 1377. 
doi:10.1001/jama.2017.12126 
Alpay, B. A., Demetci, P., Istrail, S., & Aguiar, D. (2020). Combinatorial and statistical prediction of 
gene expression from haplotype sequence. Bioinformatics, 36(Supplement_1), i194-i202. 
doi:10.1093/bioinformatics/btaa318 
Ankerst, M., Breunig, M. M., Kriegel, H.-P., & Sander, J. (1999). OPTICS. ACM SIGMOD Record, 28(2), 
49-60. doi:10.1145/304181.304187 
Baylin, S. B., & Jones, P. A. (2011). A decade of exploring the cancer epigenome — biological and 
translational implications. Nature Reviews Cancer, 11(10), 726-734. doi:10.1038/nrc3130 
Belanger, C. F., Hennekens, C. H., Rosner, B., & Speizer, F. E. (1978). The Nurses' Health Study. The 
American Journal of Nursing, 78(6), 1039-1040. doi:10.2307/3462013 
Bernstein, C., Holubec, H., Bhattacharyya, A. K., Nguyen, H., Payne, C. M., Zaitlin, B., & Bernstein, H. 
(2011). Carcinogenicity of deoxycholate, a secondary bile acid. Archives of Toxicology, 85(8), 
863-871. doi:10.1007/s00204-011-0648-7 
Bien, S. A., Su, Y.-R., Conti, D. V., Harrison, T. A., Qu, C., Guo, X., . . . Peters, U. (2019). Genetic variant 
predictors of gene expression provide new insight into risk of colorectal cancer. Human 
Genetics, 138(4), 307-326. doi:10.1007/s00439-019-01989-8 
108 
 
Bouaziz, M., Ambroise, C., & Guedj, M. (2011). Accounting for population stratification in practice: 
a comparison of the main strategies dedicated to genome-wide association studies. PLoS 
ONE, 6(12), e28845-e28845. doi:10.1371/journal.pone.0028845 
Boulesteix, A. L., Bender, A., Lorenzo Bermejo, J., & Strobl, C. (2012). Random forest Gini importance 
favours SNPs with large minor allele frequency: impact, sources and recommendations. 
Briefings in Bioinformatics, 13(3), 292-304. doi:10.1093/bib/bbr053 
Boyle, E. A., Li, Y. I., & Pritchard, J. K. (2017). An Expanded View of Complex Traits: From Polygenic 
to Omnigenic. Cell, 169(7), 1177-1186. doi:10.1016/j.cell.2017.05.038 
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer 
statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 
185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394-424. doi:10.3322/caac.21492 
Breiman, L. (2001). Random Forests. Machine Learning, 45(1), 5-32. doi:10.1023/A:1010933404324 
Brenner, H., Chang-Claude, J., Seiler, C. M., Stürmer, T., & Hoffmeister, M. (2006). Does a negative 
screening colonoscopy ever need to be repeated? Gut, 55(8), 1145-1150. 
doi:10.1136/gut.2005.087130 
Caliński, T., & Harabasz, J. (1974). A dendrite method for cluster analysis. Communications in 
Statistics, 3(1), 1-27. doi:10.1080/03610927408827101 
Calle, E. E., Rodriguez, C., Jacobs, E. J., Almon, M. L., Chao, A., McCullough, M. L., . . . Thun, M. J. 
(2002). The American Cancer Society Cancer Prevention Study II Nutrition Cohort. Cancer, 
94(2), 500-511. doi:10.1002/cncr.10197 
Calus, M. P. L., & Vandenplas, J. (2018). SNPrune: an efficient algorithm to prune large SNP array 
and sequence datasets based on high linkage disequilibrium. Genetics Selection Evolution, 
50(1). doi:10.1186/s12711-018-0404-z 
Cantor, R. M., Lange, K., & Sinsheimer, J. S. (2010). Prioritizing GWAS Results: A Review of Statistical 
Methods and Recommendations for Their Application. The American Journal of Human 
Genetics, 86(1), 6-22. doi:10.1016/j.ajhg.2009.11.017 
Chang, C. C., Chow, C. C., Tellier, L. C., Vattikuti, S., Purcell, S. M., & Lee, J. J. (2015). Second-
generation PLINK: rising to the challenge of larger and richer datasets. GigaScience, 4(1). 
doi:10.1186/s13742-015-0047-8 
Charrad, M., Ghazzali, N., Boiteau, V., & Niknafs, A. (2014). NbClust: An R Package for Determining 
the Relevant Number of Clusters in a Data Set. 2014, 61(6), 36. doi:10.18637/jss.v061.i06 
Chasioti, D., Yan, J., Nho, K., & Saykin, A. J. (2019). Progress in Polygenic Composite Scores in 
Alzheimer's and Other Complex Diseases. Trends in genetics : TIG, 35(5), 371-382. 
doi:10.1016/j.tig.2019.02.005 
Chen, C. D., Yen, M. F., Wang, W. M., Wong, J. M., & Chen, T.-H. (2003). A case–cohort study for the 
disease natural history of adenoma–carcinoma and de novo carcinoma and surveillance of 
109 
 
colon and rectum after polypectomy: implication for efficacy of colonoscopy. British Journal 
of Cancer, 88(12), 1866-1873. doi:10.1038/sj.bjc.6601007 
Chen, J., & Vitetta, L. (2018). Inflammation-Modulating Effect of Butyrate in the Prevention of Colon 
Cancer by Dietary Fiber. Clinical Colorectal Cancer, 17(3), e541-e544. 
doi:10.1016/j.clcc.2018.05.001 
Chen, T., & Guestrin, C. (2016). XGBoost: A Scalable Tree Boosting System. Paper presented at the 
Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and 
Data Mining, San Francisco, California, USA. https://doi.org/10.1145/2939672.2939785 
Chiang, M. M.-T., & Mirkin, B. (2010). Intelligent Choice of the Number of Clusters in K-Means 
Clustering: An Experimental Study with Different Cluster Spreads. Journal of Classification, 
27(1), 3-40. doi:10.1007/s00357-010-9049-5 
Choi, S. W., Mak, T. S.-H., & O’Reilly, P. F. (2020). Tutorial: a guide to performing polygenic risk score 
analyses. Nature Protocols, 15(9), 2759-2772. doi:10.1038/s41596-020-0353-1 
Choi, S. W., & O'Reilly, P. F. (2019). PRSice-2: Polygenic Risk Score software for biobank-scale data. 
GigaScience, 8(7). doi:10.1093/gigascience/giz082 
Clarke, G. M., Anderson, C. A., Pettersson, F. H., Cardon, L. R., Morris, A. P., & Zondervan, K. T. (2011). 
Basic statistical analysis in genetic case-control studies. Nature Protocols, 6(2), 121-133. 
doi:10.1038/nprot.2010.182 
Clifford, H., Wessely, F., Pendurthi, S., & Emes, R. D. (2011). Comparison of Clustering Methods for 
Investigation of Genome-Wide Methylation Array Data. Frontiers in Genetics, 2. 
doi:10.3389/fgene.2011.00088 
Dalton, L., Ballarin, V., & Brun, M. (2009). Clustering Algorithms: On Learning, Validation, 
Performance, and Applications to Genomics. Current Genomics, 10(6), 430-445. 
doi:10.2174/138920209789177601 
Danecek, P., Auton, A., Abecasis, G., Albers, C. A., Banks, E., Depristo, M. A., . . . Durbin, R. (2011). 
The variant call format and VCFtools. Bioinformatics, 27(15), 2156-2158. 
doi:10.1093/bioinformatics/btr330 
Daniel, C., Schröder, O., Zahn, N., Gaschott, T., & Stein, J. (2004). p38 MAPK signaling pathway is 
involved in butyrate-induced vitamin D receptor expression. 324(4), 1220-1226. 
doi:10.1016/j.bbrc.2004.09.191 
Daniel, C., Schroder, O., Zahn, N., Gaschott, T., Steinhilber, D., & Stein, J. M. (2007). The TGFβ/Smad 
3-signaling pathway is involved in butyrate-mediated vitamin D receptor (VDR)-expression. 
102(6), 1420-1431. doi:10.1002/jcb.21361 
Dasgupta, A., Sun, Y. V., König, I. R., Bailey-Wilson, J. E., & Malley, J. D. (2011). Brief review of 
regression-based and machine learning methods in genetic epidemiology: the Genetic 




De La Vega, F. M., & Bustamante, C. D. (2018). Polygenic risk scores: a biased prediction? Genome 
Medicine, 10(1). doi:10.1186/s13073-018-0610-x 
Demler, O. V., Pencina, M. J., & D'Agostino, R. B. (2012). Misuse of DeLong test to compare AUCs for 
nested models. Statistics in Medicine, 31(23), 2577-2587. doi:10.1002/sim.5328 
Dethlefsen, L., & Relman, D. A. (2011). Incomplete recovery and individualized responses of the 
human distal gut microbiota to repeated antibiotic perturbation. Proceedings of the National 
Academy of Sciences, 108(Supplement 1), 4554-4561. doi:10.1073/pnas.1000087107 
Devlin, B., & Roeder, K. (1999). Genomic Control for Association Studies. Biometrics, 55(4), 997-
1004. doi:10.1111/j.0006-341x.1999.00997.x 
Devlin, B., Roeder, K., & Wasserman, L. (2001). Genomic Control, a New Approach to Genetic-Based 
Association Studies. Theoretical Population Biology, 60(3), 155-166. 
doi:10.1006/tpbi.2001.1542 
Dorani, F., Hu, T., Woods, M. O., & Zhai, G. (2018). Ensemble learning for detecting gene-gene 
interactions in colorectal cancer. PeerJ, 6, e5854. doi:10.7717/peerj.5854 
Duda, R. O., & Hart, P. E. (1973). Pattern classification and scene analysis. New York: Wiley. 
Eichler, E. E., Flint, J., Gibson, G., Kong, A., Leal, S. M., Moore, J. H., & Nadeau, J. H. (2010). Missing 
heritability and strategies for finding the underlying causes of complex disease. Nature 
Reviews Genetics, 11(6), 446-450. doi:10.1038/nrg2809 
Ester, M., Kriegel, H.-P., Sander, J., & Xu, X. (1996). A density-based algorithm for discovering clusters 
in large spatial databases with noise. Paper presented at the Proceedings of the Second 
International Conference on Knowledge Discovery and Data Mining, Portland, Oregon.  
European Bioinformatics Institute. (2021). GWAS Catalog. Retrieved from 
https://www.ebi.ac.uk/gwas/home.  Retrieved 12 July 2021, from European Molecular 
Biology Laboratory https://www.ebi.ac.uk/gwas/home 
Fadista, J., Manning, A. K., Florez, J. C., & Groop, L. (2016). The (in)famous GWAS P-value threshold 
revisited and updated for low-frequency variants. European Journal of Human Genetics, 
24(8), 1202-1205. doi:10.1038/ejhg.2015.269 
Fagny, M., Platig, J., Kuijjer, M. L., Lin, X., & Quackenbush, J. (2020). Nongenic cancer-risk SNPs affect 
oncogenes, tumour-suppressor genes, and immune function. British Journal of Cancer, 
122(4), 569-577. doi:10.1038/s41416-019-0614-3 
Fahed, A. C., Wang, M., Homburger, J. R., Patel, A. P., Bick, A. G., Neben, C. L., . . . Khera, A. V. (2020). 
Polygenic background modifies penetrance of monogenic variants for tier 1 genomic 
conditions. Nature Communications, 11(1). doi:10.1038/s41467-020-17374-3 
Fang, G., Wang, W., Paunic, V., Heydari, H., Costanzo, M., Liu, X., . . . Myers, C. L. (2019). Discovering 
genetic interactions bridging pathways in genome-wide association studies. Nature 
Communications, 10(1). doi:10.1038/s41467-019-12131-7 
111 
 
Frampton, M., & Houlston, R. S. (2017). Modeling the prevention of colorectal cancer from the 
combined impact of host and behavioral risk factors. Genetics in medicine : official journal of 
the American College of Medical Genetics, 19(3), 314-321. doi:10.1038/gim.2016.101 
Frampton, M. J. E., Law, P., Litchfield, K., Morris, E. J., Kerr, D., Turnbull, C., . . . Houlston, R. S. (2015). 
Implications of polygenic risk for personalised colorectal cancer screening. mdv540. 
doi:10.1093/annonc/mdv540 
Friedman, J. H., Hastie, T., & Tibshirani, R. (2010). Regularization Paths for Generalized Linear 
Models via Coordinate Descent. 2010, 33(1), 22. doi:10.18637/jss.v033.i01 
Gallagher, M. D., & Chen-Plotkin, A. S. (2018). The Post-GWAS Era: From Association to Function. 
The American Journal of Human Genetics, 102(5), 717-730. doi:10.1016/j.ajhg.2018.04.002 
Gaschott, T., & Stein, J. (2003). Short-Chain Fatty Acids and Colon Cancer Cells: The Vitamin D 
Receptor—Butyrate Connection. Paper presented at the Vitamin D Analogs in Cancer 
Prevention and Therapy, Berlin, Heidelberg. 
Genovese, G. (2021). gtc2vcf. Retrieved from https://github.com/freeseek/gtc2vcf 
Gohagan, J. K., Prorok, P. C., Hayes, R. B., & Kramer, B.-S. (2000). The Prostate, Lung, Colorectal and 
Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, 
and status. Controlled Clinical Trials, 21(6), 251S-272S. doi:10.1016/s0197-2456(00)00097-0 
Golan, D., Rosset, S., & Lin, D.-Y. (2017). Mixed Models for Case-Control Genome-Wide Association 
Studies: Major Challenges and Partial Solutions. In Ø. Borgan, N. E. Breslow, N. Chatterjee, 
M. H. Gail, A. Scott, & C. J. Wild (Eds.), Handbook of Statistical Methods for Case-Control 
Studies (1st ed.). Boca Raton: Chapman and Hall/CRC. 
Goldstein, B. A., Hubbard, A. E., Cutler, A., & Barcellos, L. F. (2010). An application of Random Forests 
to a genome-wide association dataset: Methodological considerations & new findings. BMC 
Genetics, 11(1), 49. doi:10.1186/1471-2156-11-49 
Graff, R. E., Möller, S., Passarelli, M. N., Witte, J. S., Skytthe, A., Christensen, K., . . . Hjelmborg, J. B. 
(2017). Familial Risk and Heritability of Colorectal Cancer in the Nordic Twin Study of Cancer. 
Clin Gastroenterol Hepatol, 15(8), 1256-1264. doi:10.1016/j.cgh.2016.12.041 
Guan, Y., & Stephens, M. (2008). Practical Issues in Imputation-Based Association Mapping. PLOS 
Genetics, 4(12), e1000279. doi:10.1371/journal.pgen.1000279 
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., . . . Tejpar, S. (2015). 
The consensus molecular subtypes of colorectal cancer. Nature medicine, 21(11), 1350-1356. 
doi:10.1038/nm.3967 
Guyon, I., & Elisseeff, A. (2003). An introduction to variable and feature selection. J. Mach. Learn. 
Res., 3(null), 1157–1182.  
Hahsler, M., Piekenbrock, M., & Doran, D. (2019). dbscan: Fast Density-Based Clustering with R. 
2019, 91(1), 30. doi:10.18637/jss.v091.i01 
112 
 
Hastie, T., Tibshirani, R., & Friedman, J. H. (2009). The elements of statistical learning: data mining, 
inference, and prediction (2nd ed.). New York: Springer. 
Heath, S. C., Gut, I. G., Brennan, P., McKay, J. D., Bencko, V., Fabianova, E., . . . Lathrop, M. (2008). 
Investigation of the fine structure of European populations with applications to disease 
association studies. European Journal of Human Genetics, 16(12), 1413-1429. 
doi:10.1038/ejhg.2008.210 
Heinken, A., Ravcheev, D. A., Baldini, F., Heirendt, L., Fleming, R. M. T., & Thiele, I. (2019). Systematic 
assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic 
capabilities in inflammatory bowel disease. Microbiome, 7(1). doi:10.1186/s40168-019-
0689-3 
Hellwege, J. N., Keaton, J. M., Giri, A., Gao, X., Velez Edwards, D. R., & Edwards, T. L. (2017). 
Population Stratification in Genetic Association Studies. Current protocols in human genetics, 
95, 1.22.21-21.22.23. doi:10.1002/cphg.48 
Hemminki, K., & Chen, B. (2004). Familial Risk for Colorectal Cancers Are Mainly Due to Heritable 
Causes. Cancer Epidemiology Biomarkers &amp; Prevention, 13(7), 1253-1256. Retrieved 
from https://cebp.aacrjournals.org/content/cebp/13/7/1253.full.pdf 
Höglund, J., Rafati, N., Rask-Andersen, M., Enroth, S., Karlsson, T., Ek, W. E., & Johansson, Å. (2019). 
Improved power and precision with whole genome sequencing data in genome-wide 
association studies of inflammatory biomarkers. Scientific Reports, 9(1). 
doi:10.1038/s41598-019-53111-7 
Hong, E. P., & Park, J. W. (2012). Sample Size and Statistical Power Calculation in Genetic Association 
Studies. Genomics & Informatics, 10(2), 117. doi:10.5808/gi.2012.10.2.117 
Hsu, L., Jeon, J., Brenner, H., Gruber, S. B., Schoen, R. E., Berndt, S. I., . . . Peters, U. (2015). A Model 
to Determine Colorectal Cancer Risk Using Common Genetic Susceptibility Loci. 
Gastroenterology, 148(7), 1330-1339.e1314. doi:10.1053/j.gastro.2015.02.010 
Hu, L., Yao, X., Huang, H., Guo, Z., Cheng, X., Xu, Y., . . . Li, D. (2018). Clinical significance of germline 
copy number variation in susceptibility of human diseases. Journal of Genetics and 
Genomics, 45(1), 3-12. doi:10.1016/j.jgg.2018.01.001 
Huang, M.-W., Chen, C.-W., Lin, W.-C., Ke, S.-W., & Tsai, C.-F. (2017). SVM and SVM Ensembles in 
Breast Cancer Prediction. PLoS ONE, 12(1), e0161501. doi:10.1371/journal.pone.0161501 
Huang, S., Cai, N., Pacheco, P. P., Narrandes, S., Wang, Y., & Xu, W. (2018). Applications of Support 
Vector Machine (SVM) Learning in Cancer Genomics. Cancer Genomics & Proteomics, 15(1), 
41-51. doi:10.21873/cgp.20063 
Huyghe, J. R., Bien, S. A., Harrison, T. A., Kang, H. M., Chen, S., Schmit, S. L., . . . Peters, U. (2019). 
Discovery of common and rare genetic risk variants for colorectal cancer. Nature Genetics, 
51(1), 76-87. doi:10.1038/s41588-018-0286-6 
Islam, M. A., Alizadeh, B. Z., Van Den Heuvel, E. R., Bruggeman, R., Cahn, W., De Haan, L., . . . 
Wiersma, D. (2015). A comparison of indices for identifying the number of clusters in 
113 
 
hierarchical clustering: A study on cognition in schizophrenia patients. Communications in 
Statistics: Case Studies, Data Analysis and Applications, 1(2), 98-113. 
doi:10.1080/23737484.2015.1103670 
Jackson, D. A. (1993). Stopping rules in principal components analysis: A comparison of heuristical 
and statistical approaches. Ecology, 74(8), 2204. Retrieved from 
https://www.jstor.org/stable/1939574 
Janssens, A. C. J. W. (2019). Validity of polygenic risk scores: are we measuring what we think we 
are? Human Molecular Genetics, 28(R2), R143-R150. doi:10.1093/hmg/ddz205 
Jass, J. R. (2007). Heredity and DNA methylation in colorectal cancer. Gut, 56(1), 154-155. Retrieved 
from https://pubmed.ncbi.nlm.nih.gov/17172593 
Jay, J. J., Eblen, J. D., Zhang, Y., Benson, M., Perkins, A. D., Saxton, A. M., . . . Langston, M. A. (2012). 
A systematic comparison of genome-scale clustering algorithms. BMC Bioinformatics, 
13(Suppl 10), S7. doi:10.1186/1471-2105-13-s10-s7 
Jenkins, M. A., Makalic, E., Dowty, J. G., Schmidt, D. F., Dite, G. S., MacInnis, R. J., . . . Buchanan, D. 
D. (2016). Quantifying the utility of single nucleotide polymorphisms to guide colorectal 
cancer screening. Future oncology (London, England), 12(4), 503-513. 
doi:10.2217/fon.15.303 
Jeon, J., Du, M., Schoen, R. E., Hoffmeister, M., Newcomb, P. A., Berndt, S. I., . . . Epidemiology of 
Colorectal Cancer, C. (2018). Determining Risk of Colorectal Cancer and Starting Age of 
Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology, 154(8), 
2152-2164.e2119. doi:10.1053/j.gastro.2018.02.021 
Jia, G., Lu, Y., Wen, W., Long, J., Liu, Y., Tao, R., . . . Zheng, W. (2020). Evaluating the Utility of 
Polygenic Risk Scores in Identifying High-Risk Individuals for Eight Common Cancers. JNCI 
Cancer Spectrum. doi:10.1093/jncics/pkaa021 
Jiao, S., Hsu, L., Berndt, S., Bézieau, S., Brenner, H., Buchanan, D., . . . Peters, U. (2012). Genome-
Wide Search for Gene-Gene Interactions in Colorectal Cancer. PLoS ONE, 7(12), e52535. 
doi:10.1371/journal.pone.0052535 
Johnsen, P. V., Riemer-Sørensen, S., Dewan, A. T., Cahill, M. E., & Langaas, M. (2021). A new method 
for exploring gene–gene and gene–environment interactions in GWAS with tree ensemble 
methods and SHAP values. BMC Bioinformatics, 22(1). doi:10.1186/s12859-021-04041-7 
Johnstone, I. M., & Titterington, D. M. (2009). Statistical challenges of high-dimensional data. 
Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering 
Sciences, 367(1906), 4237-4253. doi:10.1098/rsta.2009.0159 
Jombart, T. (2008). adegenet: a R package for the multivariate analysis of genetic markers. 
Bioinformatics, 24(11), 1403-1405. doi:10.1093/bioinformatics/btn129 
Kendler, K. S., & Eaves, L. J. (1986). Models for the joint effect of genotype and environment on 
liability to psychiatric illness. Am J Psychiatry, 143(3), 279-289. doi:10.1176/ajp.143.3.279 
114 
 
Khera, A. V., Chaffin, M., Aragam, K. G., Haas, M. E., Roselli, C., Choi, S. H., . . . Kathiresan, S. (2018). 
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent 
to monogenic mutations. Nature Genetics, 50(9), 1219-1224. doi:10.1038/s41588-018-0183-
z 
Kim, J., Yum, S., Kang, C., & Kang, S.-J. (2016). Gene-gene interactions in gastrointestinal cancer 
susceptibility. Oncotarget, 7(41), 67612-67625. doi:10.18632/oncotarget.11701 
Kim, M. S., Patel, K. P., Teng, A. K., Berens, A. J., & Lachance, J. (2018). Genetic disease risks can be 
misestimated across global populations. Genome Biology, 19(1). doi:10.1186/s13059-018-
1561-7 
Kohler, K., & Bickeboller, H. (2006). Case-Control Association Tests Correcting for Population 
Stratification. Annals of Human Genetics, 70(1), 98-115. doi:10.1111/j.1529-
8817.2005.00214.x 
Kooperberg, C., Leblanc, M., & Obenchain, V. (2010). Risk prediction using genome-wide association 
studies. Genetic Epidemiology, 34(7), 643-652. doi:10.1002/gepi.20509 
Lachance, J., & Tishkoff, S. A. (2013). SNP ascertainment bias in population genetic analyses: Why it 
is important, and how to correct it. BioEssays, 35(9), 780-786. doi:10.1002/bies.201300014 
Lao, V. V., & Grady, W. M. (2011). Epigenetics and colorectal cancer. Nature Reviews 
Gastroenterology & Hepatology, 8(12), 686-700. doi:10.1038/nrgastro.2011.173 
Law, P. J., Timofeeva, M., Fernandez-Rozadilla, C., Broderick, P., Studd, J., Fernandez-Tajes, J., . . . 
Dunlop, M. G. (2019). Association analyses identify 31 new risk loci for colorectal cancer 
susceptibility. Nature Communications, 10(1). doi:10.1038/s41467-019-09775-w 
Le Marchand, L., Wilkens, L. R., Hankin, J. H., Kolonel, L. N., & Lyu, L.-C. (1999). Independent and 
Joint Effects of Family History and Lifestyle on Colorectal Cancer Risk: Implications for 
Prevention. Cancer Epidemiology Biomarkers & Prevention, 8(1), 45-51. Retrieved from 
https://cebp.aacrjournals.org/content/cebp/8/1/45.full.pdf 
Lee, S., Wright, F. A., & Zou, F. (2011). Control of population stratification by correlation-selected 
principal components. Biometrics, 67(3), 967-974. doi:10.1111/j.1541-0420.2010.01520.x 
Levy, J. J., & O’Malley, A. J. (2020). Don’t dismiss logistic regression: the case for sensible extraction 
of interactions in the era of machine learning. BMC Medical Research Methodology, 20(1). 
doi:10.1186/s12874-020-01046-3 
Li, H. (2011). A statistical framework for SNP calling, mutation discovery, association mapping and 
population genetical parameter estimation from sequencing data. Bioinformatics, 27(21), 
2987-2993. doi:10.1093/bioinformatics/btr509 
Li, X., Timofeeva, M., Spiliopoulou, A., McKeigue, P. M., He, Y., ZHANG, X., . . . Theodoratou, E. (2019). 
Prediction of Colorectal Cancer Risk Based on Profiling with Common Genetic Variants. 
medRxiv, 19010116. doi:10.1101/19010116 
115 
 
Li, Z., Yu, D., Gan, M., Shan, Q., Yin, X., Tang, S., . . . Zhang, D. (2015). A genome-wide assessment of 
rare copy number variants in colorectal cancer. Oncotarget, 6(28), 26411-26423. 
doi:10.18632/oncotarget.4621 
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., . . . Hemminki, K. 
(2000). Environmental and Heritable Factors in the Causation of Cancer — Analyses of 
Cohorts of Twins from Sweden, Denmark, and Finland. New England Journal of Medicine, 
343(2), 78-85. doi:10.1056/nejm200007133430201 
Lin, J. S., Piper, M. A., Perdue, L. A., Rutter, C. M., Webber, E. M., O’Connor, E., . . . Whitlock, E. P. 
(2016). Screening for Colorectal Cancer. JAMA, 315(23), 2576. doi:10.1001/jama.2016.3332 
Linck, E., & Battey, C. J. (2019). Minor allele frequency thresholds strongly affect population 
structure inference with genomic data sets. Molecular Ecology Resources, 19(3), 639-647. 
doi:10.1111/1755-0998.12995 
Liu, Q., Cirulli, E. T., Han, Y., Yao, S., Liu, S., & Zhu, Q. (2015). Systematic assessment of imputation 
performance using the 1000 Genomes reference panels. Briefings in Bioinformatics, 16(4), 
549-562. doi:10.1093/bib/bbu035 
Liu, T., Song, X., Khan, S., Li, Y., Guo, Z., Li, C., . . . Cao, H. (2019). The gut microbiota at the 
intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing. 
International Journal of Cancer. doi:10.1002/ijc.32563 
Liu, Y.-J., Papasian, C. J., Liu, J.-F., Hamilton, J., & Deng, H.-W. (2008). Is Replication the Gold Standard 
for Validating Genome-Wide Association Findings? PLoS ONE, 3(12), e4037. 
doi:10.1371/journal.pone.0004037 
Louis, P., Hold, G. L., & Flint, H. J. (2014). The gut microbiota, bacterial metabolites and colorectal 
cancer. Nature Reviews Microbiology, 12(10), 661-672. doi:10.1038/nrmicro3344 
Louppe, G., Wehenkel, L., Sutera, A., & Geurts, P. (2013). Understanding variable importances in 
forests of randomized trees. Paper presented at the Advances in Neural Information 
Processing Systems 26 (NIPS 2013). 
Lundberg, S. M., Erion, G., Chen, H., Degrave, A., Prutkin, J. M., Nair, B., . . . Lee, S.-I. (2020). From 
local explanations to global understanding with explainable AI for trees. Nature Machine 
Intelligence, 2(1), 56-67. doi:10.1038/s42256-019-0138-9 
Ma, S., & Shi, G. (2020). On rare variants in principal component analysis of population stratification. 
BMC Genetics, 21(1). doi:10.1186/s12863-020-0833-x 
Madia, F., Worth, A., Whelan, M., & Corvi, R. (2019). Carcinogenicity assessment: Addressing the 
challenges of cancer and chemicals in the environment. Environment international, 128, 417-
429. doi:10.1016/j.envint.2019.04.067 
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., . . . Mangelsdorf, D. J. 
(2002). Vitamin D receptor as an intestinal bile acid sensor. Science, 296(5571), 1313-1316. 
Retrieved from 10.1126/science.1070477 
116 
 
Manichaikul, A., Mychaleckyj, J. C., Rich, S. S., Daly, K., Sale, M., & Chen, W.-M. (2010). Robust 
relationship inference in genome-wide association studies. Bioinformatics, 26(22), 2867-
2873. doi:10.1093/bioinformatics/btq559 
Marchini, J., & Howie, B. (2010). Genotype imputation for genome-wide association studies. Nature 
Reviews Genetics, 11(7), 499-511. doi:10.1038/nrg2796 
Marigorta, U. M., Rodríguez, J. A., Gibson, G., & Navarro, A. (2018). Replicability and Prediction: 
Lessons and Challenges from GWAS. Trends in Genetics, 34(7), 504-517. 
doi:10.1016/j.tig.2018.03.005 
Mármol, I., Sánchez-De-Diego, C., Pradilla Dieste, A., Cerrada, E., & Rodriguez Yoldi, M. (2017). 
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer. 
International Journal of Molecular Sciences, 18(1), 197. doi:10.3390/ijms18010197 
Mavaddat, N., Michailidou, K., Dennis, J., Lush, M., Fachal, L., Lee, A., . . . Easton, D. F. (2019). 
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. The 
American Journal of Human Genetics, 104(1), 21-34. 
doi:https://doi.org/10.1016/j.ajhg.2018.11.002 
Meng, Y. A., Yu, Y., Cupples, L. A., Farrer, L. A., & Lunetta, K. L. (2009). Performance of random forest 
when SNPs are in linkage disequilibrium. 10(1), 78. doi:10.1186/1471-2105-10-78 
Menter, D. G., Davis, J. S., Broom, B. M., Overman, M. J., Morris, J., & Kopetz, S. (2019). Back to the 
Colorectal Cancer Consensus Molecular Subtype Future. Current gastroenterology reports, 
21(2), 5-5. doi:10.1007/s11894-019-0674-9 
Milligan, G. W., & Cooper, M. C. (1985). An examination of procedures for determining the number 
of clusters in a data set. Psychometrika, 50(2), 159-179. doi:10.1007/bf02294245 
Ministry of Health. (2019). Mortality 2016 data tables. Ministry of Health Retrieved from 
https://www.health.govt.nz/publication/mortality-2016-data-tables 
Ministry of Health. (2021). National Bowel Screening Programme. Retrieved from 
https://www.health.govt.nz/our-work/preventative-health-wellness/screening/national-
bowel-screening-programme 
Moons, K. G. M., Altman, D. G., Reitsma, J. B., Ioannidis, J. P. A., Macaskill, P., Steyerberg, E. W., . . . 
Collins, G. S. (2015). Transparent Reporting of a multivariable prediction model for Individual 
Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration. Annals of Internal Medicine, 
162(1), W1. doi:10.7326/m14-0698 
Moore, J. H., & Williams, S. M. (2005). Traversing the conceptual divide between biological and 
statistical epistasis: systems biology and a more modern synthesis. 27(6), 637-646. 
doi:10.1002/bies.20236 
Naber, S. K., Kundu, S., Kuntz, K. M., Dotson, W. D., Williams, M. S., Zauber, A. G., . . . Lansdorp-
Vogelaar, I. (2019). Cost-effectiveness of risk-stratified colorectal cancer screening based on 




Nartowt, B. J., Hart, G. R., Roffman, D. A., Llor, X., Ali, I., Muhammad, W., . . . Deng, J. (2019). Scoring 
colorectal cancer risk with an artificial neural network based on self-reportable personal 
health data. PLoS ONE, 14(8), e0221421. doi:10.1371/journal.pone.0221421 
Niel, C., Sinoquet, C., Dina, C., & Rocheleau, G. (2015). A survey about methods dedicated to 
epistasis detection. Frontiers in Genetics, 6. doi:10.3389/fgene.2015.00285 
Nougayrède, J.-P., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., . . . Oswald, E. 
(2006). Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells. Science, 
313(5788), 848-851. Retrieved from www.jstor.org/stable/3846936 
O'Keefe, S. J. D. (2016). Diet, microorganisms and their metabolites, and colon cancer. Nature 
reviews. Gastroenterology & hepatology, 13(12), 691-706. doi:10.1038/nrgastro.2016.165 
Oddone, E. (2014). Occupational exposures and colorectal cancers: A quantitative overview of 
epidemiological evidence. World Journal of Gastroenterology, 20(35), 12431. 
doi:10.3748/wjg.v20.i35.12431 
Olson, R. S., Cava, W. L., Mustahsan, Z., Varik, A., & Moore, J. H. (2018). Data-driven advice for 
applying machine learning to bioinformatics problems. Pacific Symposium on Biocomputing. 
Pacific Symposium on Biocomputing, 23, 192-203. Retrieved from 
https://pubmed.ncbi.nlm.nih.gov/29218881 
Ostaff, M. J., Stange, E. F., & Wehkamp, J. (2013). Antimicrobial peptides and gut microbiota in 
homeostasis and pathology. EMBO Molecular Medicine, 5(10), 1465-1483. 
doi:10.1002/emmm.201201773 
Parrish, P. C. R., Thomas, J. D., Kamlapurkar, S., Gabel, A., Bradley, R. K., & Berger, A. H. (2020). 
Discovery of synthetic lethal and tumor suppressive paralog pairs in the human genome. Cold 
Spring Harbor Laboratory.  Retrieved from https://dx.doi.org/10.1101/2020.12.20.423710 
Patterson, N., Price, A. L., & Reich, D. (2006). Population Structure and Eigenanalysis. PLOS Genetics, 
2(12), e190. doi:10.1371/journal.pgen.0020190 
Pavlou, M., Ambler, G., Seaman, S., Maria, & Omar, R. Z. (2015). Review and evaluation of penalised 
regression methods for risk prediction in low-dimensional data with few events. Statistics in 
Medicine, 1159–1177. doi:10.1002/sim.6782 
Peng, L., Balavarca, Y., Weigl, K., Hoffmeister, M., & Brenner, H. (2019). Head-to-Head Comparison 
of the Performance of 17 Risk Models for Predicting Presence of Advanced Neoplasms in 
Colorectal Cancer Screening. The American journal of gastroenterology, 114(9), 1520-1530. 
doi:10.14309/ajg.0000000000000370 
Peng, Q., Lin, K., Chang, T., Zou, L., Xing, P., Shen, Y., & Zhu, Y. (2018). Identification of genomic 
expression differences between right-sided and left-sided colon cancer based on 
bioinformatics analysis. OncoTargets and Therapy, 11, 609-618. doi:10.2147/OTT.S154207 
Peters, U., Jiao, S., Schumacher, F. R., Hutter, C. M., Aragaki, A. K., Baron, J. A., . . . Hsu, L. (2013). 
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-
analysis. Gastroenterology, 144(4), 799-807.e724. doi:10.1053/j.gastro.2012.12.020 
118 
 
Pickrell, J., Clerget-Darpoux, F., & Bourgain, C. (2007). Power of genome-wide association studies in 
the presence of interacting loci. 31(7), 748-762. doi:10.1002/gepi.20238 
Pino, M. S., & Chung, D. C. (2010). The Chromosomal Instability Pathway in Colon Cancer. 
Gastroenterology, 138(6), 2059-2072. doi:10.1053/j.gastro.2009.12.065 
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006). 
Principal components analysis corrects for stratification in genome-wide association studies. 
Nature Genetics, 38(8), 904-909. doi:10.1038/ng1847 
Price, A. L., Zaitlen, N. A., Reich, D., & Patterson, N. (2010). New approaches to population 
stratification in genome-wide association studies. Nature Reviews Genetics, 11(7), 459-463. 
doi:10.1038/nrg2813 
Privé, F., Luu, K., Blum, M. G. B., McGrath, J. J., & Vilhjálmsson, B. J. (2020). Efficient toolkit 
implementing best practices for principal component analysis of population genetic data. 
Bioinformatics, 36(16), 4449-4457. doi:10.1093/bioinformatics/btaa520 
Purcell, R. V., Pearson, J., Aitchison, A., Dixon, L., Frizelle, F. A., & Keenan, J. I. (2017). Colonization 
with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia. 
12(2), e0171602. doi:10.1371/journal.pone.0171602 
Purcell, S., Cherny, S. S., & Sham, P. C. (2003). Genetic Power Calculator: design of linkage and 
association genetic mapping studies of complex traits. Bioinformatics, 19(1), 149-150. 
doi:10.1093/bioinformatics/19.1.149 
Reich, D. E., Cargill, M., Bolk, S., Ireland, J., Sabeti, P. C., Richter, D. J., . . . Lander, E. S. (2001). Linkage 
disequilibrium in the human genome. Nature, 411(6834), 199-204. doi:10.1038/35075590 
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006). Bile salt biotransformations by human intestinal 
bacteria. Journal of Lipid Research, 47(2), 241-259. doi:10.1194/jlr.r500013-jlr200 
Ridlon, J. M., Kang, D. J., Hylemon, P. B., & Bajaj, J. S. (2014). Bile acids and the gut microbiome. 
Current opinion in gastroenterology, 30(3), 332-338. doi:10.1097/MOG.0000000000000057 
Ried, T., Meijer, G. A., Harrison, D. J., Grech, G., Franch-Expósito, S., Briffa, R., . . . Camps, J. (2019). 
The landscape of genomic copy number alterations in colorectal cancer and their 
consequences on gene expression levels and disease outcome. Molecular Aspects of 
Medicine, 69, 48-61. doi:10.1016/j.mam.2019.07.007 
Rimm, E. B., Giovannucci, E. L., Stampfer, M. J., Colditz, G. A., Litin, L. B., & Willett, W. C. (1992). 
Reproducibility and Validity of an Expanded Self-Administered Semiquantitative Food 
Frequency Questionnaire among Male Health Professionals. American Journal of 
Epidemiology, 135(10), 1114-1126. doi:10.1093/oxfordjournals.aje.a116211 
Ripley, W. N. V. a. B. D. (2002). Modern Applied Statistics with S (Fourth ed.). New York: Springer. 
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011). pROC: an 
open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics, 
12(1), 77. doi:10.1186/1471-2105-12-77 
119 
 
Rodriguez, M. Z., Comin, C. H., Casanova, D., Bruno, O. M., Amancio, D. R., Costa, L. D. F., & 
Rodrigues, F. A. (2019). Clustering algorithms: A comparative approach. PLoS ONE, 14(1), 
e0210236. doi:10.1371/journal.pone.0210236 
Rousseeuw, P. J. (1987). Silhouettes: A graphical aid to the interpretation and validation of cluster 
analysis. Journal of Computational and Applied Mathematics, 20, 53-65. doi:10.1016/0377-
0427(87)90125-7 
Rubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013). Fusobacterium nucleatum 
Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its 
FadA Adhesin. Cell Host & Microbe, 14(2), 195-206. doi:10.1016/j.chom.2013.07.012 
Scrucca, L., Fop, M., Murphy, T. B., & Raftery, A. E. (2016). mclust 5: Clustering, Classification and 
Density Estimation Using Gaussian Finite Mixture Models. The R journal, 8(1), 289-317. 
Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096736/ 
Sears, C. L., Geis, A. L., & Housseau, F. (2014). Bacteroides fragilis subverts mucosal biology: from 
symbiont to colon carcinogenesis. Journal of Clinical Investigation, 124(10), 4166-4172. 
doi:10.1172/jci72334 
Secher, T., Samba-Louaka, A., Oswald, E., & Nougayrède, J.-P. (2013). Escherichia coli Producing 
Colibactin Triggers Premature and Transmissible Senescence in Mammalian Cells. PLoS ONE, 
8(10), e77157. doi:10.1371/journal.pone.0077157 
Sharples, K., Firth, M., Hinder, V., Hill, A., Jeffery, M., Sarfati, D., . . . Findlay, M. (2018). The New 
Zealand PIPER Project: colorectal cancer survival according to rurality, ethnicity and 
socioeconomic deprivation—results from a retrospective cohort study New Zealand Medical 
Journal, 131(1476), 24-39. doi:https://www.nzma.org.nz/journal-articles/the-new-zealand-
piper-project-colorectal-cancer-survival-according-to-rurality-ethnicity-and-socioeconomic-
deprivation-results-from-a-retrospective-cohort-study#tabs-menu 
Shen, R., Olshen, A. B., & Ladanyi, M. (2009). Integrative clustering of multiple genomic data types 
using a joint latent variable model with application to breast and lung cancer subtype 
analysis. Bioinformatics, 25(22), 2906-2912. doi:10.1093/bioinformatics/btp543 
Shestak, A. G., Bukaeva, A. A., Saber, S., & Zaklyazminskaya, E. V. (2021). Allelic Dropout Is a Common 
Phenomenon That Reduces the Diagnostic Yield of PCR-Based Sequencing of Targeted Gene 
Panels. Frontiers in Genetics, 12, 620337-620337. doi:10.3389/fgene.2021.620337 
Shi, Z., Yu, H., Wu, Y., Lin, X., Bao, Q., Jia, H., . . . Xu, J. (2019). Systematic evaluation of cancer‐specific 
genetic risk score for 11 types of cancer in The Cancer Genome Atlas and Electronic Medical 
Records and Genomics cohorts. Cancer Medicine. doi:10.1002/cam4.2143 
Shussman, N., & Wexner, S. D. (2014). Colorectal polyps and polyposis syndromes. Gastroenterology 
Report, 2(1), 1-15. doi:10.1093/gastro/got041 
Steinley, D., & Brusco, M. J. (2007). Initializing K-means Batch Clustering: A Critical Evaluation of 




Stevens, A. J., Taylor, M. G., Pearce, F. G., & Kennedy, M. A. (2017). Allelic Dropout During 
Polymerase Chain Reaction due to G-Quadruplex Structures and DNA Methylation Is 
Widespread at Imprinted Human Loci. G3&amp;#58; Genes|Genomes|Genetics, 7(3), 1019-
1025. doi:10.1534/g3.116.038687 
Strobl, C., Boulesteix, A.-L., Kneib, T., Augustin, T., & Zeileis, A. (2008). Conditional variable 
importance for random forests. BMC Bioinformatics, 9(1), 307. doi:10.1186/1471-2105-9-
307 
Strobl, C., Boulesteix, A.-L., Zeileis, A., & Hothorn, T. (2007). Bias in random forest variable 
importance measures: Illustrations, sources and a solution. BMC Bioinformatics, 8(1), 25. 
doi:10.1186/1471-2105-8-25 
Sundquist, K., Sundquist, J., & Ji, J. (2015). Contribution of shared environmental factors to familial 
aggregation of common cancers: an adoption study in Sweden. Eur J Cancer Prev, 24(2), 162-
164. doi:10.1097/cej.0000000000000101 
Sundrani, S., & Lu, J. (2021). Computing the Hazard Ratios Associated With Explanatory Variables 
Using Machine Learning Models of Survival Data. JCO Clinical Cancer Informatics(5), 364-378. 
doi:10.1200/cci.20.00172 
Tam, V., Patel, N., Turcotte, M., Bossé, Y., Paré, G., & Meyre, D. (2019). Benefits and limitations of 
genome-wide association studies. Nature Reviews Genetics, 20(8), 467-484. 
doi:10.1038/s41576-019-0127-1 
Tasa, T., Puustusmaa, M., Tonisson, N., Kolk, B., & Padrik, P. (2020). Precision Colorectal Cancer 
Screening with Polygenic Risk Score. medRxiv, 2020.2008.2019.20177931. 
doi:10.1101/2020.08.19.20177931 
Tenesa, A., & Dunlop, M. G. (2009). New insights into the aetiology of colorectal cancer from 
genome-wide association studies. Nat Rev Genet, 10(6), 353-358. doi:10.1038/nrg2574 
The 1000 Genomes Project Consortium. (2015). A global reference for human genetic variation. 
Nature, 526(7571), 68-74. doi:10.1038/nature15393 
The Women’s Health Initiative Study Group. (1998). Design of the Women's Health Initiative clinical 
trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials, 
19(1), 61-109. doi:10.1016/s0197-2456(97)00078-0 
Thomas, M., Sakoda, L. C., Hoffmeister, M., Rosenthal, E. A., Lee, J. K., van Duijnhoven, F. J. B., . . . 
Hsu, L. (2020). Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk. The 
American Journal of Human Genetics, 107(3), 432-444. doi:10.1016/j.ajhg.2020.07.006 
Tibshirani, R., & Walther, G. (2005). Cluster Validation by Prediction Strength. Journal of 
Computational and Graphical Statistics, 14(3), 511-528. doi:10.1198/106186005x59243 
Tibshirani, R., Walther, G., & Hastie, T. (2001). Estimating the number of clusters in a data set via 
the gap statistic. Journal of the Royal Statistical Society: Series B (Statistical Methodology), 
63(2), 411-423. doi:10.1111/1467-9868.00293 
121 
 
Tomaz, R. A., Cavaco, B. M., & Leite, V. (2010). Differential methylation as a cause of allele dropout 
at the imprinted GNAS locus. Genet Test Mol Biomarkers, 14(4), 455-460. 
doi:10.1089/gtmb.2010.0029 
Turner, S. D. (2018). qqman: an R package for visualizing GWAS results using Q-Q and manhattan 
plots. Journal of Open Source Software, 3(25), 731. doi:10.21105/joss.00731 
Ueki, M., & Cordell, H. J. (2012). Improved Statistics for Genome-Wide Interaction Analysis. PLOS 
Genetics, 8(4), e1002625. doi:10.1371/journal.pgen.1002625 
Ultsch, A., & Lötsch, J. (2017). Machine-learned cluster identification in high-dimensional data. 
Journal of Biomedical Informatics, 66, 95-104. doi:10.1016/j.jbi.2016.12.011 
van den Bosch, T., Warps, A.-L. K., de Nerée Tot Babberich, M. P. M., Stamm, C., Geerts, B. F., 
Vermeulen, L., . . . Dutch ColoRectal, A. (2021). Predictors of 30-Day Mortality Among Dutch 
Patients Undergoing Colorectal Cancer Surgery, 2011-2016. JAMA network open, 4(4), 
e217737-e217737. doi:10.1001/jamanetworkopen.2021.7737 
Van Der Ploeg, T., Austin, P. C., & Steyerberg, E. W. (2014). Modern modelling techniques are data 
hungry: a simulation study for predicting dichotomous endpoints. BMC Medical Research 
Methodology, 14(1), 137. doi:10.1186/1471-2288-14-137 
Van Smeden, M., Moons, K. G., De Groot, J. A., Collins, G. S., Altman, D. G., Eijkemans, M. J., & 
Reitsma, J. B. (2019). Sample size for binary logistic prediction models: Beyond events per 
variable criteria. Statistical Methods in Medical Research, 28(8), 2455-2474. 
doi:10.1177/0962280218784726 
Vatcheva, K. P., Lee, M., McCormick, J. B., & Rahbar, M. H. (2016). Multicollinearity in Regression 
Analyses Conducted in Epidemiologic Studies. Epidemiology (Sunnyvale, Calif.), 6(2), 227. 
doi:10.4172/2161-1165.1000227 
Vervier, K., & Michaelson, J. J. (2016). SLINGER: large-scale learning for predicting gene expression. 
Scientific Reports, 6(1), 39360. doi:10.1038/srep39360 
Vilar, E., & Gruber, S. B. (2010). Microsatellite instability in colorectal cancer—the stable evidence. 
Nature Reviews Clinical Oncology, 7(3), 153-162. doi:10.1038/nrclinonc.2009.237 
Visscher, P. M., Wray, N. R., Zhang, Q., Sklar, P., McCarthy, M. I., Brown, M. A., & Yang, J. (2017). 10 
Years of GWAS Discovery: Biology, Function, and Translation. The American Journal of 
Human Genetics, 101(1), 5-22. doi:10.1016/j.ajhg.2017.06.005 
Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., . . . Zhao, L. (2012). Structural segregation of 
gut microbiota between colorectal cancer patients and healthy volunteers. The ISME Journal, 
6(2), 320-329. doi:10.1038/ismej.2011.109 
Ward, K. J., Ellard, S., Yajnik, C. S., Frayling, T. M., Hattersley, A. T., Venigalla, P. N., & Chandak, G. R. 
(2006). Allelic drop-out may occur with a primer binding site polymorphism for the 
commonly used RFLP assay for the -1131T>C polymorphism of the Apolipoprotein AV gene. 
Lipids in Health and Disease, 5(1), 11. doi:10.1186/1476-511x-5-11 
122 
 
Wei, E. K., Colditz, G. A., Giovannucci, E. L., Wu, K., Glynn, R. J., Fuchs, C. S., . . . Rosner, B. (2017). A 
Comprehensive Model of Colorectal Cancer by Risk Factor Status and Subsite Using Data 
From the Nurses’ Health Study. American Journal of Epidemiology. doi:10.1093/aje/kww183 
Weigl, K., Chang-Claude, J., Knebel, P., Hsu, L., Hoffmeister, M., & Brenner, H. (2018). Strongly 
enhanced colorectal cancer risk stratification by combining family history and genetic risk 
score. Clinical Epidemiology, Volume 10, 143-152. doi:10.2147/clep.s145636 
Weigl, K., Thomsen, H., Balavarca, Y., Hellwege, J. N., Shrubsole, M. J., & Brenner, H. (2018). Genetic 
Risk Score Is Associated With Prevalence of Advanced Neoplasms in a Colorectal Cancer 
Screening Population. Gastroenterology, 155(1), 88-98.e10. 
doi:10.1053/j.gastro.2018.03.030 
Wild, C. P., Weiderpass, E., & Stewart, B. W. (Eds.). (2020). World Cancer Report: Cancer Research 
for Cancer Prevention. Lyon, France: International Agency for Research on Cancer. 
Wong, J. J. L., Hawkins, N. J., & Ward, R. L. (2007). Colorectal cancer: a model for epigenetic 
tumorigenesis. Gut, 56(1), 140-148. doi:10.1136/gut.2005.088799 
Wright, M. N., Ziegler, A., & König, I. R. (2016). Do little interactions get lost in dark random forests? 
BMC Bioinformatics, 17(1). doi:10.1186/s12859-016-0995-8 
Xu, R., & Wunsch, D. C. (2010). Clustering Algorithms in Biomedical Research: A Review. IEEE Reviews 
in Biomedical Engineering, 3, 120-154. doi:10.1109/rbme.2010.2083647 
Xue, J.-H., & Titterington, D. M. (2008). Do unbalanced data have a negative effect on LDA? Pattern 
Recognition, 41(5), 1558-1571. doi:10.1016/j.patcog.2007.11.008 
Yang, J., Zaitlen, N. A., Goddard, M. E., Visscher, P. M., & Price, A. L. (2014). Advantages and pitfalls 
in the application of mixed-model association methods. Nature Genetics, 46(2), 100-106. 
doi:10.1038/ng.2876 
Yang, T., Li, X., Montazeri, Z., Little, J., Farrington, S. M., Ioannidis, J. P. A., . . . Theodoratou, E. (2019). 
Gene–environment interactions and colorectal cancer risk: An umbrella review of systematic 
reviews and meta‐analyses of observational studies. International Journal of Cancer, 145(9), 
2315-2329. doi:10.1002/ijc.32057 
Yu, M., Hazelton, W. D., Luebeck, G. E., & Grady, W. M. (2020). Epigenetic Aging: More Than Just a 
Clock When It Comes to Cancer. Cancer Research, 80(3), 367-374. doi:10.1158/0008-
5472.CAN-19-0924 
Zaidi, A. A., & Mathieson, I. (2020). Demographic history mediates the effect of stratification on 
polygenic scores. eLife, 9. doi:10.7554/elife.61548 
Zhang, D., Dey, R., & Lee, S. (2020). Fast and robust ancestry prediction using principal component 
analysis. Bioinformatics, 36(11), 3439-3446. doi:10.1093/bioinformatics/btaa152 
Zhang, H., Ahearn, T. U., Lecarpentier, J., Barnes, D., Beesley, J., Qi, G., . . . García-Closas, M. (2020). 
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from 
123 
 
overall and subtype-specific analyses. Nature Genetics, 52(6), 572-581. doi:10.1038/s41588-
020-0609-2 
Zhao, H., Mitra, N., Kanetsky, P. A., Nathanson, K. L., & Rebbeck, T. R. (2018). A practical approach 
to adjusting for population stratification in genome-wide association studies: principal 
components and propensity scores (PCAPS). Statistical applications in genetics and 
molecular biology, 17(6), /j/sagmb.2018.2017.issue-2016/sagmb-2017-0054/sagmb-2017-
0054.xml. doi:10.1515/sagmb-2017-0054 
Zhou, Q., Chen, W., Song, S., Gardner, J. R., Weinberger, K. Q., & Chen, Y. (2015). A Reduction of the 
Elastic Net to Support Vector Machines with an Application to GPU Computing. 
Zhu, T., Gao, Y., Wang, J., Li, X., Shang, S., Wang, Y., . . . Ning, S. (2019). CancerClock: A DNA 
Methylation Age Predictor to Identify and Characterize Aging Clock in Pan-Cancer. Frontiers 
in bioengineering and biotechnology, 7, 388-388. doi:10.3389/fbioe.2019.00388 
Zuk, O., Hechter, E., Sunyaev, S. R., & Lander, E. S. (2012). The mystery of missing heritability: 
Genetic interactions create phantom heritability. Proceedings of the National Academy of 
Sciences, 109(4), 1193-1198. doi:10.1073/pnas.1119675109 
 
